<!DOCTYPE html><html lang="en"><head><script src="https://cdnjs.cloudflare.com/ajax/libs/js-polyfills/0.1.42/polyfill.min.js"></script><link href="https://www.hindawi.com/static/themes/hindawi/base.css" rel="stylesheet"/><meta charSet="utf-8" class="next-head"/><meta name="viewport" content="width=device-width, initial-scale=1" class="next-head"/><title class="next-head">Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells</title><link rel="canonical" href="https://www.hindawi.com/journals/bmri/2013/210604/" class="next-head"/><link rel="shortcut icon" type="image/x-icon" href="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico" class="next-head"/><meta name="title" content="Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"/><meta rel="canonical" href="https://www.hindawi.com/journals/bmri/2013/210604/"/><meta name="description" content="Although previous studies have shown that mollugin, a bioactive phytochemical isolated from &lt;i&gt;Rubia cordifolia&lt;/i&gt; L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G&lt;sub&gt;1&lt;/sub&gt; phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B and NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2&amp;#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B."/><meta property="og:url" content="https://www.hindawi.com/journals/bmri/2013/210604/"/><meta property="og:type" content="website"/><meta property="og:image" content="https://images.hindawi.com/journals/bmri/bmri.banner.jpg"/><meta property="og:image:type" content="image/jpeg"/><meta property="og:image:width" content="600"/><meta property="og:image:height" content="315"/><meta property="og:title" content="Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"/><meta name="twitter:site" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:image" content="https://images.hindawi.com/journals/bmri/bmri.banner.jpg"/><meta name="twitter:title" content="Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"/><meta property="og:description" content="Although previous studies have shown that mollugin, a bioactive phytochemical isolated from &lt;i&gt;Rubia cordifolia&lt;/i&gt; L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G&lt;sub&gt;1&lt;/sub&gt; phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B and NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2&amp;#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B."/><meta name="twitter:description" content="Although previous studies have shown that mollugin, a bioactive phytochemical isolated from &lt;i&gt;Rubia cordifolia&lt;/i&gt; L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G&lt;sub&gt;1&lt;/sub&gt; phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B and NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2&amp;#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B."/><meta name="citation_title" content="Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"/><meta name="citation_author" content="Lee, Young-Man"/><meta name="citation_author" content="Auh, Q-Schick"/><meta name="citation_author" content="Lee, Deok-Won"/><meta name="citation_author" content="Kim, Jun-Yeol"/><meta name="citation_author" content="Jung, Ha-Jin"/><meta name="citation_author" content="Lee, Seung-Ho"/><meta name="citation_author" content="Kim, Eun-Cheol"/><meta name="citation_journal_title" content="BioMed Research International"/><meta name="citation_publisher" content="Hindawi"/><meta name="citation_volume" content="2013"/><meta name="citation_year" content="2013"/><meta name="citation_date" content="2013/05/02"/><meta name="citation_online_date" content="2013/05/02"/><meta name="citation_doi" content="https://doi.org/10.1155/2013/210604"/><meta name="citation_issn" content="2314-6133"/><meta name="citation_abstract" content="Although previous studies have shown that mollugin, a bioactive phytochemical isolated from &lt;i&gt;Rubia cordifolia&lt;/i&gt; L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G&lt;sub&gt;1&lt;/sub&gt; phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B and NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2&amp;#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B."/><meta name="citation_fulltext_html_url" content="https://www.hindawi.com/journals/bmri/2013/210604/"/><meta name="citation_pdf_url" content="https://downloads.hindawi.com/journals/bmri/2013/210604.pdf"/><meta name="citation_xml_url" content="https://downloads.hindawi.com/journals/bmri/2013/210604.xml"/><meta name="dc.creator" content="Lee, Young-Man"/><meta name="dc.creator" content="Auh, Q-Schick"/><meta name="dc.creator" content="Lee, Deok-Won"/><meta name="dc.creator" content="Kim, Jun-Yeol"/><meta name="dc.creator" content="Jung, Ha-Jin"/><meta name="dc.creator" content="Lee, Seung-Ho"/><meta name="dc.creator" content="Kim, Eun-Cheol"/><meta name="dc.title" content="Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"/><meta name="dc.description" content="Although previous studies have shown that mollugin, a bioactive phytochemical isolated from &lt;i&gt;Rubia cordifolia&lt;/i&gt; L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G&lt;sub&gt;1&lt;/sub&gt; phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B and NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2&amp;#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-&lt;i&gt;&amp;#x3ba;&lt;/i&gt;B."/><meta name="dc.publisher" content="Hindawi"/><meta name="dc.format" content="text/html"/><meta name="dc.language" content="en"/><meta name="dc.identifier" content="https://doi.org/10.1155/2013/210604"/><meta name="dc.type" content="Research Article"/><meta name="dc.date" content="2013/05/02"/><meta name="dcterms.issued" content="2013/05/02"/><meta name="prism.publicationDate" content="2013/05/02"/><meta name="prism.volume" content="2013"/><meta name="prism.section" content="Research Article"/><meta name="prism.doi" content="https://doi.org/10.1155/2013/210604"/><meta name="prism.issn" content="2314-6133"/><meta name="dc.source" content="BioMed Research International"/><meta name="prism.publicationName" content="BioMed Research International"/><meta name="authors" content="Young-Man Lee | Q-Schick Auh | ... | Eun-Cheol Kim"/><meta name="Author" content="Hindawi"/><meta name="robots" content="index"/><meta name="google-site-verification" content="AxEuDsL7vXGOxRe53-uFhOk2ODN0bbXMeuBy6Pfq4ww"/><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="fbafd62a-0a4e-4f7b-a04d-56f57fa3d716"></script><link href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/basictable.css" rel="stylesheet" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.carousel.min.css" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.theme.default.min.css" media="none" class="next-head"/><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/jquery.js" class="next-head"></script><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><script class="next-head">
        (function(w,d,s,l,i){w[l]=w[l]||[];
            w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js', });
            var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
            j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl
            ;
            f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-MQ4MGW');</script><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" as="script"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/common.19957fe3.chunk.css"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js.bf2397b9.chunk.css"/><style data-styled="NQpXC gnduKR jzXSTA bNmdOy epRoim bUhGXt gjctdt jGJLow kAzjOl ivbKJD fopjOz hbVEoI khbeDd gvAGTV kNoiZu diutvq bqeMOy bMdQcY ldSkVQ cmzomn fJLQxX kuxTps prcY bJcSpM elhyhe fTkdCR jCfZqq EwsTm mkXor dULvrJ dfaOeH jOLhQl TsaZF iiusBg cqhPZs gaRePw dEfJbW eBepOs fSPaCp bVEEaH etauus ctePXh gCIfTO OGgkt dUABlg jUTgTa eujois cQgXqt ewCAZX kdvWPs hAFFGk lkWWFY ehYbwJ legory epgILe kCfRMJ bjwAQR byflLi jXeALb UVThf dDyxFF fkVFlF dzZrgS jLUVhb dVCLgr bBmZJZ ewHMLz bbzREB jknsZc eSvjPB jntdRu iySbrx bCmGAV TdHTO bmMPie dZxdlg HfnFT fexZtq eGVCps mBGSe bkiEfx ztvYg cUsFHx duuwge lcOiDF gsmOCv kPshFw kRoxOt jZOxOO eHMFfo XkrFe irNWJI dMuGGA kfDwZY evMkvU fYrLtk fjviok hgKieC cIribm khHUcu exFqMv dbAANp eyHfWh cBTaXT becpDt kbSZJl jzTMLK gbrQxi hRnXob hymroZ cbcyj hmDWcT isgRZA ihmyEq itFKcQ cGuwDn jrsDZP gWTCXQ jGPvPL etzuBr gWgCNb WHkfb ibWUzs kdRRST cHatnS kxdGAZ jHPgUP fXBKFa hNPrIr bnbfTS cYsVdk inBNwS dkutRV hlGpbO filPdg ecHxGW gCiATD eEFYIL dsXEHZ iXKuYd" data-styled-version="4.4.1">
/* sc-component-id: sc-bdVaJa */
.EwsTm{height:200vh;width:100%;position:fixed;z-index:1;background:rgba(255,255,255,0.8);} .EwsTm.isHide{display:none;} @media (min-width:768px) and (max-width:991px){} @media (min-width:992px){.EwsTm{display:none;}}
/* sc-component-id: sc-htpNat */
.bUhGXt{color:black;-webkit-text-decoration:none;text-decoration:none;border-radius:5px;font-size:16px;} .bUhGXt:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-bxivhb */
.ivbKJD{display:inline-block;}
/* sc-component-id: sc-ifAKCX */
.fopjOz{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;padding:0;} .fopjOz li{padding:0 10px;} .fopjOz li a{padding:0;} .fopjOz a{-webkit-transition:border .25s ease-in-out 0s;transition:border .25s ease-in-out 0s;border-bottom:2px solid #fff;border-radius:0;} .fopjOz a:hover{border-bottom:2px solid #9b9b9b;padding-bottom:4px;} .fopjOz .active{border-bottom:2px solid #57a61e;}
/* sc-component-id: sc-EHOje */
.jOLhQl{vertical-align:middle;height:24px;}.TsaZF{vertical-align:middle;height:40px;}.iiusBg{vertical-align:middle;height:16px;}
/* sc-component-id: sc-bZQynM */
.bNmdOy{max-width:1440px;margin:0 auto;width:100%;}
/* sc-component-id: sc-htoDjs */
.khbeDd{vertical-align:middle;font-size:24px;}.gvAGTV{vertical-align:middle;font-size:9px;}.kNoiZu{vertical-align:middle;font-size:16px;}.diutvq{vertical-align:middle;font-size:22px;}.bqeMOy{vertical-align:middle;font-size:20px;}.bMdQcY{vertical-align:middle;font-size:11px;}
/* sc-component-id: sc-fjdhpX */
.jzXSTA{position:fixed;top:0;left:0;right:0;z-index:1000;background:#fff;height:70px;font-size:16px;font-weight:500;border-bottom:1px solid #e3e3e3;-webkit-transition:all 0.5s;transition:all 0.5s;} @media (max-width:991px){.jzXSTA{border-bottom:1px solid #e3e3e3;}} @media (max-width:767px){.jzXSTA{margin-bottom:70px;height:60px;}} .jzXSTA .header__padding{padding:0 20px;box-sizing:border-box;} @media (max-width:991px){.jzXSTA .header__padding{padding:0 0 0 20px;}} .jzXSTA .menu{position:fixed;top:60px;right:0;width:100%;background:white;} @media (max-width:991px){.jzXSTA .menu{z-index:2;}} @media (min-width:768px){.jzXSTA .menu{width:500px;top:70px;}} @media (min-width:991.5px){.jzXSTA .menu{display:none;}} .jzXSTA .menu ul{list-style-type:none;text-align:center;padding:0;margin:0;} @media (min-width:768px){.jzXSTA .menu ul{padding:0;border-left:1px solid #e3e3e3;}} .jzXSTA .menu ul li a{color:#4a4a4a;padding:10px;-webkit-text-decoration:none;text-decoration:none;display:block;border-bottom:1px solid #e3e3e3;} .jzXSTA .menu .button_wrap{width:90%;margin:10px auto;border-radius:5px;border-style:solid;border-width:1px;} @media (min-width:768px){.jzXSTA .menu .button_wrap{display:none;}} .jzXSTA .menu .button__publishing{background-color:#6ba439;color:#fff;border-color:#6ba439;} .jzXSTA .menu .button__login{display:none;background-color:#fff;color:#4D8A17;border-color:#e3e3e3;} .jzXSTA.headerUp{-webkit-transform:translateY(-100%);-ms-transform:translateY(-100%);transform:translateY(-100%);}
/* sc-component-id: sc-jzJRlG */
.jGJLow{-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .jGJLow a{padding:10px;} .jGJLow nav{-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} @media (max-width:991px){.jGJLow nav{display:none;}} .jGJLow nav ul{margin-right:16px;} .jGJLow nav ul li a{color:#4a4a4a;padding:10px 0px 4px;margin:0 6px;} @media (max-width:991px){.jGJLow .icon-themeable{border-left:1px solid #e3e3e3;padding:23px 20px;}} @media (max-width:767px){.jGJLow .icon-themeable{padding:18px 20px;}} @media (max-width:767.5px){.jGJLow.mobileButtonFlex{-ms-flex:0 0 51%;-webkit-flex:0 0 51%;-ms-flex:0 0 51%;flex:0 0 51%;max-width:51%;}}
/* sc-component-id: sc-cSHVUG */
.ldSkVQ{display:none;padding:0;background-color:#fff;border:none;height:59px;} @media (min-width:768px){.ldSkVQ{height:69px;}} .ldSkVQ img{box-sizing:content-box;width:28px;padding:17px 20px;} @media (min-width:768px){.ldSkVQ img{padding:22px 20px;}} @media (max-width:991px){.ldSkVQ{display:inline-block;}}
/* sc-component-id: sc-kAzzGY */
.epRoim a{display:inline-block;padding:15px 0;} @media (max-width:767px){.epRoim a{padding:10px 0;}} @media (max-width:767.5px){.epRoim.mobileLogoFlex{-ms-flex:0 0 49%;-webkit-flex:0 0 49%;-ms-flex:0 0 49%;flex:0 0 49%;max-width:49%;}}
/* sc-component-id: sc-chPdSV */
.hbVEoI{border:none;height:50px;background-color:#fff;margin:10px 0 0 17px;position:relative;} @media (max-width:991.5px){.hbVEoI{margin:0 3px 0 16px;padding:0;height:69px;}} @media (max-width:767.5px){.hbVEoI{height:59px;}} .hbVEoI img{box-sizing:content-box;} .hbVEoI .icon__cross{width:24px;height:24px;} @media (min-width:768px){.hbVEoI .icon__cross{padding:23px 20px;}} @media (min-width:992px){.hbVEoI .icon__cross{padding:0px;}}
/* sc-component-id: sc-ckVGcZ */
.gjctdt{vertical-align:middle;height:39px;} @media (max-width:401px){.gjctdt{max-width:100%;}}
/* sc-component-id: sc-jKJlTe */
.inBNwS{background-color:#0d2934;font-size:16px;position:relative;z-index:3;} @media (max-width:991px){.inBNwS{z-index:0;}}
/* sc-component-id: sc-eNQAEJ */
.dkutRV{border-bottom :1px solid;border-color:#828282;padding:29px 40px 30px 40px;} @media (min-width:992px){.dkutRV{padding:40px 40px 40px 35px;}} .dkutRV .primary__footer .mobile{display:block;} .dkutRV .primary__footer .desktop{display:none;} @media (min-width:992px){.dkutRV .primary__footer{-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;}.dkutRV .primary__footer .mobile{display:none;}.dkutRV .primary__footer .desktop{display:block;}} @media (min-width:992px){.dkutRV .col5{-webkit-flex:0 0 18%;-ms-flex:0 0 18%;flex:0 0 18%;max-width:18%;}} .dkutRV address{font-style:inherit;line-height:1.5;font-size:16px;display:none;border-right:1px solid #EBEBEB;} @media (max-width:767px){.dkutRV address{border-bottom:1px solid #E3E3E3;padding-bottom:20px;}} @media (min-width:992px){.dkutRV address{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;margin-right:50px;}} @media (min-width:1200px){.dkutRV address{margin-right:70px;}} .dkutRV address p{margin:0;font-size:14px;} @media (max-width:767px){.dkutRV address p{text-align:center;}} @media (min-width:1200px){.dkutRV address p{font-size:16px;}} .dkutRV nav ul{list-style:none;padding:0;line-height:2;font-size:16px;margin:18px 0 0 0;} .dkutRV nav ul:first-child{margin:0;} @media (min-width:992px){.dkutRV nav ul{margin:0;}} .dkutRV nav ul li{line-height:22px;padding:5px;} .dkutRV nav ul li a{color:#d8d8d8;font-weight:500;display:block;font-size:16px;} .dkutRV nav ul li img{padding:2.5px 0 0 10px;box-sizing:content-box;-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-hMqMXs */
.hlGpbO{padding-top:6px;color:#FFFFFF;font-weight:500;margin-bottom:29px;} @media (min-width:992px){.hlGpbO{-webkit-flex:0 0 25%;-ms-flex:0 0 25%;flex:0 0 25%;max-width:-webkit-fit-content;max-width:-moz-fit-content;max-width:fit-content;}}
/* sc-component-id: sc-kEYyzF */
.ecHxGW{margin-right:20px;} .ecHxGW:last-child{margin-right:0;}
/* sc-component-id: sc-kkGfuU */
.filPdg{margin-top:15px;}
/* sc-component-id: sc-iAyFgw */
.gCiATD{line-height:30px;font-size:11px;padding:10px 20px;text-align:center;} .gCiATD .textright{text-align:right;font-weight:500;} @media (max-width:767px){.gCiATD .textright{text-align:center;}} @media (min-width:992px){.gCiATD .textright{font-weight:100;}} .gCiATD a{font-size:13px;color:#fff;}
/* sc-component-id: sc-hSdWYo */
.etauus{display:inline-block;background-color:#fff;color:#4D8A17;border-color:#E3E3E3;width:auto;border-radius:5px;font-size:16px;border-width:1px;border-style:solid;} .etauus:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-eHgmQL */
.fTkdCR{font-size:22px;color:#000;} @media (min-width:767.5px){.fTkdCR{font-size:24px;}} @media (min-width:991.5px){.fTkdCR{font-size:25px;}} .fTkdCR:after{content:'';display:inline-block;margin-top:0.2em;margin-left:0.5em;}
/* sc-component-id: sc-iRbamj */
.jZOxOO{font-size:30px;font-weight:500;-webkit-letter-spacing:1px;-moz-letter-spacing:1px;-ms-letter-spacing:1px;letter-spacing:1px;line-height:1;margin-top:0;} @media (min-width:767.5px){.jZOxOO{font-size:40px;}} @media (min-width:991.5px){.jZOxOO{font-size:40px;}} .jZOxOO sup,.jZOxOO sub{vertical-align:baseline;position:relative;top:-10px;} .jZOxOO sub{top:10px;}
/* sc-component-id: sc-Rmtcm */
.hNPrIr{font-size:20px;font-weight:500;margin-top:0;margin-bottom:15px;}
/* sc-component-id: sc-bRBYWo */
.fXBKFa{display:inline-block;} @media (max-width:991.5px){.fXBKFa{width:100%;}} @media (min-width:991.5px){.fXBKFa.hide{display:none !important;}}
/* sc-component-id: sc-hzDkRC */
.bnbfTS{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;width:100%;padding:0 !important;border-top:1px solid #fff;} .bnbfTS li{width:100%;text-align:center;box-sizing:border-box;padding:17px 0px;min-height:48px;} .bnbfTS li a{display:block;} .bnbfTS .iconBorder{border-right:1px solid #fff;} .bnbfTS img{width:23px;} .bnbfTS img.socialLinkedin{width:28px;} .bnbfTS .wechat-container{position:relative;} .bnbfTS .wechat-container .addthis_inline_share_toolbox{position:absolute;top:0;left:0;width:100%;height:100%;opacity:0 !important;}
/* sc-component-id: sc-jtRfpW */
.OGgkt{background-color:#6BA439;color:#fff;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #fff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .OGgkt img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.OGgkt span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.OGgkt span.text{padding-left:20px;}}.dUABlg{background-color:#F2F2F2;color:#4A4A4A;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #E3E3E3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .dUABlg img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.dUABlg span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.dUABlg span.text{padding-left:20px;}}
/* sc-component-id: sc-kTUwUJ */
.eujois{width:20px;}
/* sc-component-id: sc-dqBHgY */
.cQgXqt{width:20px;height:16px;color:#6ba439;}
/* sc-component-id: sc-cbkKFq */
.kuxTps{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;position:fixed;top:60px;} @media (min-width:767.5px){.kuxTps{position:fixed;top:70px;}} @media (min-width:991.5px){.kuxTps{position:fixed;top:70px;}}.prcY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;top:0px;} @media (min-width:767.5px){.prcY{top:0px;}} @media (min-width:991.5px){.prcY{position:fixed;top:241px;}}
/* sc-component-id: sc-hGoxap */
.dEfJbW{position:relative;background:#007d8d;} @media (max-width:991px){.dEfJbW{z-index:2;}} @media (min-width:767.5px) and (max-width:991.5px){.dEfJbW{width:50%;}} @media (min-width:991.5px){.dEfJbW{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;border-top:1px solid white;}} .dEfJbW.isHide{display:none;} @media (min-width:991.5px){.dEfJbW.isHide{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .dEfJbW .submit__button{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;box-shadow:0 2px 4px rgba(0,0,0,.5);padding:0 20px;min-height:45px;} .dEfJbW .submit__button span.text{font-size:16px;} .dEfJbW .submit__button img{width:20px;} @media (min-width:767.5px){.dEfJbW .submit__button{min-height:58px;}.dEfJbW .submit__button img{width:22px;}} @media (min-width:991.5px){.dEfJbW .submit__button{display:none;}}
/* sc-component-id: sc-fjmCvl */
.fSPaCp{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.fSPaCp{padding:16px 20px;}} @media (min-width:991.5px){.fSPaCp{border-top:none;border-right:1px solid #fff;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.fSPaCp{padding:14.5px 20px;font-size:16px;}} .fSPaCp .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .fSPaCp.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.fSPaCp.button__active{border-right:1px solid #007f8f;}} .fSPaCp .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .fSPaCp .icon__hidden{display:none;}.bVEEaH{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.bVEEaH{padding:16px 20px;}} @media (min-width:991.5px){.bVEEaH{border-top:none;border-right:0;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.bVEEaH{padding:14.5px 20px;font-size:16px;}} .bVEEaH .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .bVEEaH.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.bVEEaH.button__active{border-right:1px solid #007f8f;}} .bVEEaH .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .bVEEaH .icon__hidden{display:none;}
/* sc-component-id: sc-TFwJa */
.gCIfTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:767.5px){.gCIfTO{padding:16px 20px;}} @media (min-width:991.5px){.gCIfTO{-webkit-transition:all 0.25s;transition:all 0.25s;border-top:none;border-right:1px solid #fff;border-left:0;padding:14.5px 30px 14.5px 20px;width:calc(100% / 6);font-size:14px;}.gCIfTO:hover{background:#fff;color:#4A4A4A;}} @media (min-width:1200px){.gCIfTO{font-size:16px;}}
/* sc-component-id: sc-bHwgHz */
.ctePXh{width:18px;margin-right:-4px;} @media (min-width:991.5px){.ctePXh{width:7px;font-size:7px;}} @media (min-width:1200px){.ctePXh{width:18px;}}
/* sc-component-id: sc-krDsej */
.ewCAZX{position:absolute;top:0;width:calc(100% - 20px);right:0;bottom:0;background:#fff;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;min-height:290px;box-shadow:0 2px 4px rgba(0,0,0,0.5);} .ewCAZX.hide__submenu{-webkit-transform:translateX(100%);-ms-transform:translateX(100%);transform:translateX(100%);} @media (min-width:767.5px){.ewCAZX.hide__submenu{-webkit-transform:translateX(-200%);-ms-transform:translateX(-200%);transform:translateX(-200%);}} @media (min-width:767.5px){.ewCAZX{left:100%;width:100%;padding-top:20px;z-index:-1;min-height:375px;}} @media (min-width:991.5px){.ewCAZX{display:none;}}
/* sc-component-id: sc-dTdPqK */
.lkWWFY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;display:none;} @media (min-width:991.5px){.lkWWFY.hide__submenu{-webkit-transform:translateY(-300%);-ms-transform:translateY(-300%);transform:translateY(-300%);}} @media (min-width:991.5px){.lkWWFY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:186px;top:49px;left:0;position:absolute;right:0;background:#fff;z-index:-1;box-shadow:0 4px 6px rgba(0,0,0,0.21);}}
/* sc-component-id: sc-itybZL */
.kdvWPs{font-weight:700;border:0;color:#4A4A4A;padding:10px 0;background-color:#fff;font-size:16px;line-height:20px;} .kdvWPs:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;} @media (min-width:767.5px){.kdvWPs{display:none;}}
/* sc-component-id: sc-fzsDOv */
.hAFFGk{margin:0px 10px 2px 20px;-webkit-transform:rotate(90deg);-ms-transform:rotate(90deg);transform:rotate(90deg);display:inline-block;}
/* sc-component-id: sc-gPWkxV */
.legory{width:50%;}
/* sc-component-id: sc-jVODtj */
.epgILe{color:#007B8B;width:50%;font-size:16px;line-height:26px;margin:auto;padding:0 6%;}
/* sc-component-id: sc-kUaPvJ */
.ehYbwJ{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:50%;padding:24.5px 2% 0;-webkit-order:0;-ms-flex-order:0;order:0;} @media (min-width:1024px){.ehYbwJ{padding:24.5px 3% 0;}}
/* sc-component-id: sc-giadOv */
.eBepOs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} @media (min-width:991.5px){.eBepOs{width:calc(100% / 6);}.eBepOs:first-child{border-left:none;}}
/* sc-component-id: sc-fONwsr */
.kCfRMJ{background-color:#D8D8D8;position:absolute;left:50%;display:inline-block;height:121px;width:2px;top:33px;}
/* sc-component-id: sc-LKuAh */
.lcOiDF{padding:0;margin:10px 0 25px 0;}
/* sc-component-id: sc-iBEsjs */
.kPshFw{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kPshFw:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kPshFw{margin-top:10px;}}
/* sc-component-id: sc-hzNEM */
.gsmOCv{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;background-color:#F2F2F2;padding:0 16px;} .gsmOCv.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .gsmOCv p{font-size:14px;line-height:22px;} .gsmOCv sup{margin-top:-5px;}
/* sc-component-id: sc-chbbiW */
.mBGSe{padding:0;}
/* sc-component-id: sc-kZmsYB */
.bkiEfx{font-size:14px;font-weight:700;line-height:16px;-webkit-letter-spacing:0.58px;-moz-letter-spacing:0.58px;-ms-letter-spacing:0.58px;letter-spacing:0.58px;margin:23px 0 0px !important;} @media (min-width:767.5px){.bkiEfx{margin:34px 0 0px !important;}} @media (min-width:991.5px){.bkiEfx{margin:-4px 0 0 !important;}}
/* sc-component-id: sc-RcBXQ */
.ztvYg{font-size:14px;line-height:22px;} .ztvYg a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .ztvYg a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-iSDuPN */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Bold.otf');font-weight:normal;font-style:normal;} .kRoxOt{font-weight:700;font-family:STIXGeneral-Bold;margin:19px 0 22px;font-size:25px;line-height:28px;-webkit-letter-spacing:normal;-moz-letter-spacing:normal;-ms-letter-spacing:normal;letter-spacing:normal;} @media (min-width:767.5px){.kRoxOt{font-size:25px;margin:20px 0 23px;}} @media (min-width:991.5px){.kRoxOt{font-size:30px;line-height:34px;margin:19px 0 22px;}} .kRoxOt p{margin:0;}
/* sc-component-id: sc-fZwumE */
.cUsFHx{padding:0 3px;}
/* sc-component-id: sc-fQejPQ */
.duuwge{font-size:14px;} .duuwge:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-jtRlXQ */
@font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} .exFqMv{font-family:STIXGeneral-Regular;text-align:justify;} .exFqMv a{word-break:break-all;} .exFqMv h4:first-of-type{border-top:0px solid #E3E3E3;padding-top:0;} .exFqMv h4{font-size:20px;font-family:"IBM Plex Sans",sans-serif;border-top:1px solid #E3E3E3;padding-top:23px;margin-top:15px;margin-bottom:-3px;} .exFqMv h4#abstract{margin-top:-7px;margin-bottom:-3px;} @media (min-width:767.5){.exFqMv h4#abstract{margin-top:-6px;}} @media (min-width:991.5px){.exFqMv h4#abstract{margin-top:34px;}} .exFqMv h4.references,.exFqMv h4.copyright{border-top:1px solid #E3E3E3;padding-top:23px;} .exFqMv h4.references{margin-bottom:-8px;} .exFqMv h5,.exFqMv h6{margin:22px 0;font-size:16px;word-break:break-word;} .exFqMv h6{margin:25px 0;text-align:left;} .exFqMv p{font-size:16px;word-break:break-word;} .exFqMv .floats-partial-section{border:1px solid #E3E3E3;margin:25px auto;} @media (max-width:767px){.exFqMv .floats-partial-section{margin:0 auto;overflow-x:hidden;}} .exFqMv .floats-partial-section .floats-partial-content{padding:19px 0px 19px 0px;height:254px;width:96%;overflow:hidden;margin:0 auto;position:relative;cursor:pointer;} .exFqMv .floats-partial-section .floats-partial-content table{margin:0 auto;} .exFqMv .floats-partial-section .floats-partial-content .table-group{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table object{z-index:-1;position:relative;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td{padding:4px 7px;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_left{text-align:left;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_center{text-align:center;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-content{padding:22px 0px 0 0px;height:197px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-content{padding:23px 0px 13px 0px;height:215px;}} .exFqMv .floats-partial-section .floats-partial-content:after{content:"";height:20%;position:absolute;bottom:0;right:0;left:0;background:-moz-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-webkit-gradient(linear,left top,right top,color-stop(0%,rgba(255,255,255,.7)),color-stop(56%,rgba(255,255,255,.7)),color-stop(100%,rgba(255,255,255,.7)));background:-webkit-linear-gradient(rgba(255,255,255,0) 0%,rgba(255,255,255,0.5) 30%,rgba(255,255,255,0.7) 56%,rgba(255,255,255,0.9) 75%,rgba(255,255,255,1) 100%);background:-o-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-ms-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);-webkit-filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );} .exFqMv .floats-partial-section .floats-partial-footer{background-color:#F2F2F2;border-top:1px solid #E3E3E3;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB3aWR0aD0iMTZweCIgaGVpZ2h0PSIycHgiIHZpZXdCb3g9IjAgMCAxNiAyIiB2ZXJzaW9uPSIxLjEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiPgogICAgPCEtLSBHZW5lcmF0b3I6IFNrZXRjaCA1My4yICg3MjY0MykgLSBodHRwczovL3NrZXRjaGFwcC5jb20gLS0+CiAgICA8dGl0bGU+SWNvbnMvQ2xvc2UgTWVudSAtPC90aXRsZT4KICAgIDxkZXNjPkNyZWF0ZWQgd2l0aCBTa2V0Y2guPC9kZXNjPgogICAgPGRlZnM+CiAgICAgICAgPHBhdGggZD0iTTUsMTMgTDE5LDEzIEMxOS41NTIyODQ3LDEzIDIwLDEyLjU1MjI4NDcgMjAsMTIgQzIwLDExLjQ0NzcxNTMgMTkuNTUyMjg0NywxMSAxOSwxMSBMNSwxMSBDNC40NDc3MTUyNSwxMSA0LDExLjQ0NzcxNTMgNCwxMiBDNCwxMi41NTIyODQ3IDQuNDQ3NzE1MjUsMTMgNSwxMyBaIiBpZD0icGF0aC0xIj48L3BhdGg+CiAgICA8L2RlZnM+CiAgICA8ZyBpZD0iUGFnZS0xIiBzdHJva2U9Im5vbmUiIHN0cm9rZS13aWR0aD0iMSIgZmlsbD0ibm9uZSIgZmlsbC1ydWxlPSJldmVub2RkIj4KICAgICAgICA8ZyBpZD0iQXJ0aWNsZS0tLU1vYmlsZS0tLUFsZ29yaXRobSIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTIwLjAwMDAwMCwgLTU0MS4wMDAwMDApIj4KICAgICAgICAgICAgPGcgaWQ9Ikdyb3VwIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwLjAwMDAwMCwgMjU3LjAwMDAwMCkiPgogICAgICAgICAgICAgICAgPGcgaWQ9Ikdyb3VwLTkiPgogICAgICAgICAgICAgICAgICAgIDxnIGlkPSJHcm91cC04IiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgwLjAwMDAwMCwgMjUyLjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iR3JvdXAtNyIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMC4wMDAwMDAsIDIuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iSWNvbnMvQ2xvc2UtTWVudS0tIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgxMy4wMDAwMDAsIDE2LjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJtaW51cyIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMy4wMDAwMDAsIDMuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxtYXNrIGlkPSJtYXNrLTIiIGZpbGw9IndoaXRlIj4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDx1c2UgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDwvbWFzaz4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgPHVzZSBpZD0iU2hhcGUiIGZpbGw9IiMwMDAwMDAiIGZpbGwtcnVsZT0ibm9uemVybyIgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJDT0xPUi8tUHJpbWFyeS1HcmVlbiIgbWFzaz0idXJsKCNtYXNrLTIpIiBmaWxsPSIjNkJBNDM5IiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgPHJlY3QgaWQ9IlJlY3RhbmdsZSIgeD0iMCIgeT0iMCIgd2lkdGg9IjI0IiBoZWlnaHQ9IjI0Ij48L3JlY3Q+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDwvZz4KICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgICAgIDwvZz4KICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgIDwvZz4KICAgICAgICA8L2c+CiAgICA8L2c+Cjwvc3ZnPg==') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;display:none;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{-webkit-flex:9;-ms-flex:9;flex:9;text-align:left;padding:21px 37px 10px 0px;font-size:16px;font-weight:700;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 18px 10px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 21px 10px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;padding:16px 0 16px 0;min-width:62px;max-width:62px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:16px 0 17px 0;min-width:52px;max-width:52px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:15px 0 17px 0;min-width:60px;max-width:60px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url:hover{-webkit-text-decoration:none;text-decoration:none;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{font-size:14px;padding:0px 18px 17px 22px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 15px 15px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 18px 19px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text figcaption{margin:0;padding:0;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text svg{max-width:100%;} .exFqMv ol{font-size:16px;padding-left:32px;font-family:STIXGeneral-Regular;line-height:24px;margin:15px 0;} .exFqMv ol li{margin:10px 0;padding-left:10px;word-break:normal;} .exFqMv ol li a{word-break:break-all;} .exFqMv ol li .reflinks{display:block;} .exFqMv ol li .reflinks a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .exFqMv ol li .reflinks a:hover{-webkit-text-decoration:underline;text-decoration:underline;} .exFqMv ol li .reflinks .sep{color:#000000;} .exFqMv .table-wrapper{width:auto;overflow-x:auto;} .exFqMv .table-wrapper::-webkit-scrollbar{-webkit-appearance:none;width:5px;height:5px;} .exFqMv .table-wrapper::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(0,0,0,.5);-webkit-box-shadow:0 0 1px rgba(255,255,255,.5);} @media (min-width:768px){.exFqMv .table-wrapper{overflow-x:auto;width:auto;-webkit-break-word:word-break;break-word:word-break;margin:0 auto;}} @media (min-width:992px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:1324px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:320px){.exFqMv{margin-bottom:33px;padding:0;}} @media (min-width:992px){.exFqMv{padding:0;margin-bottom:100px;}} @media (min-width:1325px){.exFqMv{margin-bottom:100px;}} .exFqMv .owl-stage{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot svg{fill:#4D8A17;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot strong{color:#4D8A17;font-weight:500;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active strong{color:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active svg{fill:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot .nowrap{white-space:nowrap;} .exFqMv .partial-carousel-dot{text-align:center;cursor:pointer;border:0;width:100px;padding-bottom:20px;background-color:#fff;display:table-cell;} .exFqMv .partial-carousel-dot:focus-visible{outline-offset:-3px;} .exFqMv .partial-carousel-dot strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel-dot strong{font-size:16px;}} .exFqMv .partial-carousel-dot img{width:90px;height:90px;border:1px solid #979797;margin:10px 0;} .exFqMv .partial-carousel-wrapper .floats-partial-middle{border-top:1px solid #e3e3e3;display:block;margin-bottom:50px;padding-top:1px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-bottom:0;}} .exFqMv .partial-carousel--single-image{overflow:hidden;text-align:center;} .exFqMv .partial-carousel--single-image img{width:100%;max-height:239px;height:auto;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image img{max-height:357px;}} @media (min-width:991.5px){.exFqMv .partial-carousel--single-image img{max-height:417px;}} .exFqMv .partial-carousel--single-image strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image strong{font-size:16px;}} .exFqMv .owl-nav,.exFqMv .owl-dots{display:none;} .exFqMv .partial-carousel-wrapper .owl-loaded{position:relative;height:auto;max-height:287px;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:287px;height:auto;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content::after,.exFqMv .owl-stage-outer::after,.exFqMv .owl-stage::after{background:transparent;} .exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:100%;overflow-x:auto;-webkit-align-items:self-start;-webkit-box-align:self-start;-ms-flex-align:self-start;align-items:self-start;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:calc(100% - 110px);}} .exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:100%;position:relative;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:20%;}} .exFqMv .floats-partial-middle{position:relative;} .exFqMv .partial-carousel-wrapper .carousel-prev{background:url('data:image/svg+xml;base64,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') no-repeat 17.5px;height:50px;width:61px;display:inline-block;border:0;border-right:1px solid #E3E3E3;padding:0;cursor:pointer;background-position-y:54.35%;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:51px;background-position-x:8px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:59px;background-position-x:16px;}} .exFqMv .partial-carousel-wrapper .carousel-next{background:url('data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB3aWR0aD0iMTgiIGhlaWdodD0iMTQiIHZpZXdCb3g9IjAgMCAxOCAxNCI+PGRlZnM+PGNsaXBQYXRoIGlkPSJhIj48cGF0aCBkPSJNMTAuMjkzLDEzLjcwN2ExLDEsMCwwLDEsMC0xLjQxNEwxNC41ODYsOEgxQTEsMSwwLDAsMSwxLDZIMTQuNTg2TDEwLjI5MywxLjcwN0ExLDEsMCwwLDEsMTEuNzA3LjI5M2w2LDZhMSwxLDAsMCwxLC4xNzIuMjMxaDBsLjAxLjAxOSwwLC4wMDUuMDA3LjAxNC4wMDYuMDEyLDAsLjAwOC4wMDguMDE4djBhMSwxLDAsMCwxLS4wMDkuODE3bDAsMEwxNy45LDcuNDRsMCwuMDA5LS4wMDUuMDExLS4wMDcuMDEzLDAsLjAwOC0uMDA4LjAxNSwwLC4wMDUtLjAxLjAxNiwwLDAtLjAxMS4wMTcsMCwwLS4wMTIuMDE4LDAsMC0uMDEyLjAxNywwLDBMMTcuOCw3LjZsMCwwLS4wMTEuMDE0LDAsLjAwNi0uMDEuMDEyLS4wMDkuMDExLS4wMDYuMDA3LS4wMTUuMDE3aDBsLS4wNC4wNDItNiw2YTEsMSwwLDAsMS0xLjQxNCwwWiIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMyA1KSIvPjwvY2xpcFBhdGg+PC9kZWZzPjxnIHRyYW5zZm9ybT0idHJhbnNsYXRlKC0zIC01KSI+PHBhdGggZD0iTTEwLjI5MywxMy43MDdhMSwxLDAsMCwxLDAtMS40MTRMMTQuNTg2LDhIMUExLDEsMCwwLDEsMSw2SDE0LjU4NkwxMC4yOTMsMS43MDdBMSwxLDAsMCwxLDExLjcwNy4yOTNsNiw2YTEsMSwwLDAsMSwuMTcyLjIzMWgwbC4wMS4wMTksMCwuMDA1LjAwNy4wMTQuMDA2LjAxMiwwLC4wMDguMDA4LjAxOHYwYTEsMSwwLDAsMS0uMDA5LjgxN2wwLDBMMTcuOSw3LjQ0bDAsLjAwOS0uMDA1LjAxMS0uMDA3LjAxMywwLC4wMDgtLjAwOC4wMTUsMCwuMDA1LS4wMS4wMTYsMCwwLS4wMTEuMDE3LDAsMC0uMDEyLjAxOCwwLDAtLjAxMi4wMTcsMCwwTDE3LjgsNy42bDAsMC0uMDExLjAxNCwwLC4wMDYtLjAxLjAxMi0uMDA5LjAxMS0uMDA2LjAwNy0uMDE1LjAxN2gwbC0uMDQuMDQyLTYsNmExLDEsMCwwLDEtMS40MTQsMFoiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDMgNSkiLz48ZyBjbGlwLXBhdGg9InVybCgjYSkiPjxyZWN0IHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCIgZmlsbD0icmdiYSgwLDAsMCwwKSIvPjxyZWN0IHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCIgZmlsbD0iIzZiYTQzOSIvPjwvZz48L2c+PC9zdmc+') no-repeat 18.5px;height:52px;width:61px;display:inline-block;padding:0px;cursor:pointer;border:0;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:51px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:59px;}} .exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{position:absolute;right:0;bottom:-50px;height:50px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{bottom:0;}} .exFqMv .partial-carousel-wrapper .floats-partial-content{padding:12px;} .exFqMv .partial-carousel-wrapper .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{border-left:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-content{display:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-image:url(https://w2o-xhtml-parsed-preprod.s3-eu-west-1.amazonaws.com/table_thumb.svg);background-repeat:no-repeat;background-position:17px 17px;background-size:100px 70px;border-top:none;min-height:110px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{cursor:pointer;position:absolute;left:17px;top:17px;height:70px;width:100px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding-left:137px;padding-right:0px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{cursor:pointer;position:absolute;top:20px;left:135px;height:20px;width:60px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{color:black;display:block !important;-webkit-text-decoration:none;text-decoration:none;width:auto;margin-left:140px;margin-right:20px;padding:0px 0px 15px 0px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .minimize_btn{display:none !important;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .expand_btn{display:none !important;} @media (max-width:567px){.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-size:60px 45px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{height:45px;width:60px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding:30px 0px 15px 95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{top:30px;left:95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{margin:0px 20px;}} .exFqMv .owl-item{overflow-y:hidden;margin-bottom:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;} .exFqMv .supplementary--docs{display:-ms-flexbox;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;padding-left:2em;} @media (min-width:767.5px){.exFqMv .supplementary--docs{padding-left:1em;}} .exFqMv .supplementary--docs li{-ms-flex:0 0 100%;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;} @media (min-width:991.5px){.exFqMv .supplementary--docs li{-ms-flex:0 0 50%;-webkit-flex:0 0 50%;-ms-flex:0 0 50%;flex:0 0 50%;max-width:50%;}} .exFqMv .supplementary--docs li a::after{content:'';background :url(data:image/svg+xml;base64,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) no-repeat 5px;padding-right:35px;background-size:14px;} .exFqMv .dataset-section .supplementary--dpis-desc{padding-left:19px;} .exFqMv .dataset-section .supplementary--dpis-desc p{margin:10px 0;} .exFqMv .table-group.fixed-width,.exFqMv .table-group.sidewaystable{min-width:auto;} .exFqMv .noliststyle{padding-left:1em;} .exFqMv .noliststyle li{padding-left:0;} .exFqMv .xml-content > hr{display:none;} .exFqMv sup,.exFqMv sub{vertical-align:baseline;position:relative;top:5px;} .exFqMv sup{top:-5px;} @media (min-width:767.5px){.exFqMv a{position:relative;}} .exFqMv a div.tooltip{cursor:auto;position:absolute;width:280px;background:#fff;border:1px solid #adadad;padding:20px;margin:0;display:none;z-index:2;color:#000;} @media (min-width:767.5px){.exFqMv a div.tooltip{width:400px;}} @media (min-width:991.5px){.exFqMv a div.tooltip{width:572px;}} .exFqMv a div.tooltip .cross{position:absolute;right:10px;top:10px;display:block;height:14px;width:14px;cursor:pointer;} .exFqMv a div.tooltip ol{margin:0;padding:0 0 10px 20px;} .exFqMv a div.tooltip ol li{text-align:left;margin:0;} .exFqMv a div.tooltip.left{left:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.left{left:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.left{left:-100px;}} .exFqMv a div.tooltip.right{right:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.right{right:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.right{right:-100px;}} .exFqMv a div.tooltip a.seeRef{padding-left:30px;} .exFqMv .gloss-abbr tr td:first-child{white-space:nowrap;} .exFqMv table.algorithm td{word-break:keep-all;} .exFqMv h4#copyright + p a{word-break:break-word;}
/* sc-component-id: sc-bGbJRg */
.dVCLgr{width:100%;} @media (min-width:991.5px){.dVCLgr{width:19%;}} @media (min-width:1280px){.dVCLgr{width:24%;max-width:350px;}} .dVCLgr p{border:1px solid #E3E3E3;}
/* sc-component-id: sc-bEjcJn */
.jLUVhb{-webkit-flex:1 0 30%;-ms-flex:1 0 30%;flex:1 0 30%;list-style:none;padding:0;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media (min-width:320px) and (max-width:991.5px){.jLUVhb{position:fixed;width:100%;z-index:2;margin:0;margin-top:50px;top:169px;max-height:calc(100vh - 165px);overflow-y:auto;}} @media (min-width:767.5px) and (max-width:991.5px){.jLUVhb{top:179px;}} @media (min-width:991.5px) and (max-width:1200px){.jLUVhb{max-width:354px;-webkit-flex:1 0 20%;-ms-flex:1 0 20%;flex:1 0 20%;}} @media (min-width:1200px){.jLUVhb{-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;max-width:354px;}} .jLUVhb p{margin:0;padding:10px 0;font-size:16px;font-weight:700;line-height:24px;display:none;} @media (min-width:991.5px){.jLUVhb p{display:block;padding:10px 20px;border:1px solid #E3E3E3;border-bottom:0;}} .jLUVhb.links__hidden{display:none;} @media (min-width:991.5px){.jLUVhb.links__hidden{display:block;}} .jLUVhb.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);} @media (min-width:768px){.jLUVhb.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.jLUVhb.translate{-webkit-transform:none;-ms-transform:none;transform:none;}.jLUVhb.translate #leftSectionMenu{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: sc-ePZHVD */
.ewHMLz{color:#4A4A4A;}
/* sc-component-id: sc-likbZx */
.bBmZJZ{font-size:16px;font-weight:500;line-height:20px;color:#4A4A4A;border:1px solid #E3E3E3;border-bottom:0;background-color:#f2f2f2;display:list-item;} @media (min-width:991px){.bBmZJZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.bBmZJZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .bBmZJZ:last-child{border-bottom:1px solid #E3E3E3;} .bBmZJZ a{display:block;padding:10px 20px;}
/* sc-component-id: sc-eKZiaR */
.dzZrgS{position:fixed;width:100%;height:50px;color:#4D8A17;background-color:#F2F2F2;border:none;font-size:16px;line-height:18px;font-weight:500;z-index:2;top:170px;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;text-align:left;border-top:1px solid #FFFFFF;} @media (min-width:320px) and (max-width:991.5px){.dzZrgS{padding-left:15px;border-bottom:4px solid #FFFFFF;}.dzZrgS.is-open{border-bottom:4px solid #F2F2F2;}} @media (min-width:767.5px){.dzZrgS{top:179px;}} @media (min-width:991.5px){.dzZrgS{display:none;}} .dzZrgS .icon__dots{cursor:pointer;-webkit-transform:rotate(90deg) translateY(8px);-ms-transform:rotate(90deg) translateY(8px);transform:rotate(90deg) translateY(8px);margin-right:15px;} @media (min-width:991.5px){.dzZrgS .icon__dots{padding-right:20px;margin-bottom:2px;-webkit-transform:none;-ms-transform:none;transform:none;}} .dzZrgS.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);top:170px;} @media(min-width:991.5px){.dzZrgS.translate{-webkit-transform :translateY(-130px) rotate(90deg);-ms-transform :translateY(-130px) rotate(90deg);transform :translateY(-130px) rotate(90deg);}}
/* sc-component-id: sc-jrIrqw */
.eHMFfo{padding:0;margin:20px 0;} .eHMFfo span{font-size:14px;} .eHMFfo span.isHide{display:none;} .eHMFfo span i{font-style:italic;} .eHMFfo span i.isHide{display:none;}
/* sc-component-id: sc-hjRWVT */
.irNWJI{width:16px;margin:0 2px 2px;}
/* sc-component-id: sc-iQtOjA */
.kfDwZY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kfDwZY:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kfDwZY{margin-top:5px;}}
/* sc-component-id: sc-fHxwqH */
.dMuGGA{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA p:first-child{margin-top:15px;} .dMuGGA p{font-size:14px;line-height:23px;display:block;} .dMuGGA sup{margin-top:-5px;}
/* sc-component-id: sc-cEvuZC */
.XkrFe{border:none;border-top:1px solid #E3E3E3;height:2px;margin:15px 0;} .XkrFe.hr__author{margin-bottom:12px;}
/* sc-component-id: sc-cBdUnI */
@media (min-width:320px) and (max-width:991.5px){.hRnXob{display:none;}} @media (min-width:991.5px){.hRnXob{z-index:1;}}
/* sc-component-id: sc-exkUMo */
.hymroZ{background-color:#6ba339;color:#ffffff;display:none;} .hymroZ span.text{padding-left:20px;} @media (min-width:991px){.hymroZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hymroZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-kcDeIU */
.cbcyj{background-color:#f2f2f2;color:#4a4a4a;display:none;} .cbcyj span.text{padding-left:20px;} @media (min-width:991.5px) and (max-width:1279.5px){.cbcyj{display:none !important;}} @media (min-width:991px){.cbcyj{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.cbcyj:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.cbcyj.hide{display:none !important;}}
/* sc-component-id: sc-BngTV */
.hmDWcT{background-color:#f2f2f2;color:#4a4a4a;display:none;} .hmDWcT span.text{padding-left:20px;} @media (min-width:1279.5px){.hmDWcT{display:none !important;}} @media (min-width:991px){.hmDWcT{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hmDWcT:hover{background-color :#5D9230;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.hmDWcT.hide{display:none !important;}}
/* sc-component-id: sc-hBbWxd */
.kdRRST{background-color:#f2f2f2;border-top:1px solid #ffffff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:14px;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;padding:20px 55px 20px 25px;} @media (max-width:1279.5px){.kdRRST{padding-right:20px;}} @media (max-width:991.5px){.kdRRST{display:none;}}
/* sc-component-id: sc-dyGzUR */
.cHatnS div{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;} .cHatnS div:last-of-type{padding-top:20px;} .cHatnS span{color:#4F4F4F;font-size:20px;font-weight:700;line-height:26px;}
/* sc-component-id: sc-drKuOJ */
.kxdGAZ{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column-reverse;-ms-flex-direction:column-reverse;flex-direction:column-reverse;height:100%;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .kxdGAZ span{padding-top:15px;}
/* sc-component-id: sc-cTjmhe */
@media (min-width:991.5px){.ihmyEq{width:100%;z-index:1;}}
/* sc-component-id: sc-cugefK */
.itFKcQ{background-color:#F2F2F2;color:#4A4A4A;border-top:1px solid #FFFFFF;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:991px){.itFKcQ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.itFKcQ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.itFKcQ.hide{display:none !important;}} .itFKcQ.active .icon-themeable{-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-fnwBNb */
.etzuBr{display:none;}
/* sc-component-id: sc-iNhVCk */
.gWgCNb{background-color:#f2f2f2;border-radius:0;border-top:1px solid #e3e3e3;font-size:16px;color:#4a4a4a;font-weight:500;padding:11px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;} @media (min-width:991px){.gWgCNb{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.gWgCNb:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-eAKXzc */
.WHkfb{-webkit-flex:1 0 90%;-ms-flex:1 0 90%;flex:1 0 90%;padding-left:50px;} @media (min-width:767.5px){.WHkfb{padding-left:93px;}} @media (min-width:991.5px){.WHkfb{padding-left:50px;}}
/* sc-component-id: sc-bfYoXt */
.cGuwDn{width:20px;height:24px;}
/* sc-component-id: sc-gbOuXE */
.jGPvPL{width:22px;height:21px;padding:2px;}
/* sc-component-id: sc-dRFtgE */
.jrsDZP{-webkit-flex:1 0 80%;-ms-flex:1 0 80%;flex:1 0 80%;padding-left:26px;} @media (min-width:767.5px){.jrsDZP{padding-left:69px;}} @media (min-width:991.5px){.jrsDZP{padding-left:20px;}} @media (min-width:991.5px) and (max-width:1279.5px){.jrsDZP{display:none;}}
/* sc-component-id: sc-gkFcWv */
.gWTCXQ{display:none;} @media (min-width:991.5px){.gWTCXQ{padding-left:20px;max-width:100px;display:inline;}} @media (min-width:1279.5px){.gWTCXQ{display:none;}}
/* sc-component-id: sc-hUfwpO */
.jHPgUP{width:100%;border-left:1px solid #f2f2f2;border-right:1px solid #f2f2f2;border-bottom:none;cursor:pointer;} .jHPgUP li{background-color:#f2f2f2;} @media (min-width:991px){.jHPgUP li{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.jHPgUP li:hover{background-color :#ffffff;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .jHPgUP h3{display:none;}
/* sc-component-id: sc-imABML */
.ibWUzs{background-color:#f2f2f2;color:#4a4a4a;display:block;border-top:1px solid #ffffff;border-radius:0;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} .ibWUzs .right__icon{padding:0;height:16px;width:20px;} @media (min-width:991px){.ibWUzs{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.ibWUzs:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.ibWUzs.hide{display:none !important;}}
/* sc-component-id: sc-cjHlYL */
.mkXor{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:25%;float:right;margin-top:-49px;} @media (max-width:374px){.mkXor{width:26.5%;}} @media (min-width:992px){.mkXor{display:none;}}
/* sc-component-id: sc-dRaagA */
.dULvrJ{background-color:#6ba339;color:white;-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;z-index:100;padding:14px 16px 10px 19px;border-radius:0px;border-bottom:1px solid #ffffff;} @media (min-width:320px) and (max-width:767px){.dULvrJ{border-bottom:none;padding:16px 16px 14px 16px;font-size:14px;}.dULvrJ .article_toolbar_icon{display:none;}}
/* sc-component-id: sc-fEUNkw */
.dfaOeH{margin-right:16px;width:24px;height:24px;}
/* sc-component-id: sc-dREXXX */
.cqhPZs{width:16px;height:auto;float:right;} @media (min-width:767.5px){.cqhPZs{width:24px;height:24px;}}
/* sc-component-id: sc-nrwXf */
.byflLi{font-size:14px;padding:16px 20px 24px;} @media (max-width:991px){.byflLi{display:none;}}
/* sc-component-id: sc-eitiEO */
.jXeALb{font-size:14px;} .jXeALb:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-bhlBdH */
.UVThf{font-size:14px;font-weight:bold;}
/* sc-component-id: sc-kDhYZr */
.iySbrx{margin:35px 0 0;display:none;} @media(max-width:767px){.iySbrx.mobile_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.iySbrx.row2{margin:15px 0 0;}} @media(min-width:768px){.iySbrx.desktop_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} @media (min-width:991.5px){.iySbrx{margin:0;}}
/* sc-component-id: sc-sPYgB */
.bCmGAV{width:15px;border-bottom:1px solid #E0E0E0;} @media(max-width:767px){.bCmGAV.row2_edge_left{-webkit-flex-basis:10%;-ms-flex-preferred-size:10%;flex-basis:10%;}.bCmGAV.row2_edge_right{-webkit-flex-basis:30%;-ms-flex-preferred-size:30%;flex-basis:30%;}}
/* sc-component-id: sc-dHIava */
.TdHTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;border-bottom:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4D8A17 !important;} .TdHTO:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.TdHTO{width:215px;}} .TdHTO:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}.bmMPie{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4A4A4A !important;} .bmMPie:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.bmMPie{width:215px;}} .bmMPie:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}
/* sc-component-id: sc-bSbAYC */
.dZxdlg{border-width:1px;border-style:solid;border-color:#C25A4A;background:#F6EAEC;padding:25px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-top:30px;}
/* sc-component-id: sc-guztPN */
.fexZtq{display:block;margin-left:15px;} @media(min-width:768px){.fexZtq{margin-left:30px;}} .fexZtq br{content:"";display:block;margin-bottom:16px;}
/* sc-component-id: sc-cFlXAS */
.HfnFT{font-family:STIXGeneral;font-size:30px;width:37px;height:37px;-webkit-flex:1 0 37px;-ms-flex:1 0 37px;flex:1 0 37px;border-radius:50%;background:#C25A4A;color:#FFFFFF;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-weight:bold;} @media(min-width:768px){.HfnFT{font-size:40px;width:48px;height:48px;-webkit-flex:1 0 48px;-ms-flex:1 0 48px;flex:1 0 48px;}}
/* sc-component-id: sc-OxbzP */
.eEFYIL{width:100%;height:auto;background-color:#4A4A4A;font-family:'IBM Plex Sans',sans-serif;font-size:14px;font-weight:500;color:#fff;padding:15px 20px;line-height:20px;position:fixed;bottom:0px;z-index:3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;-webkit-transition:-webkit-transform .25s;-webkit-transition:transform .25s;transition:transform .25s;} .eEFYIL a{color:#7ED321;} .eEFYIL p{display:inline;margin:0;} .eEFYIL.hideBanner{-webkit-transform:translateY(100%);-ms-transform:translateY(100%);transform:translateY(100%);}
/* sc-component-id: sc-bYnzgO */
.dsXEHZ{background:transparent;border:none;height:20px;width:20px;margin-left:20px;padding:0;cursor:pointer;}
/* sc-component-id: sc-cPuPxo */
.iXKuYd{min-width:20px;height:20px;}
/* sc-component-id: baseContent__Main-sc-134g3di-2 */
.cmzomn{margin-top:140px;} @media (min-width:767.5px){.cmzomn{margin-top:85px;}} @media (min-width:991.5px){.cmzomn{margin-top:70px;min-height:calc(100vh - 334px);}}
/* sc-component-id: threeColumn__ThreeColumnWrapper-sc-1bf4078-0 */
.dDyxFF{width:100%;} @media only screen and (min-width:992px){.dDyxFF{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-flow:row wrap;-ms-flex-flow:row wrap;flex-flow:row wrap;padding:0 20px;max-width:1440px;margin:0 auto;}} @media (min-width:991.5px) and (max-width:1100.5px){.dDyxFF .partenership__collabText{font-size:12px;}} @media (min-width:1100.5px) and (max-width:1200.5px){.dDyxFF .partenership__collabText{font-size:14px;}} @media (min-width:991.5px) and (max-width:1071.5px){.dDyxFF .partenership__logoWrapper img{margin-left:20px;margin-bottom:10px;}.dDyxFF .partenership__logoWrapper img:last-child{margin-left:0;margin-bottom:0;}} @media (max-width:1150px){.dDyxFF .journal-metrics-container{display:none;}.dDyxFF .journal_report_link-border-helper{display:none;}}
/* sc-component-id: threeColumn__LeftWrapper-sc-1bf4078-1 */
@media only screen and (min-width:992px){.fkVFlF{width:20%;}} @media only screen and (min-width:1280px){.fkVFlF{width:25%;}}
/* sc-component-id: threeColumn__RightWrapper-sc-1bf4078-2 */
.jzTMLK{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media only screen and (min-width:992px){.jzTMLK{width:20%;margin-bottom:60px;}.jzTMLK.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media only screen and (min-width:1280px){.jzTMLK{width:25%;}}
/* sc-component-id: threeColumn__ContentWrapper-sc-1bf4078-3 */
.bbzREB{margin:0 20px;overflow:hidden;} @media only screen and (min-width:992px){.bbzREB{width:calc(60% - 40px);}} @media only screen and (min-width:1280px){.bbzREB{width:calc(50% - 40px);}}
/* sc-component-id: threeColumn__Content-sc-1bf4078-4 */
.jknsZc{margin:0 auto;overflow:hidden;} @media only screen and (min-width:768px){.jknsZc{max-width:688px;}} @media only screen and (min-width:992px){.jknsZc{max-width:100%;}} @media only screen and (min-width:1075px){.jknsZc{max-width:572px;}}
/* sc-component-id: article__BaseStyle-sc-10qhnp8-0 */
.gnduKR{width:100%;margin-top:170px;} @media (min-width:767.5px){.gnduKR{margin-top:179px;}} @media (min-width:991.5px){.gnduKR{margin-top:180px;min-height:840px;}}
/* sc-component-id: article__StickyStyle-sc-10qhnp8-1 */
.fJLQxX{width:100%;max-width:1440px;z-index:3;-webkit-transition:all 0.5s;transition:all 0.5s;} .fJLQxX.translate{-webkit-transform:translateY(-120px);-ms-transform:translateY(-120px);transform:translateY(-120px);} @media (min-width:767.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: article__SubtitleStyled-sc-10qhnp8-2 */
.elhyhe{background-color:#007b8b;opacity:0.8;color:#fff;margin-bottom:0;margin-top:0;padding:17px 0 17px 20px;line-height:23px;height:60px;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:20px;font-weight:500;} @media (min-width:767.5px){.elhyhe{line-height:26px;}} @media (min-width:991.5px){.elhyhe{line-height:50px;padding:5px 0 5px 20px;height:60px;}}
/* sc-component-id: article__JournalMenuTitle-sc-10qhnp8-3 */
.jCfZqq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-size:16px;font-weight:500;line-height:20px;height:50px;width:100%;background-color:#007b8b;color:#fff;text-align:left;padding-left:14px;padding-right:0;border:0;border-top:1px solid #fff;} .jCfZqq span{font-size:24px;padding-right:14px;} @media (min-width:991.5px){.jCfZqq{display:none;}}
/* sc-component-id: article__WhiteWrapper-sc-10qhnp8-5 */
.bJcSpM{background-color:#fff;display:block;position:relative;} .bJcSpM h1,.bJcSpM h2{color:#fff;} .bJcSpM h2{font-size:20px;} @media (min-width:767.5px){.bJcSpM h2{font-size:25px;}} .bJcSpM h1{font-size:20px;} @media (min-width:767.5px){.bJcSpM h1{font-size:24px;}} @media (min-width:991.5px){.bJcSpM h1{font-size:40px;}}
/* sc-component-id: articleContent__ArticleContentsWrapper-sc-2yl9jy-0 */
.eSvjPB{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} .eSvjPB .author__editor--hr{display:block;}
/* sc-component-id: articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 */
.jntdRu{width:100%;} @media (max-width:991.5px){.jntdRu{margin-top:52px;}} .jntdRu p{margin:12px 0;line-height:20px;} .jntdRu .articlecontent__alignment{width:100%;min-width:306px;padding-left:7px;padding-right:7px;} @media (min-width:346px){.jntdRu .articlecontent__alignment{padding-left:20px;padding-right:20px;}} @media (min-width:767.5px){.jntdRu .articlecontent__alignment{width:543px;margin:auto;padding-left:0px;padding-right:0px;}} @media (min-width:991.5px){.jntdRu .articlecontent__alignment{max-width:612px;width:75%;margin:inherit;margin-left:50px;padding-left:20px;padding-right:20px;}} @media (min-width:1100px){.jntdRu .articlecontent__alignment{margin-left:118px;}} .jntdRu .article__title{padding-bottom:12px;} @media (min-width:767.5px){.jntdRu .article__title{padding-bottom:15px;}} .jntdRu .article__summary{padding-bottom:65px;} @media (min-width:991.5px){.jntdRu .article__summary{padding-bottom:75px;}} @media (min-width:767.5px){.jntdRu #vjs_video_3 button{-webkit-transform:none;-ms-transform:none;transform:none;left:40%;margin-top:0;}} .jntdRu .video-js .vjs-big-play-button{top:calc(50% - 22.5px);left:calc(50% - 50px);} .jntdRu .video-js{margin:20px 0;} .jntdRu a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .jntdRu a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: articleContent__ArticleWrapper-sc-2yl9jy-2 */
.eGVCps{background-position:0px 0px;background-origin:content-box;background-size:99%;margin-top:50px;}
/* sc-component-id: articleContent__EditorWrapper-sc-2yl9jy-3 */
.evMkvU{padding:0;}
/* sc-component-id: articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 */
.fjviok{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin:15px 0 30px;border-bottom:1px solid #E3E3E3;} @media (min-width:767.5px){.fjviok{border-top:1px solid #E3E3E3;margin:20px 0 30px;}}
/* sc-component-id: articleContent__PublcationCol-sc-2yl9jy-5 */
.hgKieC{-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;max-width:100%;border-right:1px solid #E3E3E3;padding:5px 0 15px;} @media (min-width:767.5px){.hgKieC{padding:5px 0;}} .hgKieC.notPublished{display:none;} @media (min-width:767.5px){.hgKieC.notPublished{display:block;}} @media (max-width:767.5px){.hgKieC.isPublished{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.hgKieC.isPublished span:first-child::after{content:':';padding-right:3px;}} .hgKieC:last-child{border-right:none;}
/* sc-component-id: articleContent__PublicationField-sc-2yl9jy-6 */
.cIribm{display:block;text-align:center;font-size:14px;font-weight:700;}
/* sc-component-id: articleContent__PublicationValue-sc-2yl9jy-7 */
.khHUcu{display:block;text-align:center;font-size:14px;}
/* sc-component-id: articleContent__TextWrapper-sc-2yl9jy-8 */
.fYrLtk{margin:-7px 0 -5px;font-size:14px;}
/* sc-component-id: biblio__Wrapper-sc-1nou1lz-0 */
.eyHfWh{position:relative;} .eyHfWh.hide{display:none;} .eyHfWh hr{position:absolute;left:0;right:0;top:-30px;border-top:1px solid #E3E3E3;border-bottom:0;}.cBTaXT.hide{display:none;} .cBTaXT hr{display:none;}
/* sc-component-id: biblio__BiblioWrapper-sc-1nou1lz-1 */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/_/hindawi-ui/fonts/STIXGeneral-Regular.otf');} .kbSZJl{padding:0 20px 20px;} .kbSZJl .bib__image{display:none;} .kbSZJl .bib__title{font-size:20px;} .kbSZJl .bib__name{font-size:18px;font-family:'STIXGeneral-Bold',serif !important;color:rgb(74,74,74);font-weight:700;} .kbSZJl .bib--split .bib__link .bib__info,.kbSZJl .bib--split .bib__link.bib__link--image .bib__info,.kbSZJl [class*='bib--txt'] .bib__link .bib__info,.kbSZJl [class*='bib--txt'] .bib__link.bib__link--image .bib__info{padding:10px 0 !important;} .kbSZJl .bib__author{font-size:14px;line-height:22px;color:rgb(132,132,132);margin-top:3px;margin-bottom:0px;margin-right:20px;opacity:1;font-family:'IBM Plex Sans',sans-serif;font-weight:500;} .kbSZJl #biblio_sidebar .bib__link{border-top:1px solid rgb(227,227,227) !important;padding-top:5px !important;padding-bottom:5px !important;} .kbSZJl #biblio_sidebar .bib__link:first-child{border-top:0 !important;padding-top:0 !important;} .kbSZJl #biblio_sidebar .bib__link:first-child .bib__info{padding-top:0 !important;} .kbSZJl #biblio_widget .bib--split .bib__link .bib__info,.kbSZJl #biblio_widget .bib--split .bib__link.bib__link--image .bib__info{padding:10px 15px 10px 0 !important;} @media (min-width:767.5px){.kbSZJl{padding:0 40px 20px;}} @media (min-width:991.5px){.kbSZJl{padding:0 20px;}}
/* sc-component-id: biblio__H4-sc-1nou1lz-2 */
.becpDt{font-size:20px;font-family:'IBM Plex Sans';color:#000;font-weight:600;margin-top:34px;margin-bottom:18px;padding:0 20px;}
/* sc-component-id: journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 */
.gbrQxi{display:none;} @media (min-width:991.5px){.gbrQxi{display:block;}.gbrQxi .article_top_toolbar{top:110px;z-index:-100;}.gbrQxi .article_top_toolbar .pdf_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.gbrQxi .article_top_toolbar .ref_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .gbrQxi .article_toolbar_views{margin-top:-58px;display:block;text-align:right;}
/* sc-component-id: journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 */
@media (min-width:991.5px){.isgRZA .article_bottom_toolbar{top:292px;z-index:-10;}}
/* sc-component-id: journal_article__BreadCrumbStyle-sc-12fk6zy-2 */
@media (min-width:991.5px){.bjwAQR{padding:16px 20px 24px;height:60px;}}
/* sc-component-id: journal_article__ArticleBaseStyle-sc-12fk6zy-3 */
.NQpXC .content,.NQpXC .contentWrapper{overflow:visible;}
/* sc-component-id: journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 */
.cYsVdk{max-width:350px;} @media (max-width:991.5px){.cYsVdk{display:none !important;}}
/* sc-component-id: journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 */
.dbAANp{background-color:#f5f5f5;padding:15px 20px 24px 20px;margin-top:2px;margin-bottom:20px;} @media (min-width:991.5px){.dbAANp{margin-top:-64px;margin-bottom:40px;}} .dbAANp .hrTitleRef{padding:0;margin-top:0;font-family:'IBM Plex Sans',sans-serif;} .dbAANp #biblio_widget{padding:0;}</style></head><body style="margin:0;box-sizing:border-box"><div id="__next"><div class="static_page"><div class="page no__focus__outline"><header class="sc-fjdhpX jzXSTA"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd header__padding"><div class="sc-kAzzGY epRoim mobileLogoFlex _1fpqArXPCxgnlv2rXZC2sl _1SoDWGr_FVsil9klRfjnhb"><a class="sc-htpNat bUhGXt link" href="/" aria-label="Home"><img alt="logo" src="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg" class="sc-ckVGcZ gjctdt"/></a></div><div class="sc-jzJRlG jGJLow mobileButtonFlex _2v1j-tLx3hx0tgKcpPzH6B _3wm8FgzqRuRWouJG31YgKx E_HUmlU2Hj3PpkDmWzKPd"><nav class="sc-bxivhb ivbKJD"><ul class="sc-ifAKCX fopjOz sc-kpOJdX kAzjOl"><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/journals/" aria-label="Journals">Journals</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publish-research/" aria-label="Publish with us">Publish with us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publishing-partnerships/" aria-label="Publishing partnerships">Publishing partnerships</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/about/" aria-label="About us">About us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/blog/" aria-label="Blog">Blog</a></li></ul></nav><button class="sc-chPdSV hbVEoI icon__search" aria-label="Search"><span class="sc-htoDjs khbeDd icon__search icon-colored _3hSk3ArgsWMFh5QJIGblNr icon-themeable" title="" font-size="24"></span></button><button aria-label="Hamburger Menu" class="sc-cSHVUG ldSkVQ"><span class="sc-htoDjs khbeDd hamburger icon-colored _20YUA8q5mREEBfJm8VsdXV icon-themeable" title="" font-size="24"></span></button></div></div></header><div class="sc-bZQynM bNmdOy"></div><main class="baseContent__Main-sc-134g3di-2 cmzomn  article__BaseStyle-sc-10qhnp8-0 gnduKR DADtd11SJ4KyWZ2l6zAnr base_style journal_article__ArticleBaseStyle-sc-12fk6zy-3 NQpXC"><div class="sc-bZQynM bNmdOy width_wrapper"><div id="journal__navigation" class="sc-cbkKFq kuxTps article__StickyStyle-sc-10qhnp8-1 fJLQxX"><a class="sc-htpNat bUhGXt link article__WhiteWrapper-sc-10qhnp8-5 bJcSpM" href="/journals/bmri/" aria-label=""><h2 class="sc-eHgmQL fTkdCR article__SubtitleStyled-sc-10qhnp8-2 elhyhe _1ZrXcsbATVL_kHOpFAan9k">BioMed Research International</h2></a><button class="article__JournalMenuTitle-sc-10qhnp8-3 jCfZqq journalNavCheck" id="journalMenuTitle"><span>+</span>Journal Menu</button><div class="sc-bdVaJa EwsTm isHide" id="fadeOut"></div><div class="sc-cjHlYL mkXor"><a class="sc-htpNat bUhGXt link sc-dRaagA dULvrJ article-toolbar-link" href="https://downloads.hindawi.com/journals/bmri/2013/210604.pdf" aria-label="" download=""><img alt=" " class="sc-EHOje jOLhQl sc-fEUNkw dfaOeH article_toolbar_icon" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/>PDF<img alt=" " class="sc-EHOje jOLhQl sc-dREXXX cqhPZs" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><nav id="journal__nav" class="sc-hGoxap dEfJbW article__JournalNavigationStyle-sc-10qhnp8-4 gaRePw isHide journalNavCheck"><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl fSPaCp journalNavCheck" color="">Journal overview<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/bmri/guidelines/" aria-label="For authors">For authors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/reviewers/" aria-label="For reviewers">For reviewers</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/editors/" aria-label="For editors">For editors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/bmri/contents/year/2022/" aria-label="Table of Contents">Table of Contents</a><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl bVEEaH journalNavCheck" color="">Special Issues<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-jtRfpW OGgkt submit__button journalNavCheck" href="https://review.hindawi.com/submit?journal=bmri" aria-label="" target="" id=""><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ jUTgTa" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Submit</span></span><span class="sc-htoDjs kNoiZu sc-dqBHgY cQgXqt fileArrow icon-colored undefined icon-themeable" title="" font-size="16"></span></a><div class="sc-krDsej ewCAZX hide__submenu journalSubmenuCheck" id="journalnav__submenu"><button class="sc-itybZL kdvWPs journalSubmenuCheck"><span class="sc-htoDjs gvAGTV sc-fzsDOv hAFFGk journalSubmenuCheck icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><div class="sc-dTdPqK lkWWFY hide__submenu journal__nav__desktop" id="journalnav__submenudesktop"><div order="0" class="sc-kUaPvJ ehYbwJ"><div class="sc-gPWkxV legory"></div><div class="sc-gPWkxV legory"></div></div><div class="sc-jVODtj epgILe"></div><span class="sc-fONwsr kCfRMJ"></span></div></nav></div><div class="sc-nrwXf byflLi breadcrumb__wrapper journal_article__BreadCrumbStyle-sc-12fk6zy-2 bjwAQR article"><a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/bmri/" aria-label="BioMed Research International">BioMed Research International</a> / <a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/bmri/contents/year/2013/" aria-label="2013">2013</a> / <span class="sc-bhlBdH UVThf">Article</span></div><div class="threeColumn__ThreeColumnWrapper-sc-1bf4078-0 dDyxFF threeColumnWrapper"><div class="threeColumn__LeftWrapper-sc-1bf4078-1 fkVFlF leftWrapper"><button type="button" class="sc-eKZiaR dzZrgS section__button  " id="sectionButton"><span class="sc-htoDjs diutvq icon__dots dots__detector icon-colored _3n-7Ho7DlfjMlZbrRr9Q4a icon-themeable" title="" font-size="22"></span>Article Sections</button><div class="sc-bEjcJn jLUVhb static_contents__section_links
           links__hidden "><div id="leftSectionMenu" class="sc-cbkKFq prcY sc-bGbJRg dVCLgr left_section_menu"><p>On this page</p><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#abstract" aria-label="">Abstract</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#introduction" aria-label="">Introduction</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#materials-and-methods" aria-label="">Materials and Methods</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#results" aria-label="">Results</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#discussion" aria-label="">Discussion</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#acknowledgments" aria-label="">Acknowledgments</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#references" aria-label="">References</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#copyright" aria-label="">Copyright</a></span></div></div></div><div class="threeColumn__ContentWrapper-sc-1bf4078-3 bbzREB contentWrapper"><div class="threeColumn__Content-sc-1bf4078-4 jknsZc content"><div class="articleContent__ArticleContentsWrapper-sc-2yl9jy-0 eSvjPB article_contents"><div class="articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 jntdRu article_contents__sections_wrapper"><div class="sc-kDhYZr iySbrx desktop_tabs"><div class="sc-sPYgB bCmGAV"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO" href="/journals/bmri/2013/210604/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie" href="/journals/bmri/2020/1915927/" aria-label="Retraction">Retraction</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie" href="/journals/bmri/2014/386742/" aria-label="Erratum">Erratum</a><div class="sc-sPYgB bCmGAV"></div></div><div class="sc-kDhYZr iySbrx mobile_tabs row1"><div class="sc-sPYgB bCmGAV row1_edge_left"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO row1_link" href="/journals/bmri/2013/210604/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie row1_link" href="/journals/bmri/2020/1915927/" aria-label="Retraction">Retraction</a><div class="sc-sPYgB bCmGAV row1_edge_right"></div></div><div class="sc-kDhYZr iySbrx mobile_tabs row2"><div class="sc-sPYgB bCmGAV row2_edge_left"></div><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie row2_link" href="/journals/bmri/2014/386742/" aria-label="Erratum">Erratum</a><div class="sc-sPYgB bCmGAV row2_edge_right"></div></div><div class="sc-bSbAYC dZxdlg"><span class="sc-cFlXAS HfnFT">!</span><span class="sc-guztPN fexZtq alert__message">This article has been <b>Retracted</b>. To view the 
  To view the article details, please click the ‘Retraction’ tab above.<br />A <b>Erratum</b> for this article has been published.
  To view the article details, please click the ‘Erratum’ tab above.</span></div><div class="articleContent__ArticleWrapper-sc-2yl9jy-2 eGVCps"><div class="sc-chbbiW mBGSe article_header_class"><p class="sc-kZmsYB bkiEfx article_type">Research Article | <!-- -->Open Access</p><div class="sc-RcBXQ ztvYg article_citation">Volume<!-- --> <!-- -->2013<!-- --> <span class="sc-fZwumE cUsFHx">|</span>Article ID<!-- --> <!-- -->210604<!-- --> <span class="sc-fZwumE cUsFHx">| </span><a class="sc-htpNat bUhGXt link sc-fQejPQ duuwge" href="https://doi.org/10.1155/2013/210604" aria-label="Doi-link">https://doi.org/10.1155/2013/210604</a></div><div class="sc-LKuAh lcOiDF article_full_citation"><div class="sc-hzNEM gsmOCv isHide"><p>Young-Man Lee, Q-Schick Auh, Deok-Won Lee, Jun-Yeol Kim, Ha-Jin Jung, Seung-Ho Lee, Eun-Cheol Kim<!-- -->,<!-- --> <!-- -->&quot;<span class="adjust-article-svg-size">Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells</span>&quot;,<!-- --> <i>BioMed Research International</i>,<!-- --> <!-- -->vol. <!-- -->2013<!-- -->,<!-- --> <!-- -->Article ID <!-- -->210604<!-- -->,<!-- --> <!-- -->14<!-- --> <!-- --> <!-- --> <!-- -->pages<!-- -->,<!-- --> <!-- -->2013<!-- -->.<!-- --> <!-- -->https://doi.org/10.1155/2013/210604</p></div><button class="sc-hSdWYo etauus sc-iBEsjs kPshFw" color="">Show citation</button></div><h1 class="sc-iRbamj jZOxOO sc-iSDuPN kRoxOt article_title adjust-article-svg-size heading-title">Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells</h1></div><div class="sc-jrIrqw eHMFfo article_authors"><hr class="sc-cEvuZC XkrFe hr__author"/><span class="">Young-Man Lee<!-- -->,<sup>1</sup> </span><span class="">Q-Schick Auh<!-- -->,<sup>2</sup> </span><span class="">Deok-Won Lee<!-- -->,<sup>3</sup> </span><span class="">Jun-Yeol Kim<!-- -->,<sup>1</sup> </span><span class="">Ha-Jin Jung<!-- -->,<sup>1</sup> </span><span class="">Seung-Ho Lee<!-- -->,<sup>4</sup> <!-- --> and </span><span class=""><b>Eun-Cheol Kim</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail Option"><span class="sc-htoDjs kNoiZu sc-hjRWVT irNWJI icon-colored _2zt-1j0LmaF8UjTQAM413G icon-themeable" title="" font-size="16"></span></a><sup>1</sup></span><div class="sc-fHxwqH dMuGGA isHide"><p><sup>1</sup><span>Department of Maxillofacial Tissue Regeneration and Research Center for Tooth & Periodontal Regeneration, School of Dentistry, Kyung Hee University, 1 Heogi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea</span></p><p><sup>2</sup><span>Department of Oral Medicine, School of Dentistry, Kyung Hee University, Heogi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea</span></p><p><sup>3</sup><span>Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyung Hee University, Heogi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea</span></p><p><sup>4</sup><span>College of Pharmacy, College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea</span></p></div><button class="sc-hSdWYo etauus sc-iQtOjA kfDwZY" color="">Show more</button></div><div class="articleContent__EditorWrapper-sc-2yl9jy-3 evMkvU"><div class="articleContent__TextWrapper-sc-2yl9jy-8 fYrLtk"><b>Academic Editor: </b>George Perry</div><div class="articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 fjviok"><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Received</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">12 Feb 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Revised</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">03 Apr 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Accepted</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">05 Apr 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC isPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Published</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">02 May 2013</span></div></div></div><article class="sc-jtRlXQ exFqMv article_body "><div><div class="xml-content"><h4 class="header" id="abstract">Abstract</h4><p>Although previous studies have shown that mollugin, a bioactive phytochemical isolated from <i>Rubia cordifolia</i> L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G<sub>1</sub> phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-<i>κ</i>B and NF-<i>κ</i>B-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2–related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-<i>κ</i>B.</p><span class="end-abs"></span><h4 id="introduction">1. Introduction</h4><p>Oral squamous cell carcinoma (OSCC) represents the fifth most common cancer worldwide and is a significant cause of cancer morbidity and mortality. Each year, approximately 300,000 new cases are diagnosed with only a 50% survival rate over 5 years. Common treatments, including surgery, radiation therapy, and chemotherapy, have very low success rates [<a href="#B1">1</a>]. Two of the most frequently used chemotherapeutic drugs, 5-fluorouracil and cisplatin, cause side effects such as bone marrow suppression, gastrointestinal toxicity, and renal damage, which remain problems that need to be resolved [<a href="#B2">2</a>]. To overcome such side effects and limitations, the direction of present research into novel antitumor agents has turned to natural products, especially plants used in traditional medicine [<a href="#B3">3</a>]. Previously, we demonstrated that highly purified sulfur [<a href="#B4">4</a>] and herbal medicines, such as <i>Caesalpinia sappan</i> [<a href="#B5">5</a>], <i>Coptidis rhizoma </i>[<a href="#B6">6</a>], and verticinone [<a href="#B7">7</a>], exerted antitumor effects on oral cancer cells<i> in vitro.</i> Moreover, we showed that a single compound isolated from <i>Caesalpinia sappan</i> heartwood, isoliquiritigenin 2′-methyl ether (ILME), had antioral cancer effects involving mitogen-activated protein kinases (MAPKs) and the nuclear factor-<i>κ</i>B (NF-<i>κ</i>B) pathway [<a href="#B8">8</a>]. In addition, we reported that a flavonoid extracted from <i>Caesalpinia sappan</i>, sappanchalcone, suppressed oral cancer cell growth and induced apoptosis through activation of p53-dependent mitochondrial MAPK and NF-<i>κ</i>B signaling [<a href="#B9">9</a>].</p><p>The roots of <i>Rubia cordifolia</i> L. have been widely used as a traditional herbal medicine in Korea to treat cough, bladder and kidney stones, joint inflammation, uterine hemorrhage, and uteritis [<a href="#B10">10</a>]. In addition, this plant has been used in traditional Chinese medicine for the treatment of arthritis, dysmenorrheal, hematorrhea, hemostasis, and psoriasis [<a href="#B11">11</a>, <a href="#B12">12</a>]. Among the bioactive components from <i>Rubia cordifolia</i>, mollugin (C<sub>17</sub>H<sub>16</sub>O<sub>4</sub>; methyl 2,2-dimethyl-6-hydroxy-<i>2H</i>-naphtho[1,2-<i>b</i>]pyran-5-carboxylate) has been reported to have antitumor and anti-inflammatory activities, and neuroprotective and apoptotic effects [<a href="#B13">13</a>–<a href="#B16">16</a>]. A recent study demonstrated that mollugin induced apoptosis through endoplasmic reticulum stress-mediated activation of c-Jun N-terminal kinase (JNK) and the mitochondria-dependent caspase cascade, regulated by Bcl-xL in human Jurkat T cells [<a href="#B14">14</a>]. Moreover, mollugin inhibited proliferation and induced apoptosis by suppressing fatty acid synthase in HER2-overexpressing human breast and ovarian cancer cells [<a href="#B17">17</a>].</p><p>Heme oxygenase-1 (HO-1) is an inducible cytoprotective enzyme that catalyzes the initial rate-limiting reaction in heme catabolism. Previously, we reported that the HO-1 pathway plays a key role in the adaptation of cells to stressful conditions and the recovery of dental pulp cells and periodontal ligament cells from injury [<a href="#B18">18</a>–<a href="#B20">20</a>]. Despite its cytoprotective properties, recent evidence suggests a role for HO-1 in promoting cancer [<a href="#B21">21</a>]. HO-1 is overexpressed in various types of cancer and is further induced by radiation and chemotherapy [<a href="#B22">22</a>, <a href="#B23">23</a>]. Regarding the mechanisms of HO-1 induction, several studies have suggested the involvement of MAPK and NF-<i>κ</i>B pathways, as well as nuclear factor erythroid 2–related factor 2 (Nrf2) [<a href="#B18">18</a>, <a href="#B24">24</a>]. However, the precise cellular mechanisms of mollugin on OSCCs are not completely understood.</p><p>The aim of this study was to investigate the chemotherapeutic effect of mollugin on human primary and metastatic OSCCs <i>in vitro</i>. In addition, we further explored whether the effect of mollugin is related to Nrf2 activation and HO-1 expression.</p><h4 id="materials-and-methods">2. Materials and Methods </h4><h5 id="sec2.1">2.1. Reagents</h5><p>Mollugin was isolated from root of heartwood of <i>Rubia cordifolia</i> L. as described previously [<a href="#B13">13</a>]. Antibody against NF-<i>κ</i>B p65, I<i>κ</i>B, Nrf2, Bcl-xL, Bcl-2, p53, p21, or phosphorylated isoforms of I<i>κ</i>B and horseradish peroxidase-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology (Delaware Avenue, CA). ERK, JNK, p38 or phosphorylation of ERK, JNK, and p38 were purchased from Cell signaling, Inc. (Beverly, MA). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), and other tissue culture reagents were purchased from Gibco BRL (Grand Island, NY). All  other chemicals were obtained from Sigma (St. Louis, MO), unless indicated otherwise. </p><h5 id="sec2.2">2.2. Cell Culture</h5><p>The cell line HNSCC4 (HN4), from a primary OSCCs, and cell line HNSCC12 (HN12), from a metastatic carcinoma of the OSCCs [<a href="#B25">25</a>], were derived in the laboratory of Dr. John F. Ensley (Wayne State University). Cells were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 <i>μ</i>g/mL streptomycin in a humidified atmosphere of 5% CO<sub>2</sub> at 37°C. Cells were dissociated with 0.25% trypsin just before transferring for experiments and counted using a hemocytometer.</p><p>Human keratinocyte cell line HaCaT (nontransformed human cell line) were incubated in DMEM supplemented with 10% FBS, 1 mM sodium pyruvate, 50 <i>μ</i>g/mL streptomycin, and 50 <i>μ</i>g/mL penicillin at 37°C in 5% CO<sub>2</sub>. Human gingival fibroblasts (HGFs) cell line by transfection with the E6/E7 open reading frames of HPV type 16 was cultured according to the following protocol, as reported by our study [<a href="#B26">26</a>]. Briefly, HGFs were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 <i>μ</i>g/mL streptomycin in a humidified atmosphere of 5% CO<sub>2</sub> at 37°C.</p><h5 id="sec2.3">2.3. Antiproliferative Assay</h5><p>Cell viability was determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, cells were seeded in flat-bottomed 96-well plates, at 1 × 10<sup>5</sup> cell/well 24 h prior to treatment. The cells were treated for various lengths of time with the agents indicated. Then 25 <i>μ</i>L of 5 mg/mL MTT was added to each well. After 4 h incubation at 37°C, 100 <i>μ</i>L of lysing buffer was added. The buffer consisted of 20% w/v of sodium dodecyl sulfate in 0.1% of HCl solution. The plates were incubated for a further analysis on an ELISA reader at 570 nm. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations.</p><h5 id="sec2.4">2.4. Flow Cytometry</h5><h6 id="sec2.4.1">2.4.1. Propidium Iodide (PI) Staining</h6><p>Cells were seeded at 5 × 10<sup>5 </sup>cells/well in six-well plates. After 24 h, cells were treated with mollugin the 3 days. After treatment, cells were harvested and pelleted by centrifugation (400 ×g, 4°C, 5 min). The cells were fixed with cold 75% ethanol for 24 h and then stained with PI solution, consisting of 45 mg/mL PI, 10 mg/mL RNase A, and 0.1% Triton X-100. After incubation in the dark at 4°C for 1 h, fluorescence-activated cells were sorted using the FACScan flow cytometer, and the data were analyzed using Cellfit Analysis Software. </p><h5 id="sec2.5">2.5. Fluorescein-Isothiocyanate-(FITC-) Annexin V and Propidium Iodide (PI) Double Staining</h5><p>Cells (5 × 10<sup>5</sup>) were seeded in 6-well plates, incubated for 24 h, and then treated with or without mollugin, and the incubation was continued for 3 days. After treatment, the cell pellet was prepared in a FACStar tube containing annexin V-FITC solution and incubated in 5% CO<sub>2</sub> at 37°C. The PI solution (without NP 40) was then added, and the ratio of PI-positive and annexin V-positive cells was measured using the flow cytometer. </p><h5 id="sec2.6">2.6. Morphological Analysis of Apoptosis by Staining with 4′,6-Diamino-2-Phenylindole Dihydrochloride (DAPI)</h5><p>To confirm that the nuclei underwent morphological changes, the cells were cultured in 60 mm dishes overnight and then washed twice in DMEM. The cells were then treated with mollugin and fixed in 4% paraformaldehyde, after which they were incubated in 1 <i>μ</i>g/mL DAPI solution for 30 min in the dark. The cells were then examined using a fluorescence microscope (Zeiss, Oberköchen, Germany). </p><h5 id="sec2.7">2.7. Western Blot Analysis</h5><p>Western blot analysis was performed by lysing cells in 20 mM Tris-HCl buffer (pH 7.4) containing protease inhibitor mixture (0.1 mM phenylmethanesulfonyl fluoride, 5 mg/mL aprotinin, 5 mg/mL pepstatin A, and 1 mg/mL chymostatin). Protein concentration was determined using the Lowry protein assay kit (P5626; Sigma). An equal amount of protein for each sample was resolved using 7% or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then electrophoretically transferred onto a Hybond-enhanced chemiluminescence (ECL) nitrocellulose membrane (Bio-Rad, Hercules, CA). The membrane was blocked with 5% skim milk and sequentially incubated with primary antibody (Santa Cruz Biotechnology) and horseradish peroxidase-conjugated secondary antibody followed by ECL detection (Amersham Pharmacia Biotech, Piscataway, NJ).</p><h5 id="sec2.8">2.8. Isolation of RNA and RT-PCR</h5><p>Total RNA was isolated using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. It was then reverse-transcribed using AccuPower RT premix (Bioneer, Daejeon, Korea). The PCR amplification of the resulting cDNA samples was performed using a GeneAmp PCR System 2400 thermal cycler (PerkinElmer, Wellesley, MA, USA). The primers information is summarized in Table <a href="tab1/" target="_blank">1</a>. The following PCR conditions were used: 34 cycles of denaturation at 95°C for 30 s, primer annealing at 60°C for 30 s, and extension at 72°C for 30 s. The PCR products were resolved on 1-2% agarose gels and stained with ethidium bromide.</p><div class="floats-partial-section partial-other-wrapper" data-section="tab1"><div class="floats-partial-content fig-content-tab1"><table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr /></td></tr><tr class="thead"><td align="left">Gene</td><td align="center">Sequence 5′-3′</td><td align="center">Size</td></tr><tr><td class="thead-hr" colspan="3"><hr /></td></tr><tr><td align="left" rowspan="2">MMP-9</td><td align="center">Forward: GTTGGGGAGGGCTGTCCGTGA</td><td align="center" rowspan="2">911 bp</td></tr><tr><td align="center">Reverse: CGTGGCGCTATCCAGCTCACC</td></tr><tr><td align="left" rowspan="2">ICAM-1</td><td align="center">Forward: CGCCCGATTGCTTTAGCTTG</td><td align="center" rowspan="2">320 bp</td></tr><tr><td align="center">Reverse: CGACTCACCTGGGAACAGAG</td></tr><tr><td align="left" rowspan="2">VEGF</td><td align="center">Forward: TCAAGGTTGGCGGAAGTGAGG</td><td align="center" rowspan="2">443 bp</td></tr><tr><td align="center">Reverse: CCCTTGCATCAGTAGGCTTCA</td></tr><tr><td align="left" rowspan="2">FGF2</td><td align="center">Forward: GCCTCATTTCCATTTCGTGG</td><td align="center" rowspan="2">224 bp</td></tr><tr><td align="center">Reverse: CGGGGGTACTGGTTTACAG</td></tr><tr><td align="left" rowspan="2"><svg height="16.6625" id="M1" style="vertical-align:-3.56265pt" version="1.1" viewbox="0 0 10 16.6625" width="10" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,12.162)"><path d="M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5&#10;t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z" id="x1D6FD"></path></g>
</svg>-actin<br /><i>　</i></td><td align="center">Forward: CATGGATGATGATATCGCCGC</td><td align="center" rowspan="2">319 bp<br /><i>　</i></td></tr><tr><td align="center">Reverse: ACATGATCTGGGTCATCTTCT</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr" /></td></tr></table></td></tr></table></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Table 1</span><a aria-label="full view" class="caption-partial-url" href="tab1/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text">Reverse transcriptase-polymerase chain reaction primers.</div></div></div><p></p><h5 id="sec2.9">2.9. HO-1 and Nrf2 siRNA Transfection</h5><p>The target sequence for human HO-1 siRNA was 5′-AACUUUCAGAAGGGCCAGGUGTT-3′ (forward) and 5′-CACCUGGCCCUUCUGAAAGUUTT-3′ (reverse). Transfection of Nrf2 siRNA was performed using the target sequence 5′-AAGAGUAUGAGCUGGAAAAACTT-3′ (forward) and 5′-GUUUUUCCAGCUCAUACUCUUTT-3′ (reverse). Cells were transfected with siRNA using Lipofectamine RNAiMAX (Invitrogen) according to the manufacture’s instruction. Silencer Negative Control siRNA (Invitrogen) was introduced into cells by the same method. Following transfection, cells were cultured in six-well plates at 37°C until required.</p><h5 id="sec2.10">2.10. Statistical Analysis</h5><p>Data are expressed as the mean ± standard deviation. Statistical comparisons of the results were made using analysis of variance (ANOVA). Significant differences (<svg height="11.375" id="M2" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>) between the means of control and sulfur-treated cells were analyzed using Dunnett’s test. </p><h4 id="results">3. Results</h4><h5 id="sec3.1">3.1. Effect of Mollugin on HN4 and HN12 Cell Viability</h5><p>To investigate the effect of mollugin on the proliferation of human OSCCs, the MTT assay was used. As shown in Figure <a href="fig1/" target="_blank">1</a>, mollugin inhibited cellular proliferation in a dose- and time-dependent manner. Moreover, mollugin displayed higher cytotoxicity in primary OSCC HN4 cells compared with metastatic OSCC HN12 cells, although the overall trend of the effects of mollugin on HN4 and HN12 cells was similar. Furthermore, we tested whether mollugin has any toxic effect on nonneoplastic human skin keratinocytes (HaCaT) and  gingival fibroblasts (GF). Interestingly, we did not find significant cytotoxicity or cell death by mollugin on HaCaT and GF (Figures <a href="fig1/#c" target="_blank">1(c)</a> and <a href="fig1/#d" target="_blank">1(d)</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig1"><div class="floats-partial-content fig-content-fig1"><div class="partial-carousel--single-image"><img alt="(a)" name="210604.fig.001a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="210604.fig.001b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="210604.fig.001c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="210604.fig.001d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig1"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="210604.fig.001a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="210604.fig.001b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="210604.fig.001c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="210604.fig.001d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig1"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 1</span><a aria-label="full view" class="caption-partial-url" href="fig1/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of mollugin on cell viability in primary (HN4, (a)), metastatic oral cancer cells (HN12, (b)), skin keratinocytes (HaCaT, (c)), and gingival fibroblasts (d) as measured by MTT assay. *Statistically significant difference as compared to control, <svg height="11.375" id="M3" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations.</table></div></div></div><h5 id="sec3.2">3.2. Effect of Mollugin on HN4 and HN12 Cell Apoptosis</h5><p>To determine whether the cause of cell death was apoptosis, HN4 and HN12 cells were exposed to 40 <i>μ</i>M mollugin for 3 days. This concentration was used because it reproducibly induced 50% growth inhibition in HN4 and HN12 cells cultured for 3 days. Cell nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI), a fluorescent DNA-binding dye (Figure <a href="fig2/#a" target="_blank">2(a)</a>). DAPI staining showed that the control nuclei were large and round without condensation or fragmentation, whereas most of the nuclei of mollugin-treated cells were condensed and fragmented, as is typical during apoptosis. The onset of apoptotic cell death by mollugin was confirmed by flow cytometry of HN4 and HN12 cells (Figure <a href="fig2/#b" target="_blank">2(b)</a>). Without treatment, only 3.88% HN4 and 2.80% HN12 cells were in the sub-G<sub>1</sub> region; however, mollugin treatment increased the proportions of cells in the sub-G<sub>1</sub> region to 20.26% and 31.46%, respectively. To determine whether the growth inhibitory effect of mollugin is associated with cell death, annexin V-propidium iodide (PI) double staining of HN4 and HN12 cells and flow cytometry was performed (Figure <a href="fig2/#c" target="_blank">2(c)</a>). Treatment of cells with mollugin for 3 days increased the number of annexin V<sup>+</sup>/PI<sup>+</sup> stained cells. These results demonstrate that the inhibition of cell growth by mollugin was caused by the induction of apoptosis.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig2"><div class="floats-partial-content fig-content-fig2"><div class="partial-carousel--single-image"><img alt="(a)" name="210604.fig.002a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="210604.fig.002b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="210604.fig.002c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002c.jpg" /><br /><strong>(c)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig2"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="210604.fig.002a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="210604.fig.002b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="210604.fig.002c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002c.jpg" /><br /><strong>(c)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig2"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 2</span><a aria-label="full view" class="caption-partial-url" href="fig2/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Confirmation of mollugin-induced apoptosis by DAPI staining (a), cell cycle analysis (b), and annexin V-PI staining (c) in OSCCs. Cells were incubated with 40 <i>μ</i>M mollugin for 3 days. Data are presented as mean ± SD from triplicate determinations (b, c). Results are representative from three independent experiments (a)–(c). </table></div></div></div><h5 id="sec3.3">3.3. Effect of Mollugin on NF-<i>κ</i>B Activation and Expression of NF-<i>κ</i>B-Regulated Genes</h5><p>Since NF-<i>κ</i>B transcription factors and their upstream activating molecules are attractive targets for cancer therapeutics, we evaluated the effect of mollugin on NF-<i>κ</i>B activation by measuring the phosphorylation and degradation of I<i>κ</i>B<i>α</i> and NF-<i>κ</i>B p65. As shown in Figure <a href="fig3/#a" target="_blank">3(a)</a>, treatment of HN4 and HN12 cells with mollugin decreased the steady-state levels of phosphorylated I<i>κ</i>B<i>α</i> and nuclear NF-<i>κ</i>B p65.</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig3"><div class="floats-partial-content fig-content-fig3"><div class="partial-carousel--single-image"><img alt="(a)" name="210604.fig.003a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="210604.fig.003b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="210604.fig.003c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003c.jpg" /><br /><strong>(c)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig3"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="210604.fig.003a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="210604.fig.003b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="210604.fig.003c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003c.jpg" /><br /><strong>(c)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig3"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 3</span><a aria-label="full view" class="caption-partial-url" href="fig3/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of mollugin on activation of NF-<i>κ</i>B (a), and expression of NF-<i>κ</i>B-regulated gene products involved in apoptosis and antiapoptosis (b), metastasis, and angiogenesis (c) in OSCCs. Cells were treated with 40 <i>μ</i>M mollugin for indicated times (a) or 3 days (b, c). The figure is representative of 3 independent experiments.</table></div></div></div><p>To clarify the molecular mechanism by which mollugin induces apoptosis in primary and metastatic OSCCs, we determined the levels of NF-<i>κ</i>B-regulated gene products involved in apoptosis and antiapoptosis (Figure <a href="fig3/#b" target="_blank">3(b)</a>). Mollugin treatment upregulated p53 and p21 expression in both HN4 and HN12 cells in a dose-dependent manner. In contrast, the expression of antiapoptotic Bcl-2 and Bcl-xl proteins was dose-dependently reduced by mollugin treatment in HN4 and HN12 cells. Next, we investigated whether mollugin could modulate levels of NF-<i>κ</i>B-regulated gene products involved in invasion (ICAM-1 and MMP-9) and angiogenesis (VEGF and FGF-2) of OSCCs. The results show that mollugin downregulated the expression of NF-<i>κ</i>B-regulated gene products, including MMP-9, ICAM-1, VEGF, and FGF-2 mRNA in a dose-dependent manner (Figure <a href="fig3/#c" target="_blank">3(c)</a>).</p><h5 id="sec3.4">3.4. Effect of Mollugin on MAPK and Nrf2 Activation</h5><p>To clarify the mechanism underlying the apoptosis, we assessed the effect of mollugin on Nrf2 and NF-<i>κ</i>B upstream pathways. Treatment with mollugin (40 <i>μ</i>M) increased levels of phosphorylated (activated) ERK, p38, and JNK; the phosphorylated proteins were easily detectable by Western blot after 30 or 60 min. In contrast, mollugin did not affect total p38, ERK, or JNK levels (Figure <a href="fig4/#a" target="_blank">4(a)</a>). </p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig4"><div class="floats-partial-content fig-content-fig4"><div class="partial-carousel--single-image"><img alt="(a)" name="210604.fig.004a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="210604.fig.004b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="210604.fig.004c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="210604.fig.004d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig4"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="210604.fig.004a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="210604.fig.004b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="210604.fig.004c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="210604.fig.004d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig4"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 4</span><a aria-label="full view" class="caption-partial-url" href="fig4/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effect of mollugin on phosphorylation of MAPK (a), activation of Nrf2 (b), and expression of HO-1 (c) in OSCCs. Effects of MAP kinase inhibitors on mollugin-induced activation of NF-<i>κ</i>B, Nrf2, and HO-1 (d). Cells were treated with 40 <i>μ</i>M mollugin for indicated times (a)–(c). Cells were pretreated with the p38 inhibitor SB203580 (20 <i>μ</i>M/L), the ERK inhibitor PD98059 (20 <i>μ</i>M/L), or the JNK inhibitor SP600125 (20 <i>μ</i>M/L) for 1 hour and treated with 40 <i>μ</i>M mollugin for 30 min (MAPK, Nrf2, and NF-<i>κ</i>B) or 3 days (HO-1). The results are representative of three independent experiments.</table></div></div></div><p>Since the stress response element/Nrf2 transcription factor pathway is important for HO-1 expression [<a href="#B23">23</a>], we next determined whether Nrf2 signaling is involved in mollugin-induced HO-1 expression and apoptosis. Initially, Nrf2 activation was assessed by the accumulation of Nrf2 in the nucleus. Treatment with mollugin resulted in an accumulation of Nrf2 in the nucleus in primary and metastatic OSCCs (Figure <a href="fig4/#b" target="_blank">4(b)</a>).</p><p>To determine whether mollugin induces expression of antioxidant genes, HO-1 expression in oral cancer cells and the change in the pattern of HO-1 expression were evaluated. HO-1 protein expression in primary and metastatic OSCCs increased following mollugin treatment in a time-dependent manner (Figure <a href="fig4/#c" target="_blank">4(c)</a>).</p><p>To confirm the involvement of MAPK pathways in the mollugin-driven activation of NF-<i>κ</i>B and Nrf2, inhibitors of ERK (PD98059), JNK (SP6100126), and p38 (SB203580) MAPK signaling were used. Mollugin-induced NF-<i>κ</i>B, Nrf2, and HO-1 expression was effectively inhibited by PD98059, SP600126, and SB203580 (Figure <a href="fig4/#d" target="_blank">4(d)</a>), suggesting that p38, ERK1/2, and JNK play important roles in activating NF-<i>κ</i>B, Nrf2, and HO-1 in HN4 and HN12 cells.</p><h5 id="sec3.5">3.5. Involvement of the HO-1 Pathway in Mollugin-Induced Apoptosis</h5><p>To examine the cytotoxic potential of tin protoporphyrin (SnPP), an HO-1 inhibitor, its effect on viability was initially measured by the MTT assay (Figure <a href="fig5/#a" target="_blank">5(a)</a>). Although, 10 or 20 <i>μ</i>M SnPP had no cytotoxicity effect for 3 h, we found that SnPP exhibited slight cytotoxicity on HN4 and HN12 cells at 16 h. Based on these findings, we chose to use SnPP for 3 h. </p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig5"><div class="floats-partial-content fig-content-fig5"><div class="partial-carousel--single-image"><img alt="(a)" name="210604.fig.005a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="210604.fig.005b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="210604.fig.005c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="210604.fig.005d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig5"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="210604.fig.005a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="210604.fig.005b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="210604.fig.005c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="210604.fig.005d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig5"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 5</span><a aria-label="full view" class="caption-partial-url" href="fig5/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of HO-1 inhibitor (SnPP) on cytotoxicity (a), mollugin-induced growth inhibition (b), apoptosis (c), and apoptosis-related proteins expression (d) in OSCCs. Cells were pretreated with SnPP for 3 h and treated for 3 days with mollugin (b)–(d). Cell viability was examined by MTT assay (a), and apoptosis was examined by flow cytometry (b), respectively. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations (a, b). Data are presented as mean values from triplicate determinations (c). Western data show one representative result of three independent experiments (d). *Statistically significant difference as compared to control, <svg height="11.375" id="M4" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>. <sup>#</sup>Statistically significant difference as compared to mollugin, <svg height="11.375" id="M5" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>.</table></div></div></div><p>To determine whether the induction of HO-1 plays a role in mollugin-induced growth inhibition and apoptosis in OSCCs, cells were treated with SnPP, an HO-1 inhibitor, for 3 h before incubation with mollugin for 3 days. MTT assays showed that mollugin-induced cytotoxicity and apoptosis in HN4 and HN12 cells were dose-dependently reversed by pretreatment with SnPP (Figures <a href="fig5/#a" target="_blank">5(a)</a> and <a href="fig5/#b" target="_blank">5(b)</a>). In addition, SnPP treatment abolished the induction of p53 and p21<sup>WAF1/CIP1</sup> expression by mollugin, but reversed the expression of Bcl-2 and Bcl-xl (Figure <a href="fig5/#c" target="_blank">5(c)</a>).</p><p> Additionally, we used a siRNA-expressing plasmid to induce HO-1 gene silencing. HN4 and HN12 cells were transfected with an HO-1-targeting siRNA expression vector (Figure <a href="fig6/" target="_blank">6</a>). The siRNA approach resulted in high silencing efficacies for HO-1, which was confirmed by Western blot analysis (Figure <a href="fig6/#c" target="_blank">6(c)</a>). Silencing of HO-1 significantly attenuated mollugin-induced cytotoxicity (Figure <a href="fig6/#a" target="_blank">6(a)</a>) and apoptosis (Figure <a href="fig6/#b" target="_blank">6(b)</a>). Moreover HO-1 RNA blocked mollugin-induced Nrf2, p53, and p21 upregulation as well as Bcl-2 and Bcl-xl downregulation (Figure <a href="fig6/#c" target="_blank">6(c)</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig6"><div class="floats-partial-content fig-content-fig6"><div class="partial-carousel--single-image"><img alt="(a)" name="210604.fig.006a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="210604.fig.006b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="210604.fig.006c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006c.jpg" /><br /><strong>(c)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig6"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="210604.fig.006a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="210604.fig.006b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="210604.fig.006c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006c.jpg" /><br /><strong>(c)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig6"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 6</span><a aria-label="full view" class="caption-partial-url" href="fig6/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effects of HO-1 siRNA on mollugin-induced growth inhibition (a), apoptosis (b), and apoptosis-related proteins expression (c) in OSCCs. Cells were pretreated with HO siRNA (30 nM) for 5 h and treated for 3 days with mollugin (a)–(c). Cell viability was examined by MTT assay (a), and apoptosis was examined by flow cytometry (b), respectively. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations (a). Data are presented as mean values from triplicate determinations (b). Western data show one representative result of three independent experiments (c). *Statistically significant difference as compared to control, <svg height="11.375" id="M6" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>. <sup>#</sup>Statistically significant difference as compared to mollugin, <svg height="11.375" id="M7" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>.</table></div></div></div><h5 id="sec3.6">3.6. Involvement of the Nrf2 Pathway in Mollugin-Induced HO-1 Induction and Apoptosis</h5><p>To investigate whether mollugin-induced apoptosis and HO-1 expression were mediated by Nrf2 activation, a specific small interfering RNA (siRNA) against Nrf2 was used. As shown in Figure <a href="fig7/#c" target="_blank">7(c)</a>, transfection with Nrf2 siRNA for 5 h in HN4 and HN12 cells blocked mollugin-induced HO-1 and Nrf2 expression. However, Nrf2 siRNA did not affect the mollugin-induced p65 expression. Transfection with Nrf2 siRNA inhibited mollugin-induced cytotoxicity and apoptosis in HN4 and HN12 cells (Figures <a href="fig7/#a" target="_blank">7(a)</a> and <a href="fig7/#b" target="_blank">7(b)</a>). Moreover, transfection with Nrf2 siRNA in HN4 and HN12 cells reduced mollugin-induced apoptosis proteins (p53 and p21), but reversed antiapoptosis proteins (Bcl-2 and Bcl-xl) (Figure <a href="fig7/#c" target="_blank">7(c)</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig7"><div class="floats-partial-content fig-content-fig7"><div class="partial-carousel--single-image"><img alt="(a)" name="210604.fig.007a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="210604.fig.007b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="210604.fig.007c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007c.jpg" /><br /><strong>(c)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig7"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="210604.fig.007a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="210604.fig.007b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="210604.fig.007c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007c.jpg" /><br /><strong>(c)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig7"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 7</span><a aria-label="full view" class="caption-partial-url" href="fig7/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Effect of Nrf2 siRNA on mollugin-induced growth inhibition (a), apoptosis (b), and apoptosis-related proteins expression (c). Cells were treated with 40 <i>μ</i>M mollugin for indicated times (a). Cells were pretreated with Nrf2 siRNA (250 nM) for 5 h and treated for 3 days with mollugin 40 <i>μ</i>m (a)–(c). *Statistically significant difference as compared to control, <svg height="11.375" id="M8" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>. <sup>#</sup>Statistically significant difference as compared to mollugin, <svg height="11.375" id="M9" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>. Data are representative of 3 independent experiments.</table></div></div></div><h4 id="discussion">4. Discussion</h4><p>This study is to our knowledge the first to demonstrate that mollugin directly induces growth inhibition and apoptosis in primary and metastatic OSCCs and to address the molecular basis of this effect. </p><p>With regard to antitumor activity, mollugin has been shown to exert cytotoxic effects on human colon cancer (Col2) cells (IC<sub>50</sub> = 12.3 <i>μ</i>M; [<a href="#B11">11</a>]), human liver carcinoma (HepG2) cells (IC<sub>50</sub> value = 60.2 <i>μ</i>M; [<a href="#B10">10</a>]), and basal HER2-expressing human breast cancer cells (IC<sub>50</sub> value = 58 <i>μ</i>M; [<a href="#B17">17</a>]). In the present study, we found that mollugin (10–80 <i>μ</i>M) resulted in significant growth inhibition, with an average IC<sub>50</sub> value of 46.3 <i>μ</i>M in metastatic OSCCs (HN12) and 43.9 <i>μ</i>M in primary OSCCs (HN4) after 3 days. These antiproliferative properties of mollugin are consistent with previous reports in human acute leukemia Jurkat T cells [<a href="#B14">14</a>] and HER2-overexpressing breast and ovarian cancer cell lines [<a href="#B17">17</a>]. Moreover, we demonstrated that mollugin induced OSCC cell death by triggering apoptosis due to the presence of several apoptotic characteristics, including sub-G<sub>1</sub> phase accumulation, increase in annexin<sup>+</sup>/PI<sup>+</sup> cells, and DNA fragmentation. </p><p>NF-<i>κ</i>B signaling is a ubiquitous pathway in cell proliferation, survival, and apoptosis. Normally, NF-<i>κ</i>B proteins are inhibited by binding to I<i>κ</i>B proteins in the cytoplasm. Stress factors cause degradation of I<i>κ</i>B proteins through the ubiquitin-proteosomal pathway, and NF-<i>κ</i>B is released to bind to the DNA of promoter regions of specific genes that increases their transcription rate [<a href="#B27">27</a>, <a href="#B28">28</a>]. To explore the mechanism underlying mollugin-induced apoptosis in OSCCs, we examined NF-<i>κ</i>B activation. In agreement with previous findings that mollugin suppressed NF-<i>κ</i>B activation in HER2-overexpressing SK-BR-3 breast cancer cells [<a href="#B17">17</a>], our results indicate that mollugin significantly inhibited NF-<i>κ</i>B activation by reducing the level of phospho-I<i>κ</i>B<i>α</i>, leading to blockage of the I<i>κ</i>B<i>α</i> pathway in NF-<i>κ</i>B activation in OSCCs. In addition, it was reported that mollugin significantly suppressed TNF-<i>α</i>-induced NF-<i>κ</i>B transcriptional activation in HT-29 human colonic epithelial cells [<a href="#B13">13</a>]. </p><p>Genes involved in the proliferation, apoptosis, antiapoptosis, angiogenesis, and metastasis of cancer are regulated by NF-<i>κ</i>B [<a href="#B29">29</a>]<i>.</i> Constitutive activation of NF-<i>κ</i>B negatively regulates the proapoptotic functions of p53 by inducing the expression of an array of antiapoptotic genes, including Bcl-2 and Bcl-xL [<a href="#B30">30</a>]. In our study, treatment with mollugin induced the downregulation of antiapoptotic Bcl-2 and Bcl-xL levels as well as the upregulation of apoptotic p53 and p21 levels in OSCCs. Another hallmark of OSCC behavior is their propensity for local invasion and metastasis. MMP-9 is frequently overexpressed in OSCCs and is dependent upon NF-<i>κ</i>B for expression [<a href="#B31">31</a>]. Adhesion molecules such as ICAM-1 are regulated by NF-<i>κ</i>B and are essential for the adhesion of tumor cells to endothelial cells and thus mediate tumor cell metastasis [<a href="#B32">32</a>]. Angiogenesis is important for tumor growth and progression. The development of angiogenesis is stimulated by cytokines and growth factors, and the expression of these cytokines and growth factors is correlated with the pathological neovascularization circumstances. Among these angiogenic factors, VEGF and FGF-2 are important angiogenic factors and essential for cancers [<a href="#B33">33</a>]. In this study, we found that mollugin inhibited the expression of NF-<i>κ</i>B-regulated gene products involved in invasion (MMP-9 and ICAM-1) and angiogenesis (FGF-2 and VEGF). Thus, our results demonstrate that mollugin inhibits NF-<i>κ</i>B, leading to suppression of proliferation, invasion, and angiogenesis in OSCCs.</p><p>The MAPKs are proline-directed Ser/Thr protein kinases that regulate many cellular processes, including cell proliferation and death. JNK and p38 are activated by cellular stress and are associated with apoptosis [<a href="#B34">34</a>]. The involvement of ERK in the induction of apoptosis by quercetin, resveratrol, and taxol has been reported [<a href="#B35">35</a>, <a href="#B36">36</a>]. In the present study, phosphorylation of p38, ERK, and JNK was detected in mollugin-treated OSCCs, which is consistent with our previous reports that sappanchalcone may exert its effect on OSCCs through p38, ERK, and JNK activation [<a href="#B9">9</a>]. Therefore, NF-<i>κ</i>B regulation downstream of the MAPK (ERK1/2, p38, and JNK) pathways may be involved in mollugin-induced apoptosis in OSCCs. However, mollugin activated p38 MAPK in hippocampal and microglial cells [<a href="#B15">15</a>] and ERK in HER2-overexpressing breast cancer cells [<a href="#B17">17</a>]. Therefore, MAPK can be differentially activated, and its involvement in apoptosis is highly context and model dependent. </p><p>The role of HO-1 in tumor development is still not understood completely. Some recent reports demonstrate discordant or even completely contrasting results. Nevertheless, accumulating evidence indicates that HO-1 is expressed or overexpressed in a wide variety of human tumors and plays a critical role in the progression of neoplastic diseases [<a href="#B37">37</a>]. For example, it has been shown that increased expression of HO-1 is associated with a higher rate of proliferation of various tumor cells [<a href="#B37">37</a>, <a href="#B38">38</a>], although opposite effects have been observed in breast cancer cells [<a href="#B39">39</a>]. Furthermore, the increased basal level of HO-1 expression in tumor cells can be further elevated by chemotherapeutics or phytochemicals, such as curcumin, carnosol, and ILME [<a href="#B8">8</a>, <a href="#B22">22</a>, <a href="#B23">23</a>]. Our results show that mollugin upregulated HO-1 expression in a time- and dose-dependent manner (data not shown), consistent with results in hippocampal and microglial cells [<a href="#B15">15</a>]. We found that growth inhibition and apoptosis of OSCCs by mollugin was reversed in the presence of an HO-1 inhibitor. In addition, mollugin induced downregulation of antiapoptotic Bcl-2 and Bcl-xL levels, while upregulation of apoptotic p53 and p21 levels was reversed by SnPP in a dose-dependent manner. These results suggest that the growth inhibition and apoptosis-inducing effect of mollugin is mediated via HO-1 expression. </p><p>Regarding HO-1, Nrf-2 is a relatively well-known transcription factor [<a href="#B40">40</a>]. In response to diverse HO-1 inducers, Nrf2 translocates from the cytosol to the nucleus where it binds to the antioxidant response element in the promoter region of the HO-1 gene [<a href="#B41">41</a>]. In our study, mollugin also induced the translocation of Nrf-2 into the nucleus, as evidenced by Western blot. Furthermore, the results of this study demonstrate a correlation between apoptotic gene upregulation and the suppression of antiapoptotic genes of OSCCs to undergo mollugin-induced growth inhibition and apoptosis when Nrf-2 is knocked down. Based on these observations, it is reasonable to conclude that Nrf2 activation mediates mollugin-induced growth inhibition and apoptosis in OSCCs. </p><p>Redox-sensitive transcription factor (NF-<i>κ</i>B, AP-1, and Nrf2) pathways are known to be important molecular targets in chemoprevention. Activation of Nrf2 and NF-<i>κ</i>B involves regulation of protein kinases, which may induce their nuclear translocation [<a href="#B42">42</a>]. It was previously shown that mollugin induced apoptosis via JNK in human Jurkat T cells [<a href="#B14">14</a>]. In this regard, specific protein kinase inhibitors of PI3 K and ERK repressed Nrf2 phosphorylation and nuclear translocation of Nrf2 and NF-<i>κ</i>B in HepG2 cells, as previously reported in different cell types [<a href="#B43">43</a>, <a href="#B44">44</a>]. The present results also suggest that the MAPK pathway plays a role in the mollugin-induced nuclear translocation of Nrf2 and NF-<i>κ</i>B in HN4 and HN12 cells. A variety of anticarcinogenic phytochemicals suppress NF-<i>κ</i>B signalling and activate the Nrf2-ARE pathway [<a href="#B45">45</a>], suggesting that the suppression of NF-<i>κ</i>B signalling and the activation of the Nrf2-ARE pathway may crosstalk with each other. Indeed, inhibition of NF-<i>κ</i>B activation by phospholipid hydroperoxide glutathione peroxidase and 15-lipoxygenase is concomitant to upregulation of HO-1, probably via Nrf2 activation [<a href="#B46">46</a>]. Thus, the findings support that the participation of NF-<i>κ</i>B p65 in the negative regulation of Nrf2-ARE signalling, providing a new insight into a possible role of NF-<i>κ</i>B in suppressing the expression of anti-inflammatory or antitumour genes [<a href="#B47">47</a>]. Our results suggest that MAPK singnaling event mediates the link between NF-<i>κ</i>B and Nrf2. Although the NF-<i>κ</i>B pathway was inhibited by mollugin exposure, Nrf2 siRNA did not seem to participate in the translocation of NF-<i>κ</i>B, suggesting that NF-<i>κ</i>B and Nrf2 pathways might act in parallel in our <i>in vitro</i> model. A summary of our results is shown in Figure <a href="fig8/" target="_blank">8</a>. </p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig8"><div class="floats-partial-content fig-content-fig8"><div class="partial-carousel--single-image"><img alt="" name="210604.fig.008" src="https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.008.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 8</span><a aria-label="full view" class="caption-partial-url" href="fig8/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Schematic diagram illustrating the Nrf2 pathway and other signaling pathways triggered by exposure to mollugin in in OSCCs. Mollugin treatment leads to the activation of the cellular stress-dependent signaling pathways mediated by MAPK activation (ERK, JNK, and p38) and subsequent transcription factor activation (NF-<i>κ</i>B and Nrf2). Ultimately, these transcription factors result in altered gene expression to produce cytoprotective gene HO-1, allowing lead to apoptosis. </table></div></div></div><p>Colectivelly, our results demonstrate for the first time that mollugin inhibits cell growth and induces apoptosis in OSCCs through the NF-<i>κ</i>B/MAPK/Nrf2/HO-1 signaling pathway. Therefore, mollugin may have potential as a chemotherapeutic agent for OSCCs. The activities of mollugin against multiple antitumor targets should be studied intensively for further clinical application either as a natural agent alone or in combination with other commonly used chemotherapeutics. Further investigation of mollugin in animal models of OSCCS will contribute to additional understanding of its <i>in vivo</i> activity toward malignant cells and its potential toxicity toward normal tissues.</p><h4 id="authors’-contribution">Authors’ Contribution</h4><p>Y.-M. Lee and Q.-S. Auh contributed equally to this work as 1st author. </p><h4 id="acknowledgments">Acknowledgments</h4><p>This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (no. 2012R1A5A2051384). </p></div><div class="xml-content"><h4 class="references" id="references">References</h4><ol><li id="B1">H. Schliephake, “Prognostic relevance of molecular markers of oral cancer&#x2014;a review,” <i>International Journal of Oral and Maxillofacial Surgery</i>, vol. 32, no. 3, pp. 233–245, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1054/ijom.2002.0383">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Prognostic%20relevance%20of%20molecular%20markers%20of%20oral%20cancer—a%20review&author=H. Schliephake&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B2">E. Yamachika, T. Habte, and D. Oda, “Artemisinin: an alternative treatment for oral squamous cell carcinoma,” <i>Anticancer Research</i>, vol. 24, no. 4, pp. 2153–2160, 2004. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Artemisinin:%20an%20alternative%20treatment%20for%20oral%20squamous%20cell%20carcinoma&author=E. Yamachika&author=T. Habte&author=&author=D. Oda&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B3">J. McCann, “Texas center studies research alternative treatments,” <i>Journal of the National Cancer Institute</i>, vol. 89, no. 20, pp. 1485–1486, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Texas%20center%20studies%20research%20alternative%20treatments&author=J. McCann&publication_year=1997" target="_blank">Google Scholar</a></span><li id="B4">J. Lee, H. J. Lee, J. D. Park et al., “Anti-cancer activity of highly purified sulfur in immortalized and malignant human oral keratinocytes,” <i>Toxicology in Vitro</i>, vol. 22, no. 1, pp. 87–95, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.tiv.2007.08.016">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Anti-cancer%20activity%20of%20highly%20purified%20sulfur%20in%20immortalized%20and%20malignant%20human%20oral%20keratinocytes&author=J. Lee&author=H. J. Lee&author=J. D. Park et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B5">E. C. Kim, Y. S. Hwang, H. J. Lee et al., “Caesalpinia sappan induces cell death by increasing the expression of p53 and p21<sup>WAF1/CIP1</sup> in head and neck cancer cells,” <i>The American Journal of Chinese Medicine</i>, vol. 33, no. 3, pp. 405–414, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1142/S0192415X05003016">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Caesalpinia%20sappan%20induces%20cell%20death%20by%20increasing%20the%20expression%20of%20p53%20and%20p21WAF1/CIP1%20in%20head%20and%20neck%20cancer%20cells&author=E. C. Kim&author=Y. S. Hwang&author=H. J. Lee et al.&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B6">H. J. Lee, D. H. Son, S. K. Lee et al., “Extract of Coptidis rhizoma induces cytochrome-c dependent apoptosis in immortalized and malignant human oral keratinocytes,” <i>Phytotherapy Research</i>, vol. 20, no. 9, pp. 773–779, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ptr.1956">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Extract%20of%20Coptidis%20rhizoma%20induces%20cytochrome-c%20dependent%20apoptosis%20in%20immortalized%20and%20malignant%20human%20oral%20keratinocytes&author=H. J. Lee&author=D. H. Son&author=S. K. Lee et al.&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B7">Y. G. Yun, B. H. Jeon, J. H. Lee et al., “Verticinone induces cell cycle arrest and apoptosis in immortalized and malignant human oral keratinocytes,” <i>Phytotherapy Research</i>, vol. 22, no. 3, pp. 416–423, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ptr.2345">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Verticinone%20induces%20cell%20cycle%20arrest%20and%20apoptosis%20in%20immortalized%20and%20malignant%20human%20oral%20keratinocytes&author=Y. G. Yun&author=B. H. Jeon&author=J. H. Lee et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B8">Y. M. Lee, G. S. Jeong, H. D. Lim, R. B. An, Y. C. Kim, and E. C. Kim, “Isoliquiritigenin 2&#x2032;-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1,” <i>Toxicology in Vitro</i>, vol. 24, no. 3, pp. 776–782, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.tiv.2009.12.024">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Isoliquiritigenin%202′-methyl%20ether%20induces%20growth%20inhibition%20and%20apoptosis%20in%20oral%20cancer%20cells%20via%20heme%20oxygenase-1&author=Y. M. Lee&author=G. S. Jeong&author=H. D. Lim&author=R. B. An&author=Y. C. Kim&author=&author=E. C. Kim&publication_year=2010" target="_blank">Google Scholar</a></span><li id="B9">Y. M. Lee, Y. C. Kim, E. C. Kim et al., “Mechanism of sappanchalcone-induced growth inhibition and apoptosis in human oral cancer cells,” <i>Toxicology in Vitro</i>, vol. 25, no. 8, pp. 1782–1788, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.tiv.2011.09.009">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mechanism%20of%20sappanchalcone-induced%20growth%20inhibition%20and%20apoptosis%20in%20human%20oral%20cancer%20cells&author=Y. M. Lee&author=Y. C. Kim&author=E. C. Kim et al.&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B10">J. K. Son, S. J. Jung, M. H. M. H. Woo et al., “Anticancer constituents from the roots of <i>Rubia cordifolia</i> L.,” <i>Chemical Pharmacology Bulletin</i>, vol. 56, no. 2, pp. 213–216, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1248/cpb.56.213">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Anticancer%20constituents%20from%20the%20roots%20of%20Rubia%20cordifolia%20L.&author=J. K. Son&author=S. J. Jung&author=M. H. M. H. Woo et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B11">L. C. Chang, D. Chavez, J. J. Gills, H. H. S. Fong, J. M. Pezzuto, and A. D. Kinghorn, “Rubiasins A-C, new anthracene derivatives from the roots and stems of <i>Rubia cordifolia</i>,” <i>Tetrahedron Letters</i>, vol. 41, no. 37, pp. 7157–7162, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Rubiasins%20A-C,%20new%20anthracene%20derivatives%20from%20the%20roots%20and%20stems%20of%20Rubia%20cordifolia&author=L. C. Chang&author=D. Chavez&author=J. J. Gills&author=H. H. S. Fong&author=J. M. Pezzuto&author=&author=A. D. Kinghorn&publication_year=2000" target="_blank">Google Scholar</a></span><li id="B12">W. P. Tse, C. H. K. Cheng, C. T. Che, M. Zhao, and Z. X. Lin, “Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: implications for psoriasis treatment,” <i>International Journal of Molecular Medicine</i>, vol. 20, no. 5, pp. 663–672, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Induction%20of%20apoptosis%20underlies%20the%20Radix%20Rubiae-mediated%20anti-proliferative%20action%20on%20human%20epidermal%20keratinocytes:%20implications%20for%20psoriasis%20treatment&author=W. P. Tse&author=C. H. K. Cheng&author=C. T. Che&author=M. Zhao&author=&author=Z. X. Lin&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B13">K. J. Kim, J. S. Lee, M. K. Kwak et al., “Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-<i>&#x3ba;</i>B activation,” <i>European Journal of Pharmacology</i>, vol. 622, no. 1-3, pp. 52–57, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ejphar.2009.09.008">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Anti-inflammatory%20action%20of%20mollugin%20and%20its%20synthetic%20derivatives%20in%20HT-29%20human%20colonic%20epithelial%20cells%20is%20mediated%20through%20inhibition%20of%20NF-κB%20activation&author=K. J. Kim&author=J. S. Lee&author=M. K. Kwak et al.&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B14">S. M. Kim, H. S. Park, D. Y. Jun et al., “Mollugin induces apoptosis in human Jurkat T cells through endoplasmic reticulum stress-mediated activation of JNK and caspase-12 and subsequent activation of mitochondria-dependent caspase cascade regulated by Bcl-xL,” <i>Toxicology and Applied Pharmacology</i>, vol. 241, no. 2, pp. 210–220, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.taap.2009.08.024">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mollugin%20induces%20apoptosis%20in%20human%20Jurkat%20T%20cells%20through%20endoplasmic%20reticulum%20stress-mediated%20activation%20of%20JNK%20and%20caspase-12%20and%20subsequent%20activation%20of%20mitochondria-dependent%20caspase%20cascade%20regulated%20by%20Bcl-xL&author=S. M. Kim&author=H. S. Park&author=D. Y. Jun et al.&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B15">G. S. Jeong, D. S. Lee, D. C. Kim et al., “Neuroprotective and anti-inflammatory effects of mollugin via up-regulation of heme oxygenase-1 in mouse hippocampal and microglial cells,” <i>European Journal of Pharmacology</i>, vol. 654, no. 3, pp. 226–234, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ejphar.2010.12.027">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Neuroprotective%20and%20anti-inflammatory%20effects%20of%20mollugin%20via%20up-regulation%20of%20heme%20oxygenase-1%20in%20mouse%20hippocampal%20and%20microglial%20cells&author=G. S. Jeong&author=D. S. Lee&author=D. C. Kim et al.&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B16">D. Y. Jun, C. R. Han, M. S. Choi, M. A. Bae, M. H. Woo, and Y. H. Kim, “Effect of mollugin on apoptosis and adipogenesis of 3T3-L1 preadipocytes,” <i>Phytotherapy Research</i>, vol. 25, no. 5, pp. 724–731, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ptr.3329">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20mollugin%20on%20apoptosis%20and%20adipogenesis%20of%203T3-L1%20preadipocytes&author=D. Y. Jun&author=C. R. Han&author=M. S. Choi&author=M. A. Bae&author=M. H. Woo&author=&author=Y. H. Kim&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B17">M. T. Do, Y. P. Hwang, H. G. Kim, M. Na, and H. G. Jeong, “Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells through modulation of a HER2/Akt/SREBP-1c signaling,” <i>Journal of Cell Physiology</i>, vol. 228, no. 5, pp. 1087–1097, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Mollugin%20inhibits%20proliferation%20and%20induces%20apoptosis%20by%20suppressing%20fatty%20acid%20synthase%20in%20HER2-overexpressing%20cancer%20cells%20through%20modulation%20of%20a%20HER2/Akt/SREBP-1c%20signaling&author=M. T. Do&author=Y. P. Hwang&author=H. G. Kim&author=M. Na&author=&author=H. G. Jeong&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B18">S. K. Lee, H. I. Choi, Y. S. Yang et al., “Nitric oxide modulates osteoblastic differentiation with heme oxygenase-1 via the mitogen activated protein kinase and nuclear factor-<i>&#x3ba;</i>B pathways in human periodontal ligament cells,” <i>Biological and Pharmaceutical Bulletin</i>, vol. 32, no. 8, pp. 1328–1334, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1248/bpb.32.1328">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Nitric%20oxide%20modulates%20osteoblastic%20differentiation%20with%20heme%20oxygenase-1%20via%20the%20mitogen%20activated%20protein%20kinase%20and%20nuclear%20factor-κB%20pathways%20in%20human%20periodontal%20ligament%20cells&author=S. K. Lee&author=H. I. Choi&author=Y. S. Yang et al.&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B19">S. K. Lee, S. H. Pi, S. H. Kim et al., “Substance P regulates macrophage inflammatory protein 3<i>&#x3b1;</i>/chemokine C-C ligand 20 (CCL20) with heme oxygenase-1 in human periodontal ligament cells,” <i>Clinical and Experimental Immunology</i>, vol. 150, no. 3, pp. 567–575, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-2249.2007.03514.x">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Substance%20P%20regulates%20macrophage%20inflammatory%20protein%203α/chemokine%20C-C%20ligand%2020%20(CCL20)%20with%20heme%20oxygenase-1%20in%20human%20periodontal%20ligament%20cells&author=S. K. Lee&author=S. H. Pi&author=S. H. Kim et al.&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B20">S. H. Pi, S. C. Kim, H. T. Kim, H. J. Lee, S. K. Lee, and E. C. Kim, “Defense mechanism of heme oxygenase-1 against cytotoxic and receptor activator of nuclear factor-<i>&#x3ba;</i>B ligand inducing effects of hydrogen peroxide in human periodontal ligament cells,” <i>Journal of Periodontal Research</i>, vol. 42, no. 4, pp. 331–339, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1600-0765.2006.00953.x">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Defense%20mechanism%20of%20heme%20oxygenase-1%20against%20cytotoxic%20and%20receptor%20activator%20of%20nuclear%20factor-κB%20ligand%20inducing%20effects%20of%20hydrogen%20peroxide%20in%20human%20periodontal%20ligament%20cells&author=S. H. Pi&author=S. C. Kim&author=H. T. Kim&author=H. J. Lee&author=S. K. Lee&author=&author=E. C. Kim&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B21">K. D. Poss and S. Tonegawa, “Reduced stress defense in heme oxygenase 1-deficient cells,” <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 94, no. 20, pp. 10925–10930, 1997. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.94.20.10925">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Reduced%20stress%20defense%20in%20heme%20oxygenase%201-deficient%20cells&author=K. D. Poss &author=S. Tonegawa&publication_year=1997" target="_blank">Google Scholar</a></span><li id="B22">E. Balogun, M. Hoque, P. Gong et al., “Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element,” <i>Biochemical Journal</i>, vol. 371, no. 3, pp. 887–895, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1042/BJ20021619">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Curcumin%20activates%20the%20haem%20oxygenase-1%20gene%20via%20regulation%20of%20Nrf2%20and%20the%20antioxidant-responsive%20element&author=E. Balogun&author=M. Hoque&author=P. Gong et al.&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B23">D. Martin, A. I. Rojo, M. Salinas et al., “Regulation of heme Oxygenase-1 expression through the phosphatidylinositol 3-kinase/akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol,” <i>The Journal of Biological Chemistry</i>, vol. 279, no. 10, pp. 8919–8929, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M309660200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Regulation%20of%20heme%20Oxygenase-1%20expression%20through%20the%20phosphatidylinositol%203-kinase/akt%20pathway%20and%20the%20Nrf2%20transcription%20factor%20in%20response%20to%20the%20antioxidant%20phytochemical%20carnosol&author=D. Martin&author=A. I. Rojo&author=M. Salinas et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B24">A. A. Anwar, F. Y. L. Li, D. S. Leake, T. Ishii, G. E. Mann, and R. C. M. Siow, “Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2,” <i>Free Radical Biology and Medicine</i>, vol. 39, no. 2, pp. 227–236, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.freeradbiomed.2005.03.012">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Induction%20of%20heme%20oxygenase%201%20by%20moderately%20oxidized%20low-density%20lipoproteins%20in%20human%20vascular%20smooth%20muscle%20cells:%20role%20of%20mitogen-activated%20protein%20kinases%20and%20Nrf2&author=A. A. Anwar&author=F. Y. L. Li&author=D. S. Leake&author=T. Ishii&author=G. E. Mann&author=&author=R. C. M. Siow&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B25">M. Cardinali, H. Pietraszkiewicz, J. F. Ensley, and K. C. Robbins, “Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies,” <i>International Journal of Cancer</i>, vol. 61, no. 1, pp. 98–103, 1995. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ijc.2910610117">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Tyrosine%20phosphorylation%20as%20a%20marker%20for%20aberrantly%20regulated%20growth-promoting%20pathways%20in%20cell%20lines%20derived%20from%20head%20and%20neck%20malignancies&author=M. Cardinali&author=H. Pietraszkiewicz&author=J. F. Ensley&author=&author=K. C. Robbins&publication_year=1995" target="_blank">Google Scholar</a></span><li id="B26">S. H. Pi, S. K. Lee, Y. S. Hwang, M. G. Choi, S. K. Lee, and E. C. Kim, “Differential expression of periodontal ligament-specific markers and osteogenic differentiation in human papilloma virus 16-immortalized human gingival fibroblasts and periodontal ligament cells,” <i>Journal of Periodontal Research</i>, vol. 42, no. 2, pp. 104–113, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1600-0765.2006.00921.x">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Differential%20expression%20of%20periodontal%20ligament-specific%20markers%20and%20osteogenic%20differentiation%20in%20human%20papilloma%20virus%2016-immortalized%20human%20gingival%20fibroblasts%20and%20periodontal%20ligament%20cells&author=S. H. Pi&author=S. K. Lee&author=Y. S. Hwang&author=M. G. Choi&author=S. K. Lee&author=&author=E. C. Kim&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B27">S. Ghosh and M. Karin, “Missing pieces in the NF-<i>&#x3ba;</i>B puzzle,” <i>Cell</i>, vol. 109, pp. S81–S96, 2002. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Missing%20pieces%20in%20the%20NF-κB%20puzzle&author=S. Ghosh &author=M. Karin&publication_year=2002" target="_blank">Google Scholar</a></span><li id="B28">Y. Suh, F. Afaq, J. J. Johnson, and H. Mukhtar, “A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-<i>&#x3ba;</i>B-signaling pathways,” <i>Carcinogenesis</i>, vol. 30, no. 2, pp. 300–307, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1093/carcin/bgn269">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20plant%20flavonoid%20fisetin%20induces%20apoptosis%20in%20colon%20cancer%20cells%20by%20inhibition%20of%20COX2%20and%20Wnt/EGFR/NF-κB-signaling%20pathways&author=Y. Suh&author=F. Afaq&author=J. J. Johnson&author=&author=H. Mukhtar&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B29">B. B. Aggarwal, “Nuclear factor <i>&#x3ba;</i>B, the enemy within,” <i>Cancer Cell</i>, vol. 6, no. 3, pp. 203–208, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ccr.2004.09.003">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Nuclear%20factor%20κB,%20the%20enemy%20within&author=B. B. Aggarwal&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B30">G. Sethi, B. Sung, and B. B. Aggarwal, “Nuclear factor-<i>&#x3ba;</i>B activation: from bench to bedside,” <i>Experimental Biology and Medicine</i>, vol. 233, no. 1, pp. 21–31, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.3181/0707-MR-196">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Nuclear%20factor-κB%20activation:%20from%20bench%20to%20bedside&author=G. Sethi&author=B. Sung&author=&author=B. B. Aggarwal&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B31">M. Bond, R. P. Fabunmi, A. H. Baker, and A. C. Newby, “Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-<i>&#x3ba;</i>B,” <i>FEBS Letters</i>, vol. 435, no. 1, pp. 29–34, 1998. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0014-5793(98)01034-5">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Synergistic%20upregulation%20of%20metalloproteinase-9%20by%20growth%20factors%20and%20inflammatory%20cytokines:%20an%20absolute%20requirement%20for%20transcription%20factor%20NF-κB&author=M. Bond&author=R. P. Fabunmi&author=A. H. Baker&author=&author=A. C. Newby&publication_year=1998" target="_blank">Google Scholar</a></span><li id="B32">C. Lawson, M. Ainsworth, M. Yacoub, and M. Rose, “Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-<i>&#x3ba;</i>B-independent mechanism,” <i>Journal of Immunology</i>, vol. 162, no. 5, pp. 2990–2996, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Ligation%20of%20ICAM-1%20on%20endothelial%20cells%20leads%20to%20expression%20of%20VCAM-1%20via%20a%20nuclear%20factor-κB-independent%20mechanism&author=C. Lawson&author=M. Ainsworth&author=M. Yacoub&author=&author=M. Rose&publication_year=1999" target="_blank">Google Scholar</a></span><li id="B33">R. S. Kerbel, “Tumor angiogenesis: past, present and the near future,” <i>Carcinogenesis</i>, vol. 21, no. 3, pp. 505–515, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Tumor%20angiogenesis:%20past,%20present%20and%20the%20near%20future&author=R. S. Kerbel&publication_year=2000" target="_blank">Google Scholar</a></span><li id="B34">D. Xiao, S. Choi, D. E. Johnson et al., “Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2,” <i>Oncogene</i>, vol. 23, no. 33, pp. 5594–5606, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1038/sj.onc.1207747">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Diallyl%20trisulfide-induced%20apoptosis%20in%20human%20prostate%20cancer%20cells%20involves%20c-Jun%20N-terminal%20kinase%20and%20extracellular-signal%20regulated%20kinase-mediated%20phosphorylation%20of%20Bcl-2&author=D. Xiao&author=S. Choi&author=D. E. Johnson et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B35">Q. B. She, A. M. Bode, W. Y. Ma, N. Y. Chen, and Z. Dong, “Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase,” <i>Cancer Research</i>, vol. 61, no. 4, pp. 1604–1610, 2001. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Resveratrol-induced%20activation%20of%20p53%20and%20apoptosis%20is%20mediated%20by%20extracellular-signal-regulated%20protein%20kinases%20and%20p38%20kinase&author=Q. B. She&author=A. M. Bode&author=W. Y. Ma&author=N. Y. Chen&author=&author=Z. Dong&publication_year=2001" target="_blank">Google Scholar</a></span><li id="B36">A. Brozovic, G. Fritz, M. Christmann et al., “Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance,” <i>International Journal of Cancer</i>, vol. 112, no. 6, pp. 974–985, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1002/ijc.20522">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Long-term%20activation%20of%20SAPK/JNK,%20p38%20kinase%20and%20fas-L%20expression%20by%20cisplatin%20is%20attenuated%20in%20human%20carcinoma%20cells%20that%20acquired%20drug%20resistance&author=A. Brozovic&author=G. Fritz&author=M. Christmann et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B37">A. Jozkowicz, H. Was, and J. Dulak, “Heme oxygenase-1 in tumors: is it a false friend?” <i>Antioxidants and Redox Signaling</i>, vol. 9, no. 12, pp. 2099–2117, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1089/ars.2007.1659">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Heme%20oxygenase-1%20in%20tumors:%20is%20it%20a%20false%20friend?&author=A. Jozkowicz&author=H. Was&author=&author=J. Dulak&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B38">P. O. Berberat, Z. Dambrauskas, A. Gulbinas et al., “Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment,” <i>Clinical Cancer Research</i>, vol. 11, no. 10, pp. 3790–3798, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1158/1078-0432.CCR-04-2159">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20heme%20oxygenase-1%20increases%20responsiveness%20of%20pancreatic%20cancer%20cells%20to%20anticancer%20treatment&author=P. O. Berberat&author=Z. Dambrauskas&author=A. Gulbinas et al.&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B39">M. Hill, V. Pereira, C. Chauveau et al., “Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase,” <i>FASEB Journal</i>, vol. 19, no. 14, pp. 1957–1968, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1096/fj.05-3875com">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Heme%20oxygenase-1%20inhibits%20rat%20and%20human%20breast%20cancer%20cell%20proliferation:%20mutual%20cross%20inhibition%20with%20indoleamine%202,3-dioxygenase&author=M. Hill&author=V. Pereira&author=C. Chauveau et al.&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B40">J. Alam and J. L. Cook, “Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway,” <i>Current Pharmaceutical Design</i>, vol. 9, no. 30, pp. 2499–2511, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.2174/1381612033453730">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Transcriptional%20regulation%20of%20the%20heme%20oxygenase-1%20gene%20via%20the%20stress%20response%20element%20pathway&author=J. Alam &author=J. L. Cook&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B41">T. Ishii, K. Itoh, S. Takahashi et al., “Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages,” <i>The Journal of Biological Chemistry</i>, vol. 275, no. 21, pp. 16023–16029, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.275.21.16023">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Transcription%20factor%20Nrf2%20coordinately%20regulates%20a%20group%20of%20oxidative%20stress-inducible%20genes%20in%20macrophages&author=T. Ishii&author=K. Itoh&author=S. Takahashi et al.&publication_year=2000" target="_blank">Google Scholar</a></span><li id="B42">J. Pi, Y. Bai, J. M. Reece et al., “Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2,” <i>Free Radical Biology and Medicine</i>, vol. 42, no. 12, pp. 1797–1806, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.freeradbiomed.2007.03.001">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Molecular%20mechanism%20of%20human%20Nrf2%20activation%20and%20degradation:%20role%20of%20sequential%20phosphorylation%20by%20protein%20kinase%20CK2&author=J. Pi&author=Y. Bai&author=J. M. Reece et al.&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B43">T. Nguyen, P. J. Sherratt, H. C. Huang, C. S. Yang, and C. B. Pickett, “Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element: degradation of Nrf2 by the 26 S proteasome,” <i>The Journal of Biological Chemistry</i>, vol. 278, no. 7, pp. 4536–4541, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M207293200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Increased%20protein%20stability%20as%20a%20mechanism%20that%20enhances%20Nrf2-mediated%20transcriptional%20activation%20of%20the%20antioxidant%20response%20element:%20degradation%20of%20Nrf2%20by%20the%2026%20S%20proteasome&author=T. Nguyen&author=P. J. Sherratt&author=H. C. Huang&author=C. S. Yang&author=&author=C. B. Pickett&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B44">G. Sethi, B. Sung, B. B. Aggarwal et al., “Nuclear factor-<i>&#x3ba;</i>B activation: from bench to bedside,” <i>Experimental Biology and Medicine</i>, vol. 6, no. 5, pp. 515–524, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Nuclear%20factor-κB%20activation:%20from%20bench%20to%20bedside&author=G. Sethi&author=B. Sung&author=B. B. Aggarwal et al.&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B45">J. H. Lim, H. S. Park, J. K. Choi, I. S. Lee, and J. C. Hyun, “Isoorientin induces Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling,” <i>Archives of Pharmacal Research</i>, vol. 30, no. 12, pp. 1590–1598, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Isoorientin%20induces%20Nrf2%20pathway-driven%20antioxidant%20response%20through%20phosphatidylinositol%203-kinase%20signaling&author=J. H. Lim&author=H. S. Park&author=J. K. Choi&author=I. S. Lee&author=&author=J. C. Hyun&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B46">W. Li, T. O. Khor, C. Xu et al., “Activation of Nrf2-antioxidant signaling attenuates NF<i>&#x3ba;</i>B-inflammatory response and elicits apoptosis,” <i>Biochemical Pharmacology</i>, vol. 76, no. 11, pp. 1485–1489, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.bcp.2008.07.017">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Activation%20of%20Nrf2-antioxidant%20signaling%20attenuates%20NFκB-inflammatory%20response%20and%20elicits%20apoptosis&author=W. Li&author=T. O. Khor&author=C. Xu et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B47">A. Banning and R. Brigelius-Floh&#xe9;, “NF-<i>&#x3ba;</i>B, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression,” <i>Antioxidants and Redox Signaling</i>, vol. 7, no. 7-8, pp. 889–899, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1089/ars.2005.7.889">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=NF-κB,%20Nrf2,%20and%20HO-1%20interplay%20in%20redox-regulated%20VCAM-1%20expression&author=A. Banning &author=R. Brigelius-Flohé&publication_year=2005" target="_blank">Google Scholar</a></span></li></ol></div><div class="xml-content"><h4 class="copyright" id="copyright">Copyright</h4><p>Copyright &#xa9; 2013 Young-Man Lee et al. This is an open access article distributed under the <a rel="license" href="http://creativecommons.org/licenses/by/3.0/">  Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></article></div></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 eyHfWh journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 dbAANp article_widget biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">More related articles</h4><div id="biblio_widget" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div><div class="threeColumn__RightWrapper-sc-1bf4078-2 jzTMLK rightWrapper" id="rightSectionMenu"><div><div class="journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 gbrQxi article_sticky_top_toolbar"><div class="sc-cBdUnI hRnXob article_top_toolbar"><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-exkUMo hymroZ pdf_desktop button__group" href="https://downloads.hindawi.com/journals/bmri/2013/210604.pdf" aria-label="" target="_blank" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/><span class="text">PDF</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-kcDeIU cbcyj ref_desktop" href="/journals/bmri/2013/210604.ris" aria-label="" target="" id="toolbar__dcNavLarge"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Download Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-BngTV hmDWcT ref_desktop" href="/journals/bmri/2013/210604.ris" aria-label="" target="" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB3aWR0aD0iMTgiIGhlaWdodD0iMjIiIHZpZXdCb3g9IjAgMCAxOCAyMiI+PGRlZnM+PGNsaXBQYXRoIGlkPSJhIj48cGF0aCBkPSJNMywyMmEzLDMsMCwwLDEtMy0zVjNBMywzLDAsMCwxLDMsMGg4YS45OTEuOTkxLDAsMCwxLC41NzMuMTgxbDAsMCwuMDA4LjAwNmEuOTU1Ljk1NSwwLDAsMSwuMTIyLjFsNiw2YTEuMDI1LDEuMDI1LDAsMCwxLC4xLjEyMmwuMDA2LjAxLDAsMEExLDEsMCwwLDEsMTgsNi45NzVWMTlhMywzLDAsMCwxLTMsM1pNMiwzVjE5YTEsMSwwLDAsMCwxLDFIMTVhMSwxLDAsMCwwLDEtMVY4SDExYTEsMSwwLDAsMS0xLTFWMkgzQTEsMSwwLDAsMCwyLDNaTTEyLDZoMi41ODdMMTIsMy40MTRaTTUsMTdhMSwxLDAsMSwxLDAtMmg4YTEsMSwwLDEsMSwwLDJabTAtNGExLDEsMCwxLDEsMC0yaDhhMSwxLDAsMSwxLDAsMlpNNSw5QTEsMSwwLDEsMSw1LDdIN0ExLDEsMCwwLDEsNyw5WiIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMyAxKSIvPjwvY2xpcFBhdGg+PC9kZWZzPjxnIHRyYW5zZm9ybT0idHJhbnNsYXRlKC0zIC0xKSI+PHBhdGggZD0iTTMsMjJhMywzLDAsMCwxLTMtM1YzQTMsMywwLDAsMSwzLDBoOGEuOTkxLjk5MSwwLDAsMSwuNTczLjE4MWwwLDAsLjAwOC4wMDZhLjk1NS45NTUsMCwwLDEsLjEyMi4xbDYsNmExLjAyNSwxLjAyNSwwLDAsMSwuMS4xMjJsLjAwNi4wMSwwLDBBMSwxLDAsMCwxLDE4LDYuOTc1VjE5YTMsMywwLDAsMS0zLDNaTTIsM1YxOWExLDEsMCwwLDAsMSwxSDE1YTEsMSwwLDAsMCwxLTFWOEgxMWExLDEsMCwwLDEtMS0xVjJIM0ExLDEsMCwwLDAsMiwzWk0xMiw2aDIuNTg3TDEyLDMuNDE0Wk01LDE3YTEsMSwwLDEsMSwwLTJoOGExLDEsMCwxLDEsMCwyWm0wLTRhMSwxLDAsMSwxLDAtMmg4YTEsMSwwLDEsMSwwLDJaTTUsOUExLDEsMCwxLDEsNSw3SDdBMSwxLDAsMCwxLDcsOVoiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDMgMSkiLz48ZyBjbGlwLXBhdGg9InVybCgjYSkiPjxyZWN0IHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCIgZmlsbD0icmdiYSgwLDAsMCwwKSIvPjxyZWN0IHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCIvPjwvZz48L2c+PC9zdmc+" height="24"/><span class="text">Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a></div></div><div class="journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 isgRZA article_sticky_bottom_toolbar"><div class="sc-cTjmhe ihmyEq article_bottom_toolbar"><div class="sc-cugefK itFKcQ accordion" property="background-color" color="#D8D8D8" id="toolbar__dofNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Download other formats</span><span class="sc-gkFcWv gWTCXQ">More</span></span><span class="sc-htoDjs bMdQcY sc-gbOuXE jGPvPL icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="11"></span></div><div class="sc-fnwBNb etzuBr"><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/bmri/2013/210604.epub" aria-label="ePub" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">ePub</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/bmri/2013/210604.xml" aria-label="XML" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">XML</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><a class="sc-htpNat bUhGXt link sc-imABML ibWUzs" href="https://reprints.hindawi.com/210604/confirm" aria-label="Order Printed Copies" target="_blank" property="background-color" color="#D8D8D8" id="toolbar__opcNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Order printed copies</span><span class="sc-gkFcWv gWTCXQ">Order</span></span><span class="sc-htoDjs kNoiZu sc-gbOuXE jGPvPL right__icon icon-colored _32KP5uexH-Bgs7Kj8Gk1Tz icon-themeable" title="" font-size="16"></span></a><div class="sc-hBbWxd kdRRST"><div class="sc-dyGzUR cHatnS"><div>Views<span>2944</span></div><div>Downloads<span>1703</span></div></div><div><div class="sc-drKuOJ kxdGAZ"><span class="__dimensions_badge_embed__" data-doi="10.1155/2013/210604" data-style="small_circle"></span>Citations</div></div></div><nav class="sc-bRBYWo fXBKFa sc-hUfwpO jHPgUP" id="toolbar__iconNav"><h3 class="sc-Rmtcm hNPrIr">Share Post</h3><ul class="sc-hzDkRC bnbfTS"><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://twitter.com/share?url=https://doi.org/10.1155/2013/210604&amp;via=Hindawi" aria-label="Sharing on Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialTwitter" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.linkedin.com/shareArticle/?url=https://doi.org/10.1155/2013/210604" aria-label="Sharing on Linkedin" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialLinkedin" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialLinkedin.svg" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.facebook.com/sharer/sharer.php?u=https://doi.org/10.1155/2013/210604" aria-label="Sharing on Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialFacebook" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialFacebook-HINDAWI.svg" height="24"/></a></li><li class="iconBorder"><div class="wechat-container"><img alt=" " class="sc-EHOje jOLhQl socialWechat" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><div class="addthis_inline_share_toolbox"></div><script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5ec5076f7164b9b5"></script></div></li><li><a class="sc-htpNat bUhGXt link" href="mailto:?subject=Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells&amp;body=https://doi.org/10.1155/2013/210604" aria-label="Sharing on Mail" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialMail" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li></ul></nav></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 cBTaXT journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 cYsVdk biblioWrapperRight biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">Related articles</h4><div id="biblio_sidebar" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div></div></div></main><footer class="sc-jKJlTe inBNwS"><section class="sc-eNQAEJ dkutRV"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd primary__footer footer__bodypadding"><div class="sc-hMqMXs hlGpbO mobile">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNDAiIGhlaWdodD0iMzkiIHZpZXdCb3g9IjAgMCA0MCAzOSIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48cGF0aCBkPSJNNDAgMTkuNDU5NUM0MCA4LjcxMzk0IDMxLjA0NCAwIDIwIDBDOC45NTU5OSAwIDAgOC43MTM5NCAwIDE5LjQ1OTVDMCAzMC4yMDUgOC45NTU5OSAzOC45MTg5IDIwIDM4LjkxODlDMjAuMTE3NSAzOC45MTg5IDIwLjIzNDQgMzguOTE2NSAyMC4zNTE2IDM4LjkxNDVWMjMuNzY2MUgxNi4wNTQ3VjE4Ljg5MzhIMjAuMzUxNlYxNS4zMDg0QzIwLjM1MTYgMTEuMTUwMiAyMi45NjA1IDguODg3MDUgMjYuNzcyOCA4Ljg4NzA1QzI4LjU5ODMgOC44ODcwNSAzMC4xNjc1IDkuMDE5NDggMzAuNjI1IDkuMDc4NTdWMTMuNDI0NEgyNy45OTYyQzI1LjkyMjIgMTMuNDI0NCAyNS41MjA2IDE0LjM4MzUgMjUuNTIwNiAxNS43OTA2VjE4Ljg5MzhIMzAuNDc5N0wyOS44MzM0IDIzLjc2NjFIMjUuNTIwNlYzOC4xNjcxQzMzLjg4MDMgMzUuODM1MyA0MCAyOC4zNDE4IDQwIDE5LjQ1OTVaIiBmaWxsPSIjRjJGMkYyIj48L3BhdGg+PC9zdmc+" height="40"/></a></nav></div><nav class="E_HUmlU2Hj3PpkDmWzKPd _3wm8FgzqRuRWouJG31YgKx" role="navigation"><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link about_us" href="/about/" aria-label="About us">About us</a></li><li><a class="sc-htpNat bUhGXt link contact_us" href="/about/contact/" aria-label="Contact us">Contact us</a></li><li><a class="sc-htpNat bUhGXt link partnerships" href="/publishing-partnerships/" aria-label="Partnerships">Partnerships</a></li><li><a class="sc-htpNat bUhGXt link blog" href="/blog/" aria-label="Blog">Blog</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link journals" href="/journals/" aria-label="Journals">Journals</a></li><li><a class="sc-htpNat bUhGXt link article_processing_charges" href="/publish-research/authors/article-processing-charges/" aria-label="Article Processing Charges">Article Processing Charges</a></li><li><a class="sc-htpNat bUhGXt link print_editions" href="/print-editions/" aria-label="Print editions">Print editions</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link authors" href="/publish-research/authors/" aria-label="Authors">Authors</a></li><li><a class="sc-htpNat bUhGXt link editors" href="/publish-research/editors/" aria-label="Editors">Editors</a></li><li><a class="sc-htpNat bUhGXt link reviewers" href="/publish-research/reviewers/" aria-label="Reviewers">Reviewers</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link hindawi_xml_corpus" href="/hindawi-xml-corpus/" aria-label="Hindawi XML Corpus">Hindawi XML Corpus</a></li><li><a class="sc-htpNat bUhGXt link open_archives_initiative" href="/open-archives-initiative/" aria-label="Open Archives Initiative">Open Archives Initiative</a></li><li><a class="sc-htpNat bUhGXt link fraud_prevention" href="/preventing-and-protecting-against-fraud/" aria-label="Fraud prevention">Fraud prevention</a></li></ul></nav><div class="sc-hMqMXs hlGpbO desktop">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNDAiIGhlaWdodD0iMzkiIHZpZXdCb3g9IjAgMCA0MCAzOSIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48cGF0aCBkPSJNNDAgMTkuNDU5NUM0MCA4LjcxMzk0IDMxLjA0NCAwIDIwIDBDOC45NTU5OSAwIDAgOC43MTM5NCAwIDE5LjQ1OTVDMCAzMC4yMDUgOC45NTU5OSAzOC45MTg5IDIwIDM4LjkxODlDMjAuMTE3NSAzOC45MTg5IDIwLjIzNDQgMzguOTE2NSAyMC4zNTE2IDM4LjkxNDVWMjMuNzY2MUgxNi4wNTQ3VjE4Ljg5MzhIMjAuMzUxNlYxNS4zMDg0QzIwLjM1MTYgMTEuMTUwMiAyMi45NjA1IDguODg3MDUgMjYuNzcyOCA4Ljg4NzA1QzI4LjU5ODMgOC44ODcwNSAzMC4xNjc1IDkuMDE5NDggMzAuNjI1IDkuMDc4NTdWMTMuNDI0NEgyNy45OTYyQzI1LjkyMjIgMTMuNDI0NCAyNS41MjA2IDE0LjM4MzUgMjUuNTIwNiAxNS43OTA2VjE4Ljg5MzhIMzAuNDc5N0wyOS44MzM0IDIzLjc2NjFIMjUuNTIwNlYzOC4xNjcxQzMzLjg4MDMgMzUuODM1MyA0MCAyOC4zNDE4IDQwIDE5LjQ1OTVaIiBmaWxsPSIjRjJGMkYyIj48L3BhdGg+PC9zdmc+" height="40"/></a></nav></div></div></section><div class="sc-bZQynM bNmdOy"><section class="sc-iAyFgw gCiATD"><a class="sc-htpNat bUhGXt link" href="/privacy/" aria-label="Privacy Policy">Privacy Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/terms/" aria-label="Terms of Service">Terms of Service<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/responsible-disclosure-policy/" aria-label="Responsible Disclosure Policy">Responsible Disclosure Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/cookie-policy/" aria-label="Cookie Policy">Cookie Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/copyright/" aria-label="Copyright">Copyright<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/modern-slavery-statement/" aria-label="Modern slavery statement">Modern slavery statement<!-- --> </a></section></div></footer><div class="sc-OxbzP eEFYIL  advWrapper hideBanner"><span><p>Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.&nbsp;<a href="https://www.hindawi.com/article-year-award/" rel="noopener noreferrer" target="_blank">Read the winning articles</a>.</p>
</span><button class="sc-bYnzgO dsXEHZ"><img alt=" " class="sc-EHOje iiusBg sc-cPuPxo iXKuYd" title="" role="presentation" src="data:image/svg+xml;base64,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" height="16"/></button></div></div></div><noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQ4MGW"
            height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></div><script id="__NEXT_DATA__" type="application/json">{"dataManager":"[]","props":{"pageProps":{"isLiveUrl":true,"appConfig":{"journals":{"call_for_paper":{"title":"Call for papers","description":"\u003cp\u003eThis Issue is now open for submissions.\u003c/p\u003e\n\u003cp\u003ePapers are published upon acceptance, regardless of the Special Issue publication date.\u003c/p\u003e\n"},"article_left_nav_keywords":["Introduction","Materials and Methods","Results","Discussion","Conclusion","Abstract","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interests","Authors’ Contributions","Funding Statement","Acknowledgements","Acknowledgments","Supplementary Materials","Reference","Dataset Description","Dataset Files","Abstract","Introduction","Introduction and Materials","Introduction and Methods","Materials","Materials and Methods","Methods","Results","Discussion","Results and Discussion","Discussion and Conclusion","Results and Conclusion","Conclusion","Conclusions","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interest","Authors’ Contributions","Funding Statement","Acknowledgements","Supplementary Materials","References","Appendix","Abbreviations","Preliminaries","Introduction and Preliminaries","Notation","Proof of Theorem","Proofs","Analysis of Results","Examples","Numerical Example","Applications","Numerical Simulation","Model","Model Formulation","Systematic Palaeontology","Nomenclatural Acts","Taxonomic Implications","Experimental","Synthesis","Overview","Characterization","Background","Experimental","Theories","Calculations","Model Verification","Model Implementation","Geographic location","Study Area","Geological setting","Data Collection","Field Testing","Data and Sampling","Dataset","Literature Review","Related Works","Related Work","System Model","Methods and Data","Experimental Results","Results and Analysis","Evaluation","Implementation","Case Presentation","Case Report","Search Terms","Case Description","Case Series","Background","Limitations","Additional Points","Case","Case 1"," Case 2 etc.","Concern Details","Retraction Details"," Copyright"],"journal_nav_static_text":"","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null},"si_message":{"open":{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}},"propose":{"title":"Special Issues","text":"Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.","type":"special","link":{"title":"Submit your proposal","url":"/si-proposal"}},"abstract":{"title":"Abstracting and Indexing","text":"This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.","type":"special","link":{"title":"Find out more","url":"/abstract-msg"}}},"menu":{"prsi":"/publish-research/editors/special-issues/proposing-special-issue","asi":"/publish-research/editors/special-issues","pe":"/publish-research/authors/publication-ethics","fr":"/publish-research/reviewers","fe":"/publish-research/editors"},"featured_article_message":{"ceased":{"title":"{journal_name} has ceased publication and is no longer accepting submissions.","summary":"All previously published articles are available through the Table of Contents. \r\n\r\nThe journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."},"sold":{"title":"{journal_name} is not currently considering new submissions.","summary":"All previously published articles are available through the Table of Contents. The journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."}},"journal_manuscript_link":"https://review.hindawi.com/submit?journal={journal_subcode}","contact_us":{"title":"Contact","text":"\u003cp\u003eEditorial enquiries should be directed to\u0026nbsp;\u003ca href=\"mailto:{journal_subcode}@hindawi.com\"\u003e{journal_subcode}@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003eGeneral enquiries should be directed to \u003ca href=\"mailto:help@hindawi.com\"\u003ehelp@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\r\n"},"open_access":{"title":"Open Access","text":"\u003cp dir=\"ltr\"\u003e\u003cem\u003e{journal_name}\u003c/em\u003e is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our \u003ca href=\"https://www.hindawi.com/copyright/\"\u003ecopyright page\u003c/a\u003e.\u003c/p\u003e\r\n"},"default_image":{"small":"","large":""}},"manuscript_link":"https://mts.hindawi.com/","willey_link":"/publishing-partnerships/wiley-hindawi-publishing-partnership","gdpr_message":"","order_printed_url":"https://reprints.hindawi.com/{article_id}/confirm","adv_banner_message":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","theme":"HINDAWI","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","social_share_options":["facebook","twitter","linkedin","wechat","mail"],"use_journal_etoc_pages":true,"GTM_ID":"GTM-MQ4MGW","SITE_NAME":"Hindawi","secureSiteUrl":"https://www.hindawi.com","features":{"isMaintenanceOn":false},"useLazyLoad":false,"hasJournalReportPage":false},"data":{"id":6603,"title":"BioMed Research International","journal_manuscript_link":"","image":{"url":"https://static-01.hindawi.com/s3fs-public/styles/featured_hero_banner/public/2020-01/bmri_hero_0.jpg?itok=wJOUAZSY","alt":" BioMed Research International "},"text_colour_code":"#ffffff","about_journal":"/journals/bmri/about","is_wiley_partner":0,"metrics_data":{"id":6603,"title":"BioMed Research International","url":"/journals/bmri","apc":{"label":"APC","value":"$2550","link":{"text":"","url":""}},"image":{"url":"https://images.hindawi.com/journals/bmri/bmri.banner.small.jpg","alt":"BioMed Research International"},"metrics":[{"label":"Acceptance rate","value":"31%"},{"label":"Submission to final decision","value":"67 days"},{"label":"Acceptance to publication","value":"30 days"},{"label":"CiteScore","value":"4.100"},{"label":"Journal Citation Indicator","value":"0.610"},{"label":"Impact Factor","value":"3.411"}],"logos":[],"toolbar_metrics_or_logo":"metrics","partner_link":false},"links_block":[{"title":"Author guidelines","link":"/journals/bmri/guidelines","icon_class":"fileText"},{"title":"Editorial board","link":"/journals/bmri/editors","icon_class":"users"},{"title":"Databases and indexing","link":"/journals/bmri/ai","icon_class":"desktop"}],"featured_type":"automatic","status":1,"journal_level":4,"journal_subcode":"bmri","journal_issn":"2314-6133","hide_marketing_msg":1,"publishing_collaborations":[],"journal_blocks":[{"title":"Journal profile","text":"\u003cp\u003e\u003cem\u003eBioMed Research International\u003c/em\u003e publishes original research articles and\u0026nbsp;review articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research.\u003c/p\u003e\r\n","type":"profile","link":{"title":"About this journal","url":"/journals/bmri/about"}},{"title":"Editor spotlight","text":"\u003cp\u003e\u003cem\u003eBioMed Research International\u003c/em\u003e maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.\u003c/p\u003e\r\n","type":"spotlight","link":{"title":"Meet the editorial board","url":"/journals/bmri/editors"}},{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}}],"si_message_type":{"type":"open","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}},"meta_info":{"title":"BioMed Research International | Hindawi","meta_data":[{"name":"title","content":"BioMed Research International | Hindawi"},{"name":"description","content":"BioMed Research International publishes original research articles and review articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research."},{"property":"og:site_name","content":"Hindawi"},{"property":"og:url","content":"current_url"},{"property":"og:title","content":"BioMed Research International"},{"property":"og:description","content":"BioMed Research International publishes original research articles and review articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research."},{"property":"og:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:description","content":"BioMed Research International publishes original research articles and review articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research."},{"name":"twitter:site","content":"Hindawi"},{"name":"twitter:title","content":"BioMed Research International"},{"name":"twitter:url","content":"current_url"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"}]},"journal_header_uses_logo":false,"global_manuscript_link":"https://review.hindawi.com/submit?journal=bmri","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null}},"meta":{"meta_data":[{"name":"title","content":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"},{"rel":"canonical","href":"https://www.hindawi.com/journals/bmri/2013/210604/"},{"name":"description","content":"Although previous studies have shown that mollugin, a bioactive phytochemical isolated from \u003ci\u003eRubia cordifolia\u003c/i\u003e L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G\u003csub\u003e1\u003c/sub\u003e phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB and NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2\u0026#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB."},{"property":"og:url","content":"current_url"},{"property":"og:type","content":"website"},{"property":"og:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"property":"og:title","content":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"},{"name":"twitter:site","content":"website"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"name":"twitter:title","content":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"},{"property":"og:description","content":"Although previous studies have shown that mollugin, a bioactive phytochemical isolated from \u003ci\u003eRubia cordifolia\u003c/i\u003e L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G\u003csub\u003e1\u003c/sub\u003e phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB and NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2\u0026#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB."},{"name":"twitter:description","content":"Although previous studies have shown that mollugin, a bioactive phytochemical isolated from \u003ci\u003eRubia cordifolia\u003c/i\u003e L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G\u003csub\u003e1\u003c/sub\u003e phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB and NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2\u0026#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB."},{"name":"citation_title","content":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"},{"name":"citation_author","content":"Lee, Young-Man"},{"name":"citation_author","content":"Auh, Q-Schick"},{"name":"citation_author","content":"Lee, Deok-Won"},{"name":"citation_author","content":"Kim, Jun-Yeol"},{"name":"citation_author","content":"Jung, Ha-Jin"},{"name":"citation_author","content":"Lee, Seung-Ho"},{"name":"citation_author","content":"Kim, Eun-Cheol"},{"name":"citation_journal_title","content":"BioMed Research International"},{"name":"citation_publisher","content":"Hindawi"},{"name":"citation_volume","content":2013},{"name":"citation_year","content":"2013"},{"name":"citation_date","content":"2013/05/02"},{"name":"citation_online_date","content":"2013/05/02"},{"name":"citation_doi","content":"https://doi.org/10.1155/2013/210604"},{"name":"citation_issn","content":"2314-6133"},{"name":"citation_abstract","content":"Although previous studies have shown that mollugin, a bioactive phytochemical isolated from \u003ci\u003eRubia cordifolia\u003c/i\u003e L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G\u003csub\u003e1\u003c/sub\u003e phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB and NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2\u0026#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB."},{"name":"citation_fulltext_html_url","content":"current_url"},{"name":"citation_pdf_url","content":"https://downloads.hindawi.com/journals/bmri/2013/210604.pdf"},{"name":"citation_xml_url","content":"https://downloads.hindawi.com/journals/bmri/2013/210604.xml"},{"name":"dc.creator","content":"Lee, Young-Man"},{"name":"dc.creator","content":"Auh, Q-Schick"},{"name":"dc.creator","content":"Lee, Deok-Won"},{"name":"dc.creator","content":"Kim, Jun-Yeol"},{"name":"dc.creator","content":"Jung, Ha-Jin"},{"name":"dc.creator","content":"Lee, Seung-Ho"},{"name":"dc.creator","content":"Kim, Eun-Cheol"},{"name":"dc.title","content":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells"},{"name":"dc.description","content":"Although previous studies have shown that mollugin, a bioactive phytochemical isolated from \u003ci\u003eRubia cordifolia\u003c/i\u003e L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G\u003csub\u003e1\u003c/sub\u003e phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB and NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2\u0026#x2013;related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB."},{"name":"dc.publisher","content":"Hindawi"},{"name":"dc.format","content":"text/html"},{"name":"dc.language","content":"en"},{"name":"dc.identifier","content":"https://doi.org/10.1155/2013/210604"},{"name":"dc.type","content":"Research Article"},{"name":"dc.date","content":"2013/05/02"},{"name":"dcterms.issued","content":"2013/05/02"},{"name":"prism.publicationDate","content":"2013/05/02"},{"name":"prism.volume","content":2013},{"name":"prism.section","content":"Research Article"},{"name":"prism.doi","content":"https://doi.org/10.1155/2013/210604"},{"name":"prism.issn","content":"2314-6133"},{"name":"dc.source","content":"BioMed Research International"},{"name":"prism.publicationName","content":"BioMed Research International"},{"name":"authors","content":"Young-Man Lee | Q-Schick Auh | ... | Eun-Cheol Kim"}],"title":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells","current_url":"https://www.hindawi.com/journals/bmri/2013/210604/","site_url":"https://www.hindawi.com","gdprMsg":"","manuscript_link":"https://mts.hindawi.com/","footerData":{"status":200,"data":{"upper_menu_items":{"footer":[{"title":"About us","external":0,"relative":"/about","expanded":0,"enabled":1},{"title":"Contact us","external":0,"relative":"/about/contact","expanded":0,"enabled":1},{"title":"Partnerships","external":0,"relative":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"Blog","external":0,"relative":"/blog","expanded":0,"enabled":1}],"footer-1":[{"title":"Journals","external":0,"relative":"/journals","expanded":0,"enabled":1},{"title":"Article Processing Charges","external":0,"relative":"/publish-research/authors/article-processing-charges","expanded":0,"enabled":1},{"title":"Print editions","external":0,"relative":"/print-editions","expanded":0,"enabled":1}],"footer-2":[{"title":"Authors","external":0,"relative":"/publish-research/authors","expanded":0,"enabled":1},{"title":"Editors","external":0,"relative":"/publish-research/editors","expanded":0,"enabled":1},{"title":"Reviewers","external":0,"relative":"/publish-research/reviewers","expanded":0,"enabled":1}],"footer-3":[{"title":"Hindawi XML Corpus","external":0,"relative":"/hindawi-xml-corpus","expanded":0,"enabled":1},{"title":"Open Archives Initiative","external":0,"relative":"/open-archives-initiative","expanded":0,"enabled":1},{"title":"Fraud prevention","external":0,"relative":"/preventing-and-protecting-against-fraud","expanded":0,"enabled":1}]},"lower_menu_items":{"lower-footer":[{"title":"Privacy Policy","external":0,"relative":"/privacy","expanded":0,"enabled":1},{"title":"Terms of Service","external":0,"relative":"/terms","expanded":0,"enabled":1},{"title":"Responsible Disclosure Policy","external":0,"relative":"/responsible-disclosure-policy","expanded":0,"enabled":1},{"title":"Cookie Policy","external":0,"relative":"/cookie-policy","expanded":0,"enabled":1},{"title":"Copyright","external":0,"relative":"/copyright","expanded":0,"enabled":1},{"title":"Modern slavery statement","external":0,"relative":"/modern-slavery-statement","expanded":0,"enabled":1}]},"config":{"footer_config_logo":"","footer_config_copyright":""}},"headers":{},"journalCode":"bmri"},"isLiveUrl":true,"advMsg":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","statusCode":false,"showPreviewButtons":false,"currentPath":"/journals/bmri/2013/210604/","bibblioKey":"0d7b3db3-a45f-4dfa-b751-991c0907e6ab","assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","headerData":{"status":200,"data":{"header_menu_items":{"header-menu":[{"title":"Journals","external":0,"link":"/journals","expanded":0,"enabled":1},{"title":"Publish with us","external":0,"link":"/publish-research","expanded":0,"enabled":1},{"title":"Publishing partnerships","external":0,"link":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"About us","external":0,"link":"/about","expanded":0,"enabled":1},{"title":"Blog","external":0,"link":"/blog","expanded":0,"enabled":1}]}},"headers":{}},"theme":"HINDAWI","sharingOptions":["facebook","twitter","linkedin","wechat","mail"],"useJournalEtocPages":true,"isUserFromChina":false,"useLazyLoad":false,"hasJournalReportPage":false},"ceased":false,"journalAlias":"/journals/bmri","journalNavigationBarData":{"items":[{"title":"Journal overview","link":"/journals/bmri/jo","key":"jo","children":[{"title":"About this Journal","link":"/journals/bmri/about","key":"about"},{"title":"Editorial Board","link":"/journals/bmri/editors","key":"editors"},{"title":"Peer Review Process","link":"/journals/bmri/prp","key":"prp"},{"title":"Publication Ethics","link":"/publish-research/authors/publication-ethics","key":"pe"},{"title":"Abstracting and Indexing","link":"/journals/bmri/ai","key":"ai"},{"title":"Article Processing Charges","link":"/journals/bmri/apc","key":"apc"}]},{"title":"For authors","link":"/journals/bmri/guidelines","key":"guidelines","children":[]},{"title":"For reviewers","link":"/publish-research/reviewers","key":"fr","children":[]},{"title":"For editors","link":"/publish-research/editors","key":"fe","children":[]},{"title":"Table of Contents","link":"/journals/bmri/contents/year/2022","children":[]},{"title":"Special Issues","link":"/journals/bmri/si","children":[{"title":"Open Special Issues","link":"/journals/bmri/osi","key":"osi"},{"title":"Published Special Issues","link":"/journals/bmri/psi","key":"psi"},{"title":"Propose Special Issue","link":"/publish-research/editors/special-issues/proposing-special-issue","key":"prsi"},{"title":"About Special Issues","link":"/publish-research/editors/special-issues","key":"asi"}]}],"archived":false,"navText":""},"journalUrl":"/journals/bmri","article":{"retracted":false,"related_articles":[{"title":"Research Article","link":"/journals/bmri/2013/210604/","childrens":[]},{"title":"Retraction","link":"/journals/bmri/2020/1915927","childrens":[]},{"title":"Erratum","link":"/journals/bmri/2014/386742","childrens":[{"special_issue":false,"volume":"2014","pdf":"downloads.hindawi.com/journals/bmri/2014/386742.pdf","abstract":"","id":"386742","type":"Erratum","title":"Erratum to \u0026#x201c;Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells\u0026#x201d;","date":"14 Jul 2014","journal":"BioMed Research International","alias":"/journals/bmri/2014/386742","authors":[{"name":"Young-Man Lee"},{"name":"Q-Schick Auh"},{"name":"Deok-Won Lee"},{"name":"Jun-Yeol Kim"},{"name":"Ha-Jin Jung"},{"name":"Seung-Ho Lee"},{"name":"Eun-Cheol Kim"}],"reference":"/journals/bmri/2014/386742.ris"}]}],"id":"210604","title":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells","title_toc":"Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells","type":"Research Article","volume":2013,"pub_year":"2013","article_id":"210604","pages":14,"first_page":"","last_page":"","issue_no":"","doi":"https://doi.org/10.1155/2013/210604","doi_simple":"10.1155/2013/210604","shorten_url":"https://doi.org/10.1155/2013/210604","inPress":false,"academic_editors":[{"name":"George Perry"}],"guest_editors":[],"published_date":"02 May 2013","received_date":"12 Feb 2013","revised_date":"03 Apr 2013","accepted_date":"05 Apr 2013","authors":[{"name":"Young-Man Lee","email":"","orcid":"","sup":["1"]},{"name":"Q-Schick Auh","email":"","orcid":"","sup":["2"]},{"name":"Deok-Won Lee","email":"","orcid":"","sup":["3"]},{"name":"Jun-Yeol Kim","email":"","orcid":"","sup":["1"]},{"name":"Ha-Jin Jung","email":"","orcid":"","sup":["1"]},{"name":"Seung-Ho Lee","email":"","orcid":"","sup":["4"]},{"name":"Eun-Cheol Kim","email":"rk.ca.uhk@mikce","orcid":"","sup":["1"]}],"affiliations":[{"id":"1","text":"Department of Maxillofacial Tissue Regeneration and Research Center for Tooth \u0026 Periodontal Regeneration, School of Dentistry, Kyung Hee University, 1 Heogi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea"},{"id":"2","text":"Department of Oral Medicine, School of Dentistry, Kyung Hee University, Heogi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea"},{"id":"3","text":"Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyung Hee University, Heogi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea"},{"id":"4","text":"College of Pharmacy, College of Pharmacy, Yeungnam University, Gyeongsan 712-749, Republic of Korea"}],"is_special_issue":0,"special_issue_details":{"title":"","url":""},"body":"\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"header\" id=\"abstract\"\u003eAbstract\u003c/h4\u003e\u003cp\u003eAlthough previous studies have shown that mollugin, a bioactive phytochemical isolated from \u003ci\u003eRubia cordifolia\u003c/i\u003e L. (Rubiaceae), exhibits antitumor effects, its biological activity in oral cancer has not been reported. We thus investigated the effects and putative mechanism of apoptosis induced by mollugin in human oral squamous cell carcinoma cells (OSCCs). Results show that mollugin induces cell death in a dose-dependent manner in primary and metastatic OSCCs. Mollugin-induced cell death involved apoptosis, characterized by the appearance of nuclear shrinkage, flow cytometric analysis of sub-G\u003csub\u003e1\u003c/sub\u003e phase arrest, and annexin V-FITC and propidium iodide staining. Western blot analysis and RT-PCR revealed that mollugin suppressed activation of NF-\u003ci\u003eκ\u003c/i\u003eB and NF-\u003ci\u003eκ\u003c/i\u003eB-dependent gene products involved in antiapoptosis (Bcl-2 and Bcl-xl), invasion (MMP-9 and ICAM-1), and angiogenesis (FGF-2 and VEGF). Furthermore, mollugin induced the activation of p38, ERK, and JNK and the expression of heme oxygenase-1 (HO-1) and nuclear factor E2–related factor 2 (Nrf2). Mollugin-induced growth inhibition and apoptosis of HO-1 were reversed by an HO-1 inhibitor and Nrf2 siRNA. Collectively, this is the first report to demonstrate the effectiveness of mollugin as a candidate for a chemotherapeutic agent in OSCCs via the upregulation of the HO-1 and Nrf2 pathways and the downregulation of NF-\u003ci\u003eκ\u003c/i\u003eB.\u003c/p\u003e\u003cspan class=\"end-abs\"\u003e\u003c/span\u003e\u003ch4 id=\"introduction\"\u003e1. Introduction\u003c/h4\u003e\u003cp\u003eOral squamous cell carcinoma (OSCC) represents the fifth most common cancer worldwide and is a significant cause of cancer morbidity and mortality. Each year, approximately 300,000 new cases are diagnosed with only a 50% survival rate over 5 years. Common treatments, including surgery, radiation therapy, and chemotherapy, have very low success rates [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e]. Two of the most frequently used chemotherapeutic drugs, 5-fluorouracil and cisplatin, cause side effects such as bone marrow suppression, gastrointestinal toxicity, and renal damage, which remain problems that need to be resolved [\u003ca href=\"#B2\"\u003e2\u003c/a\u003e]. To overcome such side effects and limitations, the direction of present research into novel antitumor agents has turned to natural products, especially plants used in traditional medicine [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e]. Previously, we demonstrated that highly purified sulfur [\u003ca href=\"#B4\"\u003e4\u003c/a\u003e] and herbal medicines, such as \u003ci\u003eCaesalpinia sappan\u003c/i\u003e [\u003ca href=\"#B5\"\u003e5\u003c/a\u003e], \u003ci\u003eCoptidis rhizoma \u003c/i\u003e[\u003ca href=\"#B6\"\u003e6\u003c/a\u003e], and verticinone [\u003ca href=\"#B7\"\u003e7\u003c/a\u003e], exerted antitumor effects on oral cancer cells\u003ci\u003e in vitro.\u003c/i\u003e Moreover, we showed that a single compound isolated from \u003ci\u003eCaesalpinia sappan\u003c/i\u003e heartwood, isoliquiritigenin 2′-methyl ether (ILME), had antioral cancer effects involving mitogen-activated protein kinases (MAPKs) and the nuclear factor-\u003ci\u003eκ\u003c/i\u003eB (NF-\u003ci\u003eκ\u003c/i\u003eB) pathway [\u003ca href=\"#B8\"\u003e8\u003c/a\u003e]. In addition, we reported that a flavonoid extracted from \u003ci\u003eCaesalpinia sappan\u003c/i\u003e, sappanchalcone, suppressed oral cancer cell growth and induced apoptosis through activation of p53-dependent mitochondrial MAPK and NF-\u003ci\u003eκ\u003c/i\u003eB signaling [\u003ca href=\"#B9\"\u003e9\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eThe roots of \u003ci\u003eRubia cordifolia\u003c/i\u003e L. have been widely used as a traditional herbal medicine in Korea to treat cough, bladder and kidney stones, joint inflammation, uterine hemorrhage, and uteritis [\u003ca href=\"#B10\"\u003e10\u003c/a\u003e]. In addition, this plant has been used in traditional Chinese medicine for the treatment of arthritis, dysmenorrheal, hematorrhea, hemostasis, and psoriasis [\u003ca href=\"#B11\"\u003e11\u003c/a\u003e, \u003ca href=\"#B12\"\u003e12\u003c/a\u003e]. Among the bioactive components from \u003ci\u003eRubia cordifolia\u003c/i\u003e, mollugin (C\u003csub\u003e17\u003c/sub\u003eH\u003csub\u003e16\u003c/sub\u003eO\u003csub\u003e4\u003c/sub\u003e; methyl 2,2-dimethyl-6-hydroxy-\u003ci\u003e2H\u003c/i\u003e-naphtho[1,2-\u003ci\u003eb\u003c/i\u003e]pyran-5-carboxylate) has been reported to have antitumor and anti-inflammatory activities, and neuroprotective and apoptotic effects [\u003ca href=\"#B13\"\u003e13\u003c/a\u003e–\u003ca href=\"#B16\"\u003e16\u003c/a\u003e]. A recent study demonstrated that mollugin induced apoptosis through endoplasmic reticulum stress-mediated activation of c-Jun N-terminal kinase (JNK) and the mitochondria-dependent caspase cascade, regulated by Bcl-xL in human Jurkat T cells [\u003ca href=\"#B14\"\u003e14\u003c/a\u003e]. Moreover, mollugin inhibited proliferation and induced apoptosis by suppressing fatty acid synthase in HER2-overexpressing human breast and ovarian cancer cells [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eHeme oxygenase-1 (HO-1) is an inducible cytoprotective enzyme that catalyzes the initial rate-limiting reaction in heme catabolism. Previously, we reported that the HO-1 pathway plays a key role in the adaptation of cells to stressful conditions and the recovery of dental pulp cells and periodontal ligament cells from injury [\u003ca href=\"#B18\"\u003e18\u003c/a\u003e–\u003ca href=\"#B20\"\u003e20\u003c/a\u003e]. Despite its cytoprotective properties, recent evidence suggests a role for HO-1 in promoting cancer [\u003ca href=\"#B21\"\u003e21\u003c/a\u003e]. HO-1 is overexpressed in various types of cancer and is further induced by radiation and chemotherapy [\u003ca href=\"#B22\"\u003e22\u003c/a\u003e, \u003ca href=\"#B23\"\u003e23\u003c/a\u003e]. Regarding the mechanisms of HO-1 induction, several studies have suggested the involvement of MAPK and NF-\u003ci\u003eκ\u003c/i\u003eB pathways, as well as nuclear factor erythroid 2–related factor 2 (Nrf2) [\u003ca href=\"#B18\"\u003e18\u003c/a\u003e, \u003ca href=\"#B24\"\u003e24\u003c/a\u003e]. However, the precise cellular mechanisms of mollugin on OSCCs are not completely understood.\u003c/p\u003e\u003cp\u003eThe aim of this study was to investigate the chemotherapeutic effect of mollugin on human primary and metastatic OSCCs \u003ci\u003ein vitro\u003c/i\u003e. In addition, we further explored whether the effect of mollugin is related to Nrf2 activation and HO-1 expression.\u003c/p\u003e\u003ch4 id=\"materials-and-methods\"\u003e2. Materials and Methods \u003c/h4\u003e\u003ch5 id=\"sec2.1\"\u003e2.1. Reagents\u003c/h5\u003e\u003cp\u003eMollugin was isolated from root of heartwood of \u003ci\u003eRubia cordifolia\u003c/i\u003e L. as described previously [\u003ca href=\"#B13\"\u003e13\u003c/a\u003e]. Antibody against NF-\u003ci\u003eκ\u003c/i\u003eB p65, I\u003ci\u003eκ\u003c/i\u003eB, Nrf2, Bcl-xL, Bcl-2, p53, p21, or phosphorylated isoforms of I\u003ci\u003eκ\u003c/i\u003eB and horseradish peroxidase-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology (Delaware Avenue, CA). ERK, JNK, p38 or phosphorylation of ERK, JNK, and p38 were purchased from Cell signaling, Inc. (Beverly, MA). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), and other tissue culture reagents were purchased from Gibco BRL (Grand Island, NY). All  other chemicals were obtained from Sigma (St. Louis, MO), unless indicated otherwise. \u003c/p\u003e\u003ch5 id=\"sec2.2\"\u003e2.2. Cell Culture\u003c/h5\u003e\u003cp\u003eThe cell line HNSCC4 (HN4), from a primary OSCCs, and cell line HNSCC12 (HN12), from a metastatic carcinoma of the OSCCs [\u003ca href=\"#B25\"\u003e25\u003c/a\u003e], were derived in the laboratory of Dr. John F. Ensley (Wayne State University). Cells were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 \u003ci\u003eμ\u003c/i\u003eg/mL streptomycin in a humidified atmosphere of 5% CO\u003csub\u003e2\u003c/sub\u003e at 37°C. Cells were dissociated with 0.25% trypsin just before transferring for experiments and counted using a hemocytometer.\u003c/p\u003e\u003cp\u003eHuman keratinocyte cell line HaCaT (nontransformed human cell line) were incubated in DMEM supplemented with 10% FBS, 1 mM sodium pyruvate, 50 \u003ci\u003eμ\u003c/i\u003eg/mL streptomycin, and 50 \u003ci\u003eμ\u003c/i\u003eg/mL penicillin at 37°C in 5% CO\u003csub\u003e2\u003c/sub\u003e. Human gingival fibroblasts (HGFs) cell line by transfection with the E6/E7 open reading frames of HPV type 16 was cultured according to the following protocol, as reported by our study [\u003ca href=\"#B26\"\u003e26\u003c/a\u003e]. Briefly, HGFs were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 \u003ci\u003eμ\u003c/i\u003eg/mL streptomycin in a humidified atmosphere of 5% CO\u003csub\u003e2\u003c/sub\u003e at 37°C.\u003c/p\u003e\u003ch5 id=\"sec2.3\"\u003e2.3. Antiproliferative Assay\u003c/h5\u003e\u003cp\u003eCell viability was determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, cells were seeded in flat-bottomed 96-well plates, at 1 × 10\u003csup\u003e5\u003c/sup\u003e cell/well 24 h prior to treatment. The cells were treated for various lengths of time with the agents indicated. Then 25 \u003ci\u003eμ\u003c/i\u003eL of 5 mg/mL MTT was added to each well. After 4 h incubation at 37°C, 100 \u003ci\u003eμ\u003c/i\u003eL of lysing buffer was added. The buffer consisted of 20% w/v of sodium dodecyl sulfate in 0.1% of HCl solution. The plates were incubated for a further analysis on an ELISA reader at 570 nm. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations.\u003c/p\u003e\u003ch5 id=\"sec2.4\"\u003e2.4. Flow Cytometry\u003c/h5\u003e\u003ch6 id=\"sec2.4.1\"\u003e2.4.1. Propidium Iodide (PI) Staining\u003c/h6\u003e\u003cp\u003eCells were seeded at 5 × 10\u003csup\u003e5 \u003c/sup\u003ecells/well in six-well plates. After 24 h, cells were treated with mollugin the 3 days. After treatment, cells were harvested and pelleted by centrifugation (400 ×g, 4°C, 5 min). The cells were fixed with cold 75% ethanol for 24 h and then stained with PI solution, consisting of 45 mg/mL PI, 10 mg/mL RNase A, and 0.1% Triton X-100. After incubation in the dark at 4°C for 1 h, fluorescence-activated cells were sorted using the FACScan flow cytometer, and the data were analyzed using Cellfit Analysis Software. \u003c/p\u003e\u003ch5 id=\"sec2.5\"\u003e2.5. Fluorescein-Isothiocyanate-(FITC-) Annexin V and Propidium Iodide (PI) Double Staining\u003c/h5\u003e\u003cp\u003eCells (5 × 10\u003csup\u003e5\u003c/sup\u003e) were seeded in 6-well plates, incubated for 24 h, and then treated with or without mollugin, and the incubation was continued for 3 days. After treatment, the cell pellet was prepared in a FACStar tube containing annexin V-FITC solution and incubated in 5% CO\u003csub\u003e2\u003c/sub\u003e at 37°C. The PI solution (without NP 40) was then added, and the ratio of PI-positive and annexin V-positive cells was measured using the flow cytometer. \u003c/p\u003e\u003ch5 id=\"sec2.6\"\u003e2.6. Morphological Analysis of Apoptosis by Staining with 4′,6-Diamino-2-Phenylindole Dihydrochloride (DAPI)\u003c/h5\u003e\u003cp\u003eTo confirm that the nuclei underwent morphological changes, the cells were cultured in 60 mm dishes overnight and then washed twice in DMEM. The cells were then treated with mollugin and fixed in 4% paraformaldehyde, after which they were incubated in 1 \u003ci\u003eμ\u003c/i\u003eg/mL DAPI solution for 30 min in the dark. The cells were then examined using a fluorescence microscope (Zeiss, Oberköchen, Germany). \u003c/p\u003e\u003ch5 id=\"sec2.7\"\u003e2.7. Western Blot Analysis\u003c/h5\u003e\u003cp\u003eWestern blot analysis was performed by lysing cells in 20 mM Tris-HCl buffer (pH 7.4) containing protease inhibitor mixture (0.1 mM phenylmethanesulfonyl fluoride, 5 mg/mL aprotinin, 5 mg/mL pepstatin A, and 1 mg/mL chymostatin). Protein concentration was determined using the Lowry protein assay kit (P5626; Sigma). An equal amount of protein for each sample was resolved using 7% or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then electrophoretically transferred onto a Hybond-enhanced chemiluminescence (ECL) nitrocellulose membrane (Bio-Rad, Hercules, CA). The membrane was blocked with 5% skim milk and sequentially incubated with primary antibody (Santa Cruz Biotechnology) and horseradish peroxidase-conjugated secondary antibody followed by ECL detection (Amersham Pharmacia Biotech, Piscataway, NJ).\u003c/p\u003e\u003ch5 id=\"sec2.8\"\u003e2.8. Isolation of RNA and RT-PCR\u003c/h5\u003e\u003cp\u003eTotal RNA was isolated using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions. It was then reverse-transcribed using AccuPower RT premix (Bioneer, Daejeon, Korea). The PCR amplification of the resulting cDNA samples was performed using a GeneAmp PCR System 2400 thermal cycler (PerkinElmer, Wellesley, MA, USA). The primers information is summarized in Table \u003ca href=\"tab1/\" target=\"_blank\"\u003e1\u003c/a\u003e. The following PCR conditions were used: 34 cycles of denaturation at 95°C for 30 s, primer annealing at 60°C for 30 s, and extension at 72°C for 30 s. The PCR products were resolved on 1-2% agarose gels and stained with ethidium bromide.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-other-wrapper\" data-section=\"tab1\"\u003e\u003cdiv class=\"floats-partial-content fig-content-tab1\"\u003e\u003ctable class=\"table-group\" id=\"tab1\"\u003e\u003ctr\u003e\u003ctd\u003e\u003ctable class=\"table\"\u003e\u003ctr\u003e\u003ctd class=\"thead-hr\" colspan=\"3\"\u003e\u003chr /\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr class=\"thead\"\u003e\u003ctd align=\"left\"\u003eGene\u003c/td\u003e\u003ctd align=\"center\"\u003eSequence 5′-3′\u003c/td\u003e\u003ctd align=\"center\"\u003eSize\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd class=\"thead-hr\" colspan=\"3\"\u003e\u003chr /\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003eMMP-9\u003c/td\u003e\u003ctd align=\"center\"\u003eForward: GTTGGGGAGGGCTGTCCGTGA\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003e911 bp\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eReverse: CGTGGCGCTATCCAGCTCACC\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003eICAM-1\u003c/td\u003e\u003ctd align=\"center\"\u003eForward: CGCCCGATTGCTTTAGCTTG\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003e320 bp\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eReverse: CGACTCACCTGGGAACAGAG\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003eVEGF\u003c/td\u003e\u003ctd align=\"center\"\u003eForward: TCAAGGTTGGCGGAAGTGAGG\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003e443 bp\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eReverse: CCCTTGCATCAGTAGGCTTCA\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003eFGF2\u003c/td\u003e\u003ctd align=\"center\"\u003eForward: GCCTCATTTCCATTTCGTGG\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003e224 bp\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eReverse: CGGGGGTACTGGTTTACAG\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003e\u003csvg height=\"16.6625\" id=\"M1\" style=\"vertical-align:-3.56265pt\" version=\"1.1\" viewbox=\"0 0 10 16.6625\" width=\"10\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,12.162)\"\u003e\u003cpath d=\"M558 587q0 -32 -14 -61t-40 -53.5t-48.5 -41t-54.5 -36.5q144 -51 144 -174q0 -55 -43.5 -108t-104.5 -87q-77 -42 -131 -42q-31 0 -54 20t-31 47l11 18q48 -29 108 -29q79 0 119.5 43t40.5 109t-44.5 107.5t-119.5 50.5l22 47q34 1 65 21q96 61 96 157q0 42 -24 67.5\u0026#10;t-62 25.5q-24 0 -43.5 -9t-35 -29.5t-27 -44t-22.5 -63t-19.5 -75.5t-18.5 -91q-57 -294 -68 -380q-26 -190 -35 -200q-26 -31 -97 -37l-4 26q19 9 48 170l77 413q23 121 52.5 187.5t83.5 114.5q70 62 148 62q51 0 88.5 -34t37.5 -91z\" id=\"x1D6FD\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e-actin\u003cbr /\u003e\u003ci\u003e　\u003c/i\u003e\u003c/td\u003e\u003ctd align=\"center\"\u003eForward: CATGGATGATGATATCGCCGC\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003e319 bp\u003cbr /\u003e\u003ci\u003e　\u003c/i\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eReverse: ACATGATCTGGGTCATCTTCT\u003c/td\u003e\u003c/tr\u003e\u003ctr class=\"table-tr\"\u003e\u003ctd colspan=\"3\"\u003e\u003chr class=\"tbody-hr\" /\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eTable 1\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"tab1/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003eReverse transcriptase-polymerase chain reaction primers.\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003e\u003c/p\u003e\u003ch5 id=\"sec2.9\"\u003e2.9. HO-1 and Nrf2 siRNA Transfection\u003c/h5\u003e\u003cp\u003eThe target sequence for human HO-1 siRNA was 5′-AACUUUCAGAAGGGCCAGGUGTT-3′ (forward) and 5′-CACCUGGCCCUUCUGAAAGUUTT-3′ (reverse). Transfection of Nrf2 siRNA was performed using the target sequence 5′-AAGAGUAUGAGCUGGAAAAACTT-3′ (forward) and 5′-GUUUUUCCAGCUCAUACUCUUTT-3′ (reverse). Cells were transfected with siRNA using Lipofectamine RNAiMAX (Invitrogen) according to the manufacture’s instruction. Silencer Negative Control siRNA (Invitrogen) was introduced into cells by the same method. Following transfection, cells were cultured in six-well plates at 37°C until required.\u003c/p\u003e\u003ch5 id=\"sec2.10\"\u003e2.10. Statistical Analysis\u003c/h5\u003e\u003cp\u003eData are expressed as the mean ± standard deviation. Statistical comparisons of the results were made using analysis of variance (ANOVA). Significant differences (\u003csvg height=\"11.375\" id=\"M2\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e) between the means of control and sulfur-treated cells were analyzed using Dunnett’s test. \u003c/p\u003e\u003ch4 id=\"results\"\u003e3. Results\u003c/h4\u003e\u003ch5 id=\"sec3.1\"\u003e3.1. Effect of Mollugin on HN4 and HN12 Cell Viability\u003c/h5\u003e\u003cp\u003eTo investigate the effect of mollugin on the proliferation of human OSCCs, the MTT assay was used. As shown in Figure \u003ca href=\"fig1/\" target=\"_blank\"\u003e1\u003c/a\u003e, mollugin inhibited cellular proliferation in a dose- and time-dependent manner. Moreover, mollugin displayed higher cytotoxicity in primary OSCC HN4 cells compared with metastatic OSCC HN12 cells, although the overall trend of the effects of mollugin on HN4 and HN12 cells was similar. Furthermore, we tested whether mollugin has any toxic effect on nonneoplastic human skin keratinocytes (HaCaT) and  gingival fibroblasts (GF). Interestingly, we did not find significant cytotoxicity or cell death by mollugin on HaCaT and GF (Figures \u003ca href=\"fig1/#c\" target=\"_blank\"\u003e1(c)\u003c/a\u003e and \u003ca href=\"fig1/#d\" target=\"_blank\"\u003e1(d)\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig1\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig1\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.001a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.001b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.001c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"210604.fig.001d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig1\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.001a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.001b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.001c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"210604.fig.001d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.001d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig1\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 1\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig1/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of mollugin on cell viability in primary (HN4, (a)), metastatic oral cancer cells (HN12, (b)), skin keratinocytes (HaCaT, (c)), and gingival fibroblasts (d) as measured by MTT assay. *Statistically significant difference as compared to control, \u003csvg height=\"11.375\" id=\"M3\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.2\"\u003e3.2. Effect of Mollugin on HN4 and HN12 Cell Apoptosis\u003c/h5\u003e\u003cp\u003eTo determine whether the cause of cell death was apoptosis, HN4 and HN12 cells were exposed to 40 \u003ci\u003eμ\u003c/i\u003eM mollugin for 3 days. This concentration was used because it reproducibly induced 50% growth inhibition in HN4 and HN12 cells cultured for 3 days. Cell nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI), a fluorescent DNA-binding dye (Figure \u003ca href=\"fig2/#a\" target=\"_blank\"\u003e2(a)\u003c/a\u003e). DAPI staining showed that the control nuclei were large and round without condensation or fragmentation, whereas most of the nuclei of mollugin-treated cells were condensed and fragmented, as is typical during apoptosis. The onset of apoptotic cell death by mollugin was confirmed by flow cytometry of HN4 and HN12 cells (Figure \u003ca href=\"fig2/#b\" target=\"_blank\"\u003e2(b)\u003c/a\u003e). Without treatment, only 3.88% HN4 and 2.80% HN12 cells were in the sub-G\u003csub\u003e1\u003c/sub\u003e region; however, mollugin treatment increased the proportions of cells in the sub-G\u003csub\u003e1\u003c/sub\u003e region to 20.26% and 31.46%, respectively. To determine whether the growth inhibitory effect of mollugin is associated with cell death, annexin V-propidium iodide (PI) double staining of HN4 and HN12 cells and flow cytometry was performed (Figure \u003ca href=\"fig2/#c\" target=\"_blank\"\u003e2(c)\u003c/a\u003e). Treatment of cells with mollugin for 3 days increased the number of annexin V\u003csup\u003e+\u003c/sup\u003e/PI\u003csup\u003e+\u003c/sup\u003e stained cells. These results demonstrate that the inhibition of cell growth by mollugin was caused by the induction of apoptosis.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig2\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig2\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.002a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.002b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.002c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig2\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.002a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.002b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.002c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.002c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig2\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 2\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig2/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eConfirmation of mollugin-induced apoptosis by DAPI staining (a), cell cycle analysis (b), and annexin V-PI staining (c) in OSCCs. Cells were incubated with 40 \u003ci\u003eμ\u003c/i\u003eM mollugin for 3 days. Data are presented as mean ± SD from triplicate determinations (b, c). Results are representative from three independent experiments (a)–(c). \u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.3\"\u003e3.3. Effect of Mollugin on NF-\u003ci\u003eκ\u003c/i\u003eB Activation and Expression of NF-\u003ci\u003eκ\u003c/i\u003eB-Regulated Genes\u003c/h5\u003e\u003cp\u003eSince NF-\u003ci\u003eκ\u003c/i\u003eB transcription factors and their upstream activating molecules are attractive targets for cancer therapeutics, we evaluated the effect of mollugin on NF-\u003ci\u003eκ\u003c/i\u003eB activation by measuring the phosphorylation and degradation of I\u003ci\u003eκ\u003c/i\u003eB\u003ci\u003eα\u003c/i\u003e and NF-\u003ci\u003eκ\u003c/i\u003eB p65. As shown in Figure \u003ca href=\"fig3/#a\" target=\"_blank\"\u003e3(a)\u003c/a\u003e, treatment of HN4 and HN12 cells with mollugin decreased the steady-state levels of phosphorylated I\u003ci\u003eκ\u003c/i\u003eB\u003ci\u003eα\u003c/i\u003e and nuclear NF-\u003ci\u003eκ\u003c/i\u003eB p65.\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig3\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig3\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.003a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.003b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.003c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig3\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.003a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.003b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.003c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.003c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig3\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 3\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig3/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of mollugin on activation of NF-\u003ci\u003eκ\u003c/i\u003eB (a), and expression of NF-\u003ci\u003eκ\u003c/i\u003eB-regulated gene products involved in apoptosis and antiapoptosis (b), metastasis, and angiogenesis (c) in OSCCs. Cells were treated with 40 \u003ci\u003eμ\u003c/i\u003eM mollugin for indicated times (a) or 3 days (b, c). The figure is representative of 3 independent experiments.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003eTo clarify the molecular mechanism by which mollugin induces apoptosis in primary and metastatic OSCCs, we determined the levels of NF-\u003ci\u003eκ\u003c/i\u003eB-regulated gene products involved in apoptosis and antiapoptosis (Figure \u003ca href=\"fig3/#b\" target=\"_blank\"\u003e3(b)\u003c/a\u003e). Mollugin treatment upregulated p53 and p21 expression in both HN4 and HN12 cells in a dose-dependent manner. In contrast, the expression of antiapoptotic Bcl-2 and Bcl-xl proteins was dose-dependently reduced by mollugin treatment in HN4 and HN12 cells. Next, we investigated whether mollugin could modulate levels of NF-\u003ci\u003eκ\u003c/i\u003eB-regulated gene products involved in invasion (ICAM-1 and MMP-9) and angiogenesis (VEGF and FGF-2) of OSCCs. The results show that mollugin downregulated the expression of NF-\u003ci\u003eκ\u003c/i\u003eB-regulated gene products, including MMP-9, ICAM-1, VEGF, and FGF-2 mRNA in a dose-dependent manner (Figure \u003ca href=\"fig3/#c\" target=\"_blank\"\u003e3(c)\u003c/a\u003e).\u003c/p\u003e\u003ch5 id=\"sec3.4\"\u003e3.4. Effect of Mollugin on MAPK and Nrf2 Activation\u003c/h5\u003e\u003cp\u003eTo clarify the mechanism underlying the apoptosis, we assessed the effect of mollugin on Nrf2 and NF-\u003ci\u003eκ\u003c/i\u003eB upstream pathways. Treatment with mollugin (40 \u003ci\u003eμ\u003c/i\u003eM) increased levels of phosphorylated (activated) ERK, p38, and JNK; the phosphorylated proteins were easily detectable by Western blot after 30 or 60 min. In contrast, mollugin did not affect total p38, ERK, or JNK levels (Figure \u003ca href=\"fig4/#a\" target=\"_blank\"\u003e4(a)\u003c/a\u003e). \u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig4\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig4\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.004a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.004b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.004c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"210604.fig.004d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig4\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.004a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.004b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.004c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"210604.fig.004d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.004d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig4\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 4\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig4/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffect of mollugin on phosphorylation of MAPK (a), activation of Nrf2 (b), and expression of HO-1 (c) in OSCCs. Effects of MAP kinase inhibitors on mollugin-induced activation of NF-\u003ci\u003eκ\u003c/i\u003eB, Nrf2, and HO-1 (d). Cells were treated with 40 \u003ci\u003eμ\u003c/i\u003eM mollugin for indicated times (a)–(c). Cells were pretreated with the p38 inhibitor SB203580 (20 \u003ci\u003eμ\u003c/i\u003eM/L), the ERK inhibitor PD98059 (20 \u003ci\u003eμ\u003c/i\u003eM/L), or the JNK inhibitor SP600125 (20 \u003ci\u003eμ\u003c/i\u003eM/L) for 1 hour and treated with 40 \u003ci\u003eμ\u003c/i\u003eM mollugin for 30 min (MAPK, Nrf2, and NF-\u003ci\u003eκ\u003c/i\u003eB) or 3 days (HO-1). The results are representative of three independent experiments.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003eSince the stress response element/Nrf2 transcription factor pathway is important for HO-1 expression [\u003ca href=\"#B23\"\u003e23\u003c/a\u003e], we next determined whether Nrf2 signaling is involved in mollugin-induced HO-1 expression and apoptosis. Initially, Nrf2 activation was assessed by the accumulation of Nrf2 in the nucleus. Treatment with mollugin resulted in an accumulation of Nrf2 in the nucleus in primary and metastatic OSCCs (Figure \u003ca href=\"fig4/#b\" target=\"_blank\"\u003e4(b)\u003c/a\u003e).\u003c/p\u003e\u003cp\u003eTo determine whether mollugin induces expression of antioxidant genes, HO-1 expression in oral cancer cells and the change in the pattern of HO-1 expression were evaluated. HO-1 protein expression in primary and metastatic OSCCs increased following mollugin treatment in a time-dependent manner (Figure \u003ca href=\"fig4/#c\" target=\"_blank\"\u003e4(c)\u003c/a\u003e).\u003c/p\u003e\u003cp\u003eTo confirm the involvement of MAPK pathways in the mollugin-driven activation of NF-\u003ci\u003eκ\u003c/i\u003eB and Nrf2, inhibitors of ERK (PD98059), JNK (SP6100126), and p38 (SB203580) MAPK signaling were used. Mollugin-induced NF-\u003ci\u003eκ\u003c/i\u003eB, Nrf2, and HO-1 expression was effectively inhibited by PD98059, SP600126, and SB203580 (Figure \u003ca href=\"fig4/#d\" target=\"_blank\"\u003e4(d)\u003c/a\u003e), suggesting that p38, ERK1/2, and JNK play important roles in activating NF-\u003ci\u003eκ\u003c/i\u003eB, Nrf2, and HO-1 in HN4 and HN12 cells.\u003c/p\u003e\u003ch5 id=\"sec3.5\"\u003e3.5. Involvement of the HO-1 Pathway in Mollugin-Induced Apoptosis\u003c/h5\u003e\u003cp\u003eTo examine the cytotoxic potential of tin protoporphyrin (SnPP), an HO-1 inhibitor, its effect on viability was initially measured by the MTT assay (Figure \u003ca href=\"fig5/#a\" target=\"_blank\"\u003e5(a)\u003c/a\u003e). Although, 10 or 20 \u003ci\u003eμ\u003c/i\u003eM SnPP had no cytotoxicity effect for 3 h, we found that SnPP exhibited slight cytotoxicity on HN4 and HN12 cells at 16 h. Based on these findings, we chose to use SnPP for 3 h. \u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig5\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig5\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.005a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.005b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.005c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"210604.fig.005d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig5\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.005a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.005b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.005c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"210604.fig.005d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.005d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig5\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 5\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig5/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of HO-1 inhibitor (SnPP) on cytotoxicity (a), mollugin-induced growth inhibition (b), apoptosis (c), and apoptosis-related proteins expression (d) in OSCCs. Cells were pretreated with SnPP for 3 h and treated for 3 days with mollugin (b)–(d). Cell viability was examined by MTT assay (a), and apoptosis was examined by flow cytometry (b), respectively. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations (a, b). Data are presented as mean values from triplicate determinations (c). Western data show one representative result of three independent experiments (d). *Statistically significant difference as compared to control, \u003csvg height=\"11.375\" id=\"M4\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e. \u003csup\u003e#\u003c/sup\u003eStatistically significant difference as compared to mollugin, \u003csvg height=\"11.375\" id=\"M5\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003eTo determine whether the induction of HO-1 plays a role in mollugin-induced growth inhibition and apoptosis in OSCCs, cells were treated with SnPP, an HO-1 inhibitor, for 3 h before incubation with mollugin for 3 days. MTT assays showed that mollugin-induced cytotoxicity and apoptosis in HN4 and HN12 cells were dose-dependently reversed by pretreatment with SnPP (Figures \u003ca href=\"fig5/#a\" target=\"_blank\"\u003e5(a)\u003c/a\u003e and \u003ca href=\"fig5/#b\" target=\"_blank\"\u003e5(b)\u003c/a\u003e). In addition, SnPP treatment abolished the induction of p53 and p21\u003csup\u003eWAF1/CIP1\u003c/sup\u003e expression by mollugin, but reversed the expression of Bcl-2 and Bcl-xl (Figure \u003ca href=\"fig5/#c\" target=\"_blank\"\u003e5(c)\u003c/a\u003e).\u003c/p\u003e\u003cp\u003e Additionally, we used a siRNA-expressing plasmid to induce HO-1 gene silencing. HN4 and HN12 cells were transfected with an HO-1-targeting siRNA expression vector (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e). The siRNA approach resulted in high silencing efficacies for HO-1, which was confirmed by Western blot analysis (Figure \u003ca href=\"fig6/#c\" target=\"_blank\"\u003e6(c)\u003c/a\u003e). Silencing of HO-1 significantly attenuated mollugin-induced cytotoxicity (Figure \u003ca href=\"fig6/#a\" target=\"_blank\"\u003e6(a)\u003c/a\u003e) and apoptosis (Figure \u003ca href=\"fig6/#b\" target=\"_blank\"\u003e6(b)\u003c/a\u003e). Moreover HO-1 RNA blocked mollugin-induced Nrf2, p53, and p21 upregulation as well as Bcl-2 and Bcl-xl downregulation (Figure \u003ca href=\"fig6/#c\" target=\"_blank\"\u003e6(c)\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig6\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig6\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.006a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.006b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.006c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig6\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.006a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.006b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.006c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.006c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig6\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 6\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig6/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffects of HO-1 siRNA on mollugin-induced growth inhibition (a), apoptosis (b), and apoptosis-related proteins expression (c) in OSCCs. Cells were pretreated with HO siRNA (30 nM) for 5 h and treated for 3 days with mollugin (a)–(c). Cell viability was examined by MTT assay (a), and apoptosis was examined by flow cytometry (b), respectively. The same experiment was repeated in three separate cultures, and the data were presented as the means ± SD of five observations (a). Data are presented as mean values from triplicate determinations (b). Western data show one representative result of three independent experiments (c). *Statistically significant difference as compared to control, \u003csvg height=\"11.375\" id=\"M6\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e. \u003csup\u003e#\u003c/sup\u003eStatistically significant difference as compared to mollugin, \u003csvg height=\"11.375\" id=\"M7\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.6\"\u003e3.6. Involvement of the Nrf2 Pathway in Mollugin-Induced HO-1 Induction and Apoptosis\u003c/h5\u003e\u003cp\u003eTo investigate whether mollugin-induced apoptosis and HO-1 expression were mediated by Nrf2 activation, a specific small interfering RNA (siRNA) against Nrf2 was used. As shown in Figure \u003ca href=\"fig7/#c\" target=\"_blank\"\u003e7(c)\u003c/a\u003e, transfection with Nrf2 siRNA for 5 h in HN4 and HN12 cells blocked mollugin-induced HO-1 and Nrf2 expression. However, Nrf2 siRNA did not affect the mollugin-induced p65 expression. Transfection with Nrf2 siRNA inhibited mollugin-induced cytotoxicity and apoptosis in HN4 and HN12 cells (Figures \u003ca href=\"fig7/#a\" target=\"_blank\"\u003e7(a)\u003c/a\u003e and \u003ca href=\"fig7/#b\" target=\"_blank\"\u003e7(b)\u003c/a\u003e). Moreover, transfection with Nrf2 siRNA in HN4 and HN12 cells reduced mollugin-induced apoptosis proteins (p53 and p21), but reversed antiapoptosis proteins (Bcl-2 and Bcl-xl) (Figure \u003ca href=\"fig7/#c\" target=\"_blank\"\u003e7(c)\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig7\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig7\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.007a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.007b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.007c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig7\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"210604.fig.007a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"210604.fig.007b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"210604.fig.007c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.007c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig7\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 7\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig7/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEffect of Nrf2 siRNA on mollugin-induced growth inhibition (a), apoptosis (b), and apoptosis-related proteins expression (c). Cells were treated with 40 \u003ci\u003eμ\u003c/i\u003eM mollugin for indicated times (a). Cells were pretreated with Nrf2 siRNA (250 nM) for 5 h and treated for 3 days with mollugin 40 \u003ci\u003eμ\u003c/i\u003em (a)–(c). *Statistically significant difference as compared to control, \u003csvg height=\"11.375\" id=\"M8\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e. \u003csup\u003e#\u003c/sup\u003eStatistically significant difference as compared to mollugin, \u003csvg height=\"11.375\" id=\"M9\" style=\"vertical-align:-0.1638pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e. Data are representative of 3 independent experiments.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch4 id=\"discussion\"\u003e4. Discussion\u003c/h4\u003e\u003cp\u003eThis study is to our knowledge the first to demonstrate that mollugin directly induces growth inhibition and apoptosis in primary and metastatic OSCCs and to address the molecular basis of this effect. \u003c/p\u003e\u003cp\u003eWith regard to antitumor activity, mollugin has been shown to exert cytotoxic effects on human colon cancer (Col2) cells (IC\u003csub\u003e50\u003c/sub\u003e = 12.3 \u003ci\u003eμ\u003c/i\u003eM; [\u003ca href=\"#B11\"\u003e11\u003c/a\u003e]), human liver carcinoma (HepG2) cells (IC\u003csub\u003e50\u003c/sub\u003e value = 60.2 \u003ci\u003eμ\u003c/i\u003eM; [\u003ca href=\"#B10\"\u003e10\u003c/a\u003e]), and basal HER2-expressing human breast cancer cells (IC\u003csub\u003e50\u003c/sub\u003e value = 58 \u003ci\u003eμ\u003c/i\u003eM; [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]). In the present study, we found that mollugin (10–80 \u003ci\u003eμ\u003c/i\u003eM) resulted in significant growth inhibition, with an average IC\u003csub\u003e50\u003c/sub\u003e value of 46.3 \u003ci\u003eμ\u003c/i\u003eM in metastatic OSCCs (HN12) and 43.9 \u003ci\u003eμ\u003c/i\u003eM in primary OSCCs (HN4) after 3 days. These antiproliferative properties of mollugin are consistent with previous reports in human acute leukemia Jurkat T cells [\u003ca href=\"#B14\"\u003e14\u003c/a\u003e] and HER2-overexpressing breast and ovarian cancer cell lines [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. Moreover, we demonstrated that mollugin induced OSCC cell death by triggering apoptosis due to the presence of several apoptotic characteristics, including sub-G\u003csub\u003e1\u003c/sub\u003e phase accumulation, increase in annexin\u003csup\u003e+\u003c/sup\u003e/PI\u003csup\u003e+\u003c/sup\u003e cells, and DNA fragmentation. \u003c/p\u003e\u003cp\u003eNF-\u003ci\u003eκ\u003c/i\u003eB signaling is a ubiquitous pathway in cell proliferation, survival, and apoptosis. Normally, NF-\u003ci\u003eκ\u003c/i\u003eB proteins are inhibited by binding to I\u003ci\u003eκ\u003c/i\u003eB proteins in the cytoplasm. Stress factors cause degradation of I\u003ci\u003eκ\u003c/i\u003eB proteins through the ubiquitin-proteosomal pathway, and NF-\u003ci\u003eκ\u003c/i\u003eB is released to bind to the DNA of promoter regions of specific genes that increases their transcription rate [\u003ca href=\"#B27\"\u003e27\u003c/a\u003e, \u003ca href=\"#B28\"\u003e28\u003c/a\u003e]. To explore the mechanism underlying mollugin-induced apoptosis in OSCCs, we examined NF-\u003ci\u003eκ\u003c/i\u003eB activation. In agreement with previous findings that mollugin suppressed NF-\u003ci\u003eκ\u003c/i\u003eB activation in HER2-overexpressing SK-BR-3 breast cancer cells [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e], our results indicate that mollugin significantly inhibited NF-\u003ci\u003eκ\u003c/i\u003eB activation by reducing the level of phospho-I\u003ci\u003eκ\u003c/i\u003eB\u003ci\u003eα\u003c/i\u003e, leading to blockage of the I\u003ci\u003eκ\u003c/i\u003eB\u003ci\u003eα\u003c/i\u003e pathway in NF-\u003ci\u003eκ\u003c/i\u003eB activation in OSCCs. In addition, it was reported that mollugin significantly suppressed TNF-\u003ci\u003eα\u003c/i\u003e-induced NF-\u003ci\u003eκ\u003c/i\u003eB transcriptional activation in HT-29 human colonic epithelial cells [\u003ca href=\"#B13\"\u003e13\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eGenes involved in the proliferation, apoptosis, antiapoptosis, angiogenesis, and metastasis of cancer are regulated by NF-\u003ci\u003eκ\u003c/i\u003eB [\u003ca href=\"#B29\"\u003e29\u003c/a\u003e]\u003ci\u003e.\u003c/i\u003e Constitutive activation of NF-\u003ci\u003eκ\u003c/i\u003eB negatively regulates the proapoptotic functions of p53 by inducing the expression of an array of antiapoptotic genes, including Bcl-2 and Bcl-xL [\u003ca href=\"#B30\"\u003e30\u003c/a\u003e]. In our study, treatment with mollugin induced the downregulation of antiapoptotic Bcl-2 and Bcl-xL levels as well as the upregulation of apoptotic p53 and p21 levels in OSCCs. Another hallmark of OSCC behavior is their propensity for local invasion and metastasis. MMP-9 is frequently overexpressed in OSCCs and is dependent upon NF-\u003ci\u003eκ\u003c/i\u003eB for expression [\u003ca href=\"#B31\"\u003e31\u003c/a\u003e]. Adhesion molecules such as ICAM-1 are regulated by NF-\u003ci\u003eκ\u003c/i\u003eB and are essential for the adhesion of tumor cells to endothelial cells and thus mediate tumor cell metastasis [\u003ca href=\"#B32\"\u003e32\u003c/a\u003e]. Angiogenesis is important for tumor growth and progression. The development of angiogenesis is stimulated by cytokines and growth factors, and the expression of these cytokines and growth factors is correlated with the pathological neovascularization circumstances. Among these angiogenic factors, VEGF and FGF-2 are important angiogenic factors and essential for cancers [\u003ca href=\"#B33\"\u003e33\u003c/a\u003e]. In this study, we found that mollugin inhibited the expression of NF-\u003ci\u003eκ\u003c/i\u003eB-regulated gene products involved in invasion (MMP-9 and ICAM-1) and angiogenesis (FGF-2 and VEGF). Thus, our results demonstrate that mollugin inhibits NF-\u003ci\u003eκ\u003c/i\u003eB, leading to suppression of proliferation, invasion, and angiogenesis in OSCCs.\u003c/p\u003e\u003cp\u003eThe MAPKs are proline-directed Ser/Thr protein kinases that regulate many cellular processes, including cell proliferation and death. JNK and p38 are activated by cellular stress and are associated with apoptosis [\u003ca href=\"#B34\"\u003e34\u003c/a\u003e]. The involvement of ERK in the induction of apoptosis by quercetin, resveratrol, and taxol has been reported [\u003ca href=\"#B35\"\u003e35\u003c/a\u003e, \u003ca href=\"#B36\"\u003e36\u003c/a\u003e]. In the present study, phosphorylation of p38, ERK, and JNK was detected in mollugin-treated OSCCs, which is consistent with our previous reports that sappanchalcone may exert its effect on OSCCs through p38, ERK, and JNK activation [\u003ca href=\"#B9\"\u003e9\u003c/a\u003e]. Therefore, NF-\u003ci\u003eκ\u003c/i\u003eB regulation downstream of the MAPK (ERK1/2, p38, and JNK) pathways may be involved in mollugin-induced apoptosis in OSCCs. However, mollugin activated p38 MAPK in hippocampal and microglial cells [\u003ca href=\"#B15\"\u003e15\u003c/a\u003e] and ERK in HER2-overexpressing breast cancer cells [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. Therefore, MAPK can be differentially activated, and its involvement in apoptosis is highly context and model dependent. \u003c/p\u003e\u003cp\u003eThe role of HO-1 in tumor development is still not understood completely. Some recent reports demonstrate discordant or even completely contrasting results. Nevertheless, accumulating evidence indicates that HO-1 is expressed or overexpressed in a wide variety of human tumors and plays a critical role in the progression of neoplastic diseases [\u003ca href=\"#B37\"\u003e37\u003c/a\u003e]. For example, it has been shown that increased expression of HO-1 is associated with a higher rate of proliferation of various tumor cells [\u003ca href=\"#B37\"\u003e37\u003c/a\u003e, \u003ca href=\"#B38\"\u003e38\u003c/a\u003e], although opposite effects have been observed in breast cancer cells [\u003ca href=\"#B39\"\u003e39\u003c/a\u003e]. Furthermore, the increased basal level of HO-1 expression in tumor cells can be further elevated by chemotherapeutics or phytochemicals, such as curcumin, carnosol, and ILME [\u003ca href=\"#B8\"\u003e8\u003c/a\u003e, \u003ca href=\"#B22\"\u003e22\u003c/a\u003e, \u003ca href=\"#B23\"\u003e23\u003c/a\u003e]. Our results show that mollugin upregulated HO-1 expression in a time- and dose-dependent manner (data not shown), consistent with results in hippocampal and microglial cells [\u003ca href=\"#B15\"\u003e15\u003c/a\u003e]. We found that growth inhibition and apoptosis of OSCCs by mollugin was reversed in the presence of an HO-1 inhibitor. In addition, mollugin induced downregulation of antiapoptotic Bcl-2 and Bcl-xL levels, while upregulation of apoptotic p53 and p21 levels was reversed by SnPP in a dose-dependent manner. These results suggest that the growth inhibition and apoptosis-inducing effect of mollugin is mediated via HO-1 expression. \u003c/p\u003e\u003cp\u003eRegarding HO-1, Nrf-2 is a relatively well-known transcription factor [\u003ca href=\"#B40\"\u003e40\u003c/a\u003e]. In response to diverse HO-1 inducers, Nrf2 translocates from the cytosol to the nucleus where it binds to the antioxidant response element in the promoter region of the HO-1 gene [\u003ca href=\"#B41\"\u003e41\u003c/a\u003e]. In our study, mollugin also induced the translocation of Nrf-2 into the nucleus, as evidenced by Western blot. Furthermore, the results of this study demonstrate a correlation between apoptotic gene upregulation and the suppression of antiapoptotic genes of OSCCs to undergo mollugin-induced growth inhibition and apoptosis when Nrf-2 is knocked down. Based on these observations, it is reasonable to conclude that Nrf2 activation mediates mollugin-induced growth inhibition and apoptosis in OSCCs. \u003c/p\u003e\u003cp\u003eRedox-sensitive transcription factor (NF-\u003ci\u003eκ\u003c/i\u003eB, AP-1, and Nrf2) pathways are known to be important molecular targets in chemoprevention. Activation of Nrf2 and NF-\u003ci\u003eκ\u003c/i\u003eB involves regulation of protein kinases, which may induce their nuclear translocation [\u003ca href=\"#B42\"\u003e42\u003c/a\u003e]. It was previously shown that mollugin induced apoptosis via JNK in human Jurkat T cells [\u003ca href=\"#B14\"\u003e14\u003c/a\u003e]. In this regard, specific protein kinase inhibitors of PI3 K and ERK repressed Nrf2 phosphorylation and nuclear translocation of Nrf2 and NF-\u003ci\u003eκ\u003c/i\u003eB in HepG2 cells, as previously reported in different cell types [\u003ca href=\"#B43\"\u003e43\u003c/a\u003e, \u003ca href=\"#B44\"\u003e44\u003c/a\u003e]. The present results also suggest that the MAPK pathway plays a role in the mollugin-induced nuclear translocation of Nrf2 and NF-\u003ci\u003eκ\u003c/i\u003eB in HN4 and HN12 cells. A variety of anticarcinogenic phytochemicals suppress NF-\u003ci\u003eκ\u003c/i\u003eB signalling and activate the Nrf2-ARE pathway [\u003ca href=\"#B45\"\u003e45\u003c/a\u003e], suggesting that the suppression of NF-\u003ci\u003eκ\u003c/i\u003eB signalling and the activation of the Nrf2-ARE pathway may crosstalk with each other. Indeed, inhibition of NF-\u003ci\u003eκ\u003c/i\u003eB activation by phospholipid hydroperoxide glutathione peroxidase and 15-lipoxygenase is concomitant to upregulation of HO-1, probably via Nrf2 activation [\u003ca href=\"#B46\"\u003e46\u003c/a\u003e]. Thus, the findings support that the participation of NF-\u003ci\u003eκ\u003c/i\u003eB p65 in the negative regulation of Nrf2-ARE signalling, providing a new insight into a possible role of NF-\u003ci\u003eκ\u003c/i\u003eB in suppressing the expression of anti-inflammatory or antitumour genes [\u003ca href=\"#B47\"\u003e47\u003c/a\u003e]. Our results suggest that MAPK singnaling event mediates the link between NF-\u003ci\u003eκ\u003c/i\u003eB and Nrf2. Although the NF-\u003ci\u003eκ\u003c/i\u003eB pathway was inhibited by mollugin exposure, Nrf2 siRNA did not seem to participate in the translocation of NF-\u003ci\u003eκ\u003c/i\u003eB, suggesting that NF-\u003ci\u003eκ\u003c/i\u003eB and Nrf2 pathways might act in parallel in our \u003ci\u003ein vitro\u003c/i\u003e model. A summary of our results is shown in Figure \u003ca href=\"fig8/\" target=\"_blank\"\u003e8\u003c/a\u003e. \u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig8\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig8\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"210604.fig.008\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/210604/figures/210604.fig.008.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 8\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig8/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eSchematic diagram illustrating the Nrf2 pathway and other signaling pathways triggered by exposure to mollugin in in OSCCs. Mollugin treatment leads to the activation of the cellular stress-dependent signaling pathways mediated by MAPK activation (ERK, JNK, and p38) and subsequent transcription factor activation (NF-\u003ci\u003eκ\u003c/i\u003eB and Nrf2). Ultimately, these transcription factors result in altered gene expression to produce cytoprotective gene HO-1, allowing lead to apoptosis. \u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003eColectivelly, our results demonstrate for the first time that mollugin inhibits cell growth and induces apoptosis in OSCCs through the NF-\u003ci\u003eκ\u003c/i\u003eB/MAPK/Nrf2/HO-1 signaling pathway. Therefore, mollugin may have potential as a chemotherapeutic agent for OSCCs. The activities of mollugin against multiple antitumor targets should be studied intensively for further clinical application either as a natural agent alone or in combination with other commonly used chemotherapeutics. Further investigation of mollugin in animal models of OSCCS will contribute to additional understanding of its \u003ci\u003ein vivo\u003c/i\u003e activity toward malignant cells and its potential toxicity toward normal tissues.\u003c/p\u003e\u003ch4 id=\"authors’-contribution\"\u003eAuthors’ Contribution\u003c/h4\u003e\u003cp\u003eY.-M. Lee and Q.-S. Auh contributed equally to this work as 1st author. \u003c/p\u003e\u003ch4 id=\"acknowledgments\"\u003eAcknowledgments\u003c/h4\u003e\u003cp\u003eThis work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (no. 2012R1A5A2051384). \u003c/p\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"references\" id=\"references\"\u003eReferences\u003c/h4\u003e\u003col\u003e\u003cli id=\"B1\"\u003eH. Schliephake, “Prognostic relevance of molecular markers of oral cancer\u0026#x2014;a review,” \u003ci\u003eInternational Journal of Oral and Maxillofacial Surgery\u003c/i\u003e, vol. 32, no. 3, pp. 233–245, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1054/ijom.2002.0383\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Prognostic%20relevance%20of%20molecular%20markers%20of%20oral%20cancer—a%20review\u0026author=H. Schliephake\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B2\"\u003eE. Yamachika, T. Habte, and D. Oda, “Artemisinin: an alternative treatment for oral squamous cell carcinoma,” \u003ci\u003eAnticancer Research\u003c/i\u003e, vol. 24, no. 4, pp. 2153–2160, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Artemisinin:%20an%20alternative%20treatment%20for%20oral%20squamous%20cell%20carcinoma\u0026author=E. Yamachika\u0026author=T. Habte\u0026author=\u0026author=D. Oda\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B3\"\u003eJ. McCann, “Texas center studies research alternative treatments,” \u003ci\u003eJournal of the National Cancer Institute\u003c/i\u003e, vol. 89, no. 20, pp. 1485–1486, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Texas%20center%20studies%20research%20alternative%20treatments\u0026author=J. McCann\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B4\"\u003eJ. Lee, H. J. Lee, J. D. Park et al., “Anti-cancer activity of highly purified sulfur in immortalized and malignant human oral keratinocytes,” \u003ci\u003eToxicology in Vitro\u003c/i\u003e, vol. 22, no. 1, pp. 87–95, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.tiv.2007.08.016\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Anti-cancer%20activity%20of%20highly%20purified%20sulfur%20in%20immortalized%20and%20malignant%20human%20oral%20keratinocytes\u0026author=J. Lee\u0026author=H. J. Lee\u0026author=J. D. Park et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B5\"\u003eE. C. Kim, Y. S. Hwang, H. J. Lee et al., “Caesalpinia sappan induces cell death by increasing the expression of p53 and p21\u003csup\u003eWAF1/CIP1\u003c/sup\u003e in head and neck cancer cells,” \u003ci\u003eThe American Journal of Chinese Medicine\u003c/i\u003e, vol. 33, no. 3, pp. 405–414, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1142/S0192415X05003016\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Caesalpinia%20sappan%20induces%20cell%20death%20by%20increasing%20the%20expression%20of%20p53%20and%20p21WAF1/CIP1%20in%20head%20and%20neck%20cancer%20cells\u0026author=E. C. Kim\u0026author=Y. S. Hwang\u0026author=H. J. Lee et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B6\"\u003eH. J. Lee, D. H. Son, S. K. Lee et al., “Extract of Coptidis rhizoma induces cytochrome-c dependent apoptosis in immortalized and malignant human oral keratinocytes,” \u003ci\u003ePhytotherapy Research\u003c/i\u003e, vol. 20, no. 9, pp. 773–779, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ptr.1956\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Extract%20of%20Coptidis%20rhizoma%20induces%20cytochrome-c%20dependent%20apoptosis%20in%20immortalized%20and%20malignant%20human%20oral%20keratinocytes\u0026author=H. J. Lee\u0026author=D. H. Son\u0026author=S. K. Lee et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B7\"\u003eY. G. Yun, B. H. Jeon, J. H. Lee et al., “Verticinone induces cell cycle arrest and apoptosis in immortalized and malignant human oral keratinocytes,” \u003ci\u003ePhytotherapy Research\u003c/i\u003e, vol. 22, no. 3, pp. 416–423, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ptr.2345\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Verticinone%20induces%20cell%20cycle%20arrest%20and%20apoptosis%20in%20immortalized%20and%20malignant%20human%20oral%20keratinocytes\u0026author=Y. G. Yun\u0026author=B. H. Jeon\u0026author=J. H. Lee et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B8\"\u003eY. M. Lee, G. S. Jeong, H. D. Lim, R. B. An, Y. C. Kim, and E. C. Kim, “Isoliquiritigenin 2\u0026#x2032;-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1,” \u003ci\u003eToxicology in Vitro\u003c/i\u003e, vol. 24, no. 3, pp. 776–782, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.tiv.2009.12.024\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Isoliquiritigenin%202′-methyl%20ether%20induces%20growth%20inhibition%20and%20apoptosis%20in%20oral%20cancer%20cells%20via%20heme%20oxygenase-1\u0026author=Y. M. Lee\u0026author=G. S. Jeong\u0026author=H. D. Lim\u0026author=R. B. An\u0026author=Y. C. Kim\u0026author=\u0026author=E. C. Kim\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B9\"\u003eY. M. Lee, Y. C. Kim, E. C. Kim et al., “Mechanism of sappanchalcone-induced growth inhibition and apoptosis in human oral cancer cells,” \u003ci\u003eToxicology in Vitro\u003c/i\u003e, vol. 25, no. 8, pp. 1782–1788, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.tiv.2011.09.009\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mechanism%20of%20sappanchalcone-induced%20growth%20inhibition%20and%20apoptosis%20in%20human%20oral%20cancer%20cells\u0026author=Y. M. Lee\u0026author=Y. C. Kim\u0026author=E. C. Kim et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B10\"\u003eJ. K. Son, S. J. Jung, M. H. M. H. Woo et al., “Anticancer constituents from the roots of \u003ci\u003eRubia cordifolia\u003c/i\u003e L.,” \u003ci\u003eChemical Pharmacology Bulletin\u003c/i\u003e, vol. 56, no. 2, pp. 213–216, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1248/cpb.56.213\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Anticancer%20constituents%20from%20the%20roots%20of%20Rubia%20cordifolia%20L.\u0026author=J. K. Son\u0026author=S. J. Jung\u0026author=M. H. M. H. Woo et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B11\"\u003eL. C. Chang, D. Chavez, J. J. Gills, H. H. S. Fong, J. M. Pezzuto, and A. D. Kinghorn, “Rubiasins A-C, new anthracene derivatives from the roots and stems of \u003ci\u003eRubia cordifolia\u003c/i\u003e,” \u003ci\u003eTetrahedron Letters\u003c/i\u003e, vol. 41, no. 37, pp. 7157–7162, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Rubiasins%20A-C,%20new%20anthracene%20derivatives%20from%20the%20roots%20and%20stems%20of%20Rubia%20cordifolia\u0026author=L. C. Chang\u0026author=D. Chavez\u0026author=J. J. Gills\u0026author=H. H. S. Fong\u0026author=J. M. Pezzuto\u0026author=\u0026author=A. D. Kinghorn\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B12\"\u003eW. P. Tse, C. H. K. Cheng, C. T. Che, M. Zhao, and Z. X. Lin, “Induction of apoptosis underlies the Radix Rubiae-mediated anti-proliferative action on human epidermal keratinocytes: implications for psoriasis treatment,” \u003ci\u003eInternational Journal of Molecular Medicine\u003c/i\u003e, vol. 20, no. 5, pp. 663–672, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Induction%20of%20apoptosis%20underlies%20the%20Radix%20Rubiae-mediated%20anti-proliferative%20action%20on%20human%20epidermal%20keratinocytes:%20implications%20for%20psoriasis%20treatment\u0026author=W. P. Tse\u0026author=C. H. K. Cheng\u0026author=C. T. Che\u0026author=M. Zhao\u0026author=\u0026author=Z. X. Lin\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B13\"\u003eK. J. Kim, J. S. Lee, M. K. Kwak et al., “Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB activation,” \u003ci\u003eEuropean Journal of Pharmacology\u003c/i\u003e, vol. 622, no. 1-3, pp. 52–57, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ejphar.2009.09.008\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Anti-inflammatory%20action%20of%20mollugin%20and%20its%20synthetic%20derivatives%20in%20HT-29%20human%20colonic%20epithelial%20cells%20is%20mediated%20through%20inhibition%20of%20NF-κB%20activation\u0026author=K. J. Kim\u0026author=J. S. Lee\u0026author=M. K. Kwak et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B14\"\u003eS. M. Kim, H. S. Park, D. Y. Jun et al., “Mollugin induces apoptosis in human Jurkat T cells through endoplasmic reticulum stress-mediated activation of JNK and caspase-12 and subsequent activation of mitochondria-dependent caspase cascade regulated by Bcl-xL,” \u003ci\u003eToxicology and Applied Pharmacology\u003c/i\u003e, vol. 241, no. 2, pp. 210–220, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.taap.2009.08.024\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mollugin%20induces%20apoptosis%20in%20human%20Jurkat%20T%20cells%20through%20endoplasmic%20reticulum%20stress-mediated%20activation%20of%20JNK%20and%20caspase-12%20and%20subsequent%20activation%20of%20mitochondria-dependent%20caspase%20cascade%20regulated%20by%20Bcl-xL\u0026author=S. M. Kim\u0026author=H. S. Park\u0026author=D. Y. Jun et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B15\"\u003eG. S. Jeong, D. S. Lee, D. C. Kim et al., “Neuroprotective and anti-inflammatory effects of mollugin via up-regulation of heme oxygenase-1 in mouse hippocampal and microglial cells,” \u003ci\u003eEuropean Journal of Pharmacology\u003c/i\u003e, vol. 654, no. 3, pp. 226–234, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ejphar.2010.12.027\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Neuroprotective%20and%20anti-inflammatory%20effects%20of%20mollugin%20via%20up-regulation%20of%20heme%20oxygenase-1%20in%20mouse%20hippocampal%20and%20microglial%20cells\u0026author=G. S. Jeong\u0026author=D. S. Lee\u0026author=D. C. Kim et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B16\"\u003eD. Y. Jun, C. R. Han, M. S. Choi, M. A. Bae, M. H. Woo, and Y. H. Kim, “Effect of mollugin on apoptosis and adipogenesis of 3T3-L1 preadipocytes,” \u003ci\u003ePhytotherapy Research\u003c/i\u003e, vol. 25, no. 5, pp. 724–731, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ptr.3329\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effect%20of%20mollugin%20on%20apoptosis%20and%20adipogenesis%20of%203T3-L1%20preadipocytes\u0026author=D. Y. Jun\u0026author=C. R. Han\u0026author=M. S. Choi\u0026author=M. A. Bae\u0026author=M. H. Woo\u0026author=\u0026author=Y. H. Kim\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B17\"\u003eM. T. Do, Y. P. Hwang, H. G. Kim, M. Na, and H. G. Jeong, “Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells through modulation of a HER2/Akt/SREBP-1c signaling,” \u003ci\u003eJournal of Cell Physiology\u003c/i\u003e, vol. 228, no. 5, pp. 1087–1097, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mollugin%20inhibits%20proliferation%20and%20induces%20apoptosis%20by%20suppressing%20fatty%20acid%20synthase%20in%20HER2-overexpressing%20cancer%20cells%20through%20modulation%20of%20a%20HER2/Akt/SREBP-1c%20signaling\u0026author=M. T. Do\u0026author=Y. P. Hwang\u0026author=H. G. Kim\u0026author=M. Na\u0026author=\u0026author=H. G. Jeong\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B18\"\u003eS. K. Lee, H. I. Choi, Y. S. Yang et al., “Nitric oxide modulates osteoblastic differentiation with heme oxygenase-1 via the mitogen activated protein kinase and nuclear factor-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB pathways in human periodontal ligament cells,” \u003ci\u003eBiological and Pharmaceutical Bulletin\u003c/i\u003e, vol. 32, no. 8, pp. 1328–1334, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1248/bpb.32.1328\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Nitric%20oxide%20modulates%20osteoblastic%20differentiation%20with%20heme%20oxygenase-1%20via%20the%20mitogen%20activated%20protein%20kinase%20and%20nuclear%20factor-κB%20pathways%20in%20human%20periodontal%20ligament%20cells\u0026author=S. K. Lee\u0026author=H. I. Choi\u0026author=Y. S. Yang et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B19\"\u003eS. K. Lee, S. H. Pi, S. H. Kim et al., “Substance P regulates macrophage inflammatory protein 3\u003ci\u003e\u0026#x3b1;\u003c/i\u003e/chemokine C-C ligand 20 (CCL20) with heme oxygenase-1 in human periodontal ligament cells,” \u003ci\u003eClinical and Experimental Immunology\u003c/i\u003e, vol. 150, no. 3, pp. 567–575, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1365-2249.2007.03514.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Substance%20P%20regulates%20macrophage%20inflammatory%20protein%203α/chemokine%20C-C%20ligand%2020%20(CCL20)%20with%20heme%20oxygenase-1%20in%20human%20periodontal%20ligament%20cells\u0026author=S. K. Lee\u0026author=S. H. Pi\u0026author=S. H. Kim et al.\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B20\"\u003eS. H. Pi, S. C. Kim, H. T. Kim, H. J. Lee, S. K. Lee, and E. C. Kim, “Defense mechanism of heme oxygenase-1 against cytotoxic and receptor activator of nuclear factor-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB ligand inducing effects of hydrogen peroxide in human periodontal ligament cells,” \u003ci\u003eJournal of Periodontal Research\u003c/i\u003e, vol. 42, no. 4, pp. 331–339, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1600-0765.2006.00953.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Defense%20mechanism%20of%20heme%20oxygenase-1%20against%20cytotoxic%20and%20receptor%20activator%20of%20nuclear%20factor-κB%20ligand%20inducing%20effects%20of%20hydrogen%20peroxide%20in%20human%20periodontal%20ligament%20cells\u0026author=S. H. Pi\u0026author=S. C. Kim\u0026author=H. T. Kim\u0026author=H. J. Lee\u0026author=S. K. Lee\u0026author=\u0026author=E. C. Kim\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B21\"\u003eK. D. Poss and S. Tonegawa, “Reduced stress defense in heme oxygenase 1-deficient cells,” \u003ci\u003eProceedings of the National Academy of Sciences of the United States of America\u003c/i\u003e, vol. 94, no. 20, pp. 10925–10930, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1073/pnas.94.20.10925\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Reduced%20stress%20defense%20in%20heme%20oxygenase%201-deficient%20cells\u0026author=K. D. Poss \u0026author=S. Tonegawa\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B22\"\u003eE. Balogun, M. Hoque, P. Gong et al., “Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element,” \u003ci\u003eBiochemical Journal\u003c/i\u003e, vol. 371, no. 3, pp. 887–895, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1042/BJ20021619\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Curcumin%20activates%20the%20haem%20oxygenase-1%20gene%20via%20regulation%20of%20Nrf2%20and%20the%20antioxidant-responsive%20element\u0026author=E. Balogun\u0026author=M. Hoque\u0026author=P. Gong et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B23\"\u003eD. Martin, A. I. Rojo, M. Salinas et al., “Regulation of heme Oxygenase-1 expression through the phosphatidylinositol 3-kinase/akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol,” \u003ci\u003eThe Journal of Biological Chemistry\u003c/i\u003e, vol. 279, no. 10, pp. 8919–8929, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M309660200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Regulation%20of%20heme%20Oxygenase-1%20expression%20through%20the%20phosphatidylinositol%203-kinase/akt%20pathway%20and%20the%20Nrf2%20transcription%20factor%20in%20response%20to%20the%20antioxidant%20phytochemical%20carnosol\u0026author=D. Martin\u0026author=A. I. Rojo\u0026author=M. Salinas et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B24\"\u003eA. A. Anwar, F. Y. L. Li, D. S. Leake, T. Ishii, G. E. Mann, and R. C. M. Siow, “Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2,” \u003ci\u003eFree Radical Biology and Medicine\u003c/i\u003e, vol. 39, no. 2, pp. 227–236, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.freeradbiomed.2005.03.012\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Induction%20of%20heme%20oxygenase%201%20by%20moderately%20oxidized%20low-density%20lipoproteins%20in%20human%20vascular%20smooth%20muscle%20cells:%20role%20of%20mitogen-activated%20protein%20kinases%20and%20Nrf2\u0026author=A. A. Anwar\u0026author=F. Y. L. Li\u0026author=D. S. Leake\u0026author=T. Ishii\u0026author=G. E. Mann\u0026author=\u0026author=R. C. M. Siow\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B25\"\u003eM. Cardinali, H. Pietraszkiewicz, J. F. Ensley, and K. C. Robbins, “Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies,” \u003ci\u003eInternational Journal of Cancer\u003c/i\u003e, vol. 61, no. 1, pp. 98–103, 1995. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ijc.2910610117\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Tyrosine%20phosphorylation%20as%20a%20marker%20for%20aberrantly%20regulated%20growth-promoting%20pathways%20in%20cell%20lines%20derived%20from%20head%20and%20neck%20malignancies\u0026author=M. Cardinali\u0026author=H. Pietraszkiewicz\u0026author=J. F. Ensley\u0026author=\u0026author=K. C. Robbins\u0026publication_year=1995\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B26\"\u003eS. H. Pi, S. K. Lee, Y. S. Hwang, M. G. Choi, S. K. Lee, and E. C. Kim, “Differential expression of periodontal ligament-specific markers and osteogenic differentiation in human papilloma virus 16-immortalized human gingival fibroblasts and periodontal ligament cells,” \u003ci\u003eJournal of Periodontal Research\u003c/i\u003e, vol. 42, no. 2, pp. 104–113, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1600-0765.2006.00921.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Differential%20expression%20of%20periodontal%20ligament-specific%20markers%20and%20osteogenic%20differentiation%20in%20human%20papilloma%20virus%2016-immortalized%20human%20gingival%20fibroblasts%20and%20periodontal%20ligament%20cells\u0026author=S. H. Pi\u0026author=S. K. Lee\u0026author=Y. S. Hwang\u0026author=M. G. Choi\u0026author=S. K. Lee\u0026author=\u0026author=E. C. Kim\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B27\"\u003eS. Ghosh and M. Karin, “Missing pieces in the NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB puzzle,” \u003ci\u003eCell\u003c/i\u003e, vol. 109, pp. S81–S96, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Missing%20pieces%20in%20the%20NF-κB%20puzzle\u0026author=S. Ghosh \u0026author=M. Karin\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B28\"\u003eY. Suh, F. Afaq, J. J. Johnson, and H. Mukhtar, “A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-signaling pathways,” \u003ci\u003eCarcinogenesis\u003c/i\u003e, vol. 30, no. 2, pp. 300–307, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/carcin/bgn269\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20plant%20flavonoid%20fisetin%20induces%20apoptosis%20in%20colon%20cancer%20cells%20by%20inhibition%20of%20COX2%20and%20Wnt/EGFR/NF-κB-signaling%20pathways\u0026author=Y. Suh\u0026author=F. Afaq\u0026author=J. J. Johnson\u0026author=\u0026author=H. Mukhtar\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B29\"\u003eB. B. Aggarwal, “Nuclear factor \u003ci\u003e\u0026#x3ba;\u003c/i\u003eB, the enemy within,” \u003ci\u003eCancer Cell\u003c/i\u003e, vol. 6, no. 3, pp. 203–208, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ccr.2004.09.003\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Nuclear%20factor%20κB,%20the%20enemy%20within\u0026author=B. B. Aggarwal\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B30\"\u003eG. Sethi, B. Sung, and B. B. Aggarwal, “Nuclear factor-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB activation: from bench to bedside,” \u003ci\u003eExperimental Biology and Medicine\u003c/i\u003e, vol. 233, no. 1, pp. 21–31, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3181/0707-MR-196\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Nuclear%20factor-κB%20activation:%20from%20bench%20to%20bedside\u0026author=G. Sethi\u0026author=B. Sung\u0026author=\u0026author=B. B. Aggarwal\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B31\"\u003eM. Bond, R. P. Fabunmi, A. H. Baker, and A. C. Newby, “Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB,” \u003ci\u003eFEBS Letters\u003c/i\u003e, vol. 435, no. 1, pp. 29–34, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0014-5793(98)01034-5\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Synergistic%20upregulation%20of%20metalloproteinase-9%20by%20growth%20factors%20and%20inflammatory%20cytokines:%20an%20absolute%20requirement%20for%20transcription%20factor%20NF-κB\u0026author=M. Bond\u0026author=R. P. Fabunmi\u0026author=A. H. Baker\u0026author=\u0026author=A. C. Newby\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B32\"\u003eC. Lawson, M. Ainsworth, M. Yacoub, and M. Rose, “Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-independent mechanism,” \u003ci\u003eJournal of Immunology\u003c/i\u003e, vol. 162, no. 5, pp. 2990–2996, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Ligation%20of%20ICAM-1%20on%20endothelial%20cells%20leads%20to%20expression%20of%20VCAM-1%20via%20a%20nuclear%20factor-κB-independent%20mechanism\u0026author=C. Lawson\u0026author=M. Ainsworth\u0026author=M. Yacoub\u0026author=\u0026author=M. Rose\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B33\"\u003eR. S. Kerbel, “Tumor angiogenesis: past, present and the near future,” \u003ci\u003eCarcinogenesis\u003c/i\u003e, vol. 21, no. 3, pp. 505–515, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Tumor%20angiogenesis:%20past,%20present%20and%20the%20near%20future\u0026author=R. S. Kerbel\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B34\"\u003eD. Xiao, S. Choi, D. E. Johnson et al., “Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2,” \u003ci\u003eOncogene\u003c/i\u003e, vol. 23, no. 33, pp. 5594–5606, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/sj.onc.1207747\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Diallyl%20trisulfide-induced%20apoptosis%20in%20human%20prostate%20cancer%20cells%20involves%20c-Jun%20N-terminal%20kinase%20and%20extracellular-signal%20regulated%20kinase-mediated%20phosphorylation%20of%20Bcl-2\u0026author=D. Xiao\u0026author=S. Choi\u0026author=D. E. Johnson et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B35\"\u003eQ. B. She, A. M. Bode, W. Y. Ma, N. Y. Chen, and Z. Dong, “Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase,” \u003ci\u003eCancer Research\u003c/i\u003e, vol. 61, no. 4, pp. 1604–1610, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Resveratrol-induced%20activation%20of%20p53%20and%20apoptosis%20is%20mediated%20by%20extracellular-signal-regulated%20protein%20kinases%20and%20p38%20kinase\u0026author=Q. B. She\u0026author=A. M. Bode\u0026author=W. Y. Ma\u0026author=N. Y. Chen\u0026author=\u0026author=Z. Dong\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B36\"\u003eA. Brozovic, G. Fritz, M. Christmann et al., “Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance,” \u003ci\u003eInternational Journal of Cancer\u003c/i\u003e, vol. 112, no. 6, pp. 974–985, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/ijc.20522\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Long-term%20activation%20of%20SAPK/JNK,%20p38%20kinase%20and%20fas-L%20expression%20by%20cisplatin%20is%20attenuated%20in%20human%20carcinoma%20cells%20that%20acquired%20drug%20resistance\u0026author=A. Brozovic\u0026author=G. Fritz\u0026author=M. Christmann et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B37\"\u003eA. Jozkowicz, H. Was, and J. Dulak, “Heme oxygenase-1 in tumors: is it a false friend?” \u003ci\u003eAntioxidants and Redox Signaling\u003c/i\u003e, vol. 9, no. 12, pp. 2099–2117, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/ars.2007.1659\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Heme%20oxygenase-1%20in%20tumors:%20is%20it%20a%20false%20friend?\u0026author=A. Jozkowicz\u0026author=H. Was\u0026author=\u0026author=J. Dulak\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B38\"\u003eP. O. Berberat, Z. Dambrauskas, A. Gulbinas et al., “Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment,” \u003ci\u003eClinical Cancer Research\u003c/i\u003e, vol. 11, no. 10, pp. 3790–3798, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1158/1078-0432.CCR-04-2159\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20heme%20oxygenase-1%20increases%20responsiveness%20of%20pancreatic%20cancer%20cells%20to%20anticancer%20treatment\u0026author=P. O. Berberat\u0026author=Z. Dambrauskas\u0026author=A. Gulbinas et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B39\"\u003eM. Hill, V. Pereira, C. Chauveau et al., “Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase,” \u003ci\u003eFASEB Journal\u003c/i\u003e, vol. 19, no. 14, pp. 1957–1968, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1096/fj.05-3875com\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Heme%20oxygenase-1%20inhibits%20rat%20and%20human%20breast%20cancer%20cell%20proliferation:%20mutual%20cross%20inhibition%20with%20indoleamine%202,3-dioxygenase\u0026author=M. Hill\u0026author=V. Pereira\u0026author=C. Chauveau et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B40\"\u003eJ. Alam and J. L. Cook, “Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway,” \u003ci\u003eCurrent Pharmaceutical Design\u003c/i\u003e, vol. 9, no. 30, pp. 2499–2511, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.2174/1381612033453730\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Transcriptional%20regulation%20of%20the%20heme%20oxygenase-1%20gene%20via%20the%20stress%20response%20element%20pathway\u0026author=J. Alam \u0026author=J. L. Cook\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B41\"\u003eT. Ishii, K. Itoh, S. Takahashi et al., “Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages,” \u003ci\u003eThe Journal of Biological Chemistry\u003c/i\u003e, vol. 275, no. 21, pp. 16023–16029, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.275.21.16023\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Transcription%20factor%20Nrf2%20coordinately%20regulates%20a%20group%20of%20oxidative%20stress-inducible%20genes%20in%20macrophages\u0026author=T. Ishii\u0026author=K. Itoh\u0026author=S. Takahashi et al.\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B42\"\u003eJ. Pi, Y. Bai, J. M. Reece et al., “Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2,” \u003ci\u003eFree Radical Biology and Medicine\u003c/i\u003e, vol. 42, no. 12, pp. 1797–1806, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.freeradbiomed.2007.03.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Molecular%20mechanism%20of%20human%20Nrf2%20activation%20and%20degradation:%20role%20of%20sequential%20phosphorylation%20by%20protein%20kinase%20CK2\u0026author=J. Pi\u0026author=Y. Bai\u0026author=J. M. Reece et al.\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B43\"\u003eT. Nguyen, P. J. Sherratt, H. C. Huang, C. S. Yang, and C. B. Pickett, “Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element: degradation of Nrf2 by the 26 S proteasome,” \u003ci\u003eThe Journal of Biological Chemistry\u003c/i\u003e, vol. 278, no. 7, pp. 4536–4541, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M207293200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Increased%20protein%20stability%20as%20a%20mechanism%20that%20enhances%20Nrf2-mediated%20transcriptional%20activation%20of%20the%20antioxidant%20response%20element:%20degradation%20of%20Nrf2%20by%20the%2026%20S%20proteasome\u0026author=T. Nguyen\u0026author=P. J. Sherratt\u0026author=H. C. Huang\u0026author=C. S. Yang\u0026author=\u0026author=C. B. Pickett\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B44\"\u003eG. Sethi, B. Sung, B. B. Aggarwal et al., “Nuclear factor-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB activation: from bench to bedside,” \u003ci\u003eExperimental Biology and Medicine\u003c/i\u003e, vol. 6, no. 5, pp. 515–524, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Nuclear%20factor-κB%20activation:%20from%20bench%20to%20bedside\u0026author=G. Sethi\u0026author=B. Sung\u0026author=B. B. Aggarwal et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B45\"\u003eJ. H. Lim, H. S. Park, J. K. Choi, I. S. Lee, and J. C. Hyun, “Isoorientin induces Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling,” \u003ci\u003eArchives of Pharmacal Research\u003c/i\u003e, vol. 30, no. 12, pp. 1590–1598, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Isoorientin%20induces%20Nrf2%20pathway-driven%20antioxidant%20response%20through%20phosphatidylinositol%203-kinase%20signaling\u0026author=J. H. Lim\u0026author=H. S. Park\u0026author=J. K. Choi\u0026author=I. S. Lee\u0026author=\u0026author=J. C. Hyun\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B46\"\u003eW. Li, T. O. Khor, C. Xu et al., “Activation of Nrf2-antioxidant signaling attenuates NF\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB-inflammatory response and elicits apoptosis,” \u003ci\u003eBiochemical Pharmacology\u003c/i\u003e, vol. 76, no. 11, pp. 1485–1489, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.bcp.2008.07.017\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Activation%20of%20Nrf2-antioxidant%20signaling%20attenuates%20NFκB-inflammatory%20response%20and%20elicits%20apoptosis\u0026author=W. Li\u0026author=T. O. Khor\u0026author=C. Xu et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B47\"\u003eA. Banning and R. Brigelius-Floh\u0026#xe9;, “NF-\u003ci\u003e\u0026#x3ba;\u003c/i\u003eB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression,” \u003ci\u003eAntioxidants and Redox Signaling\u003c/i\u003e, vol. 7, no. 7-8, pp. 889–899, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/ars.2005.7.889\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=NF-κB,%20Nrf2,%20and%20HO-1%20interplay%20in%20redox-regulated%20VCAM-1%20expression\u0026author=A. Banning \u0026author=R. Brigelius-Flohé\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"copyright\" id=\"copyright\"\u003eCopyright\u003c/h4\u003e\u003cp\u003eCopyright \u0026#xa9; 2013 Young-Man Lee et al. This is an open access article distributed under the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/3.0/\"\u003e  Creative Commons Attribution License\u003c/a\u003e, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\u003c/p\u003e\u003c/div\u003e","section_links":[{"hash":"abstract","title":"Abstract"},{"hash":"introduction","title":"Introduction"},{"hash":"materials-and-methods","title":"Materials and Methods"},{"hash":"results","title":"Results"},{"hash":"discussion","title":"Discussion"},{"hash":"authors’-contribution","title":"Authors’ Contribution"},{"hash":"acknowledgments","title":"Acknowledgments"},{"hash":"references","title":"References"},{"hash":"copyright","title":"Copyright"}],"style":"","block_links":[{"title":"PDF","type":"PDF","url":"downloads.hindawi.com/journals/bmri/2013/210604.pdf","childrens":[]},{"title":"Download Reference","type":"RIS","url":"/journals/bmri/2013/210604.ris","childrens":[]},{"title":"Download other formats","type":"","url":"","childrens":[{"title":"ePub","type":"ePUB","url":"downloads.hindawi.com/journals/bmri/2013/210604.epub"},{"title":"XML","type":"XML","url":"downloads.hindawi.com/journals/bmri/2013/210604.xml"}]}],"articleStats":{"no_of_views":2944,"no_of_downloads":1703,"no_of_citations":42},"relatedArticleChildren":{"articles":[]},"alertMessage":{"HIGH":["This article has been \u003cb\u003eRetracted\u003c/b\u003e. To view the \n  To view the article details, please click the ‘Retraction’ tab above."],"MODERATE":[],"LOW":["A \u003cb\u003eErratum\u003c/b\u003e for this article has been published.\n  To view the article details, please click the ‘Erratum’ tab above."]}},"year":"2013","statusCode":false},"currentUrl":"https://www.hindawi.com/journals/bmri/2013/210604/","siteUrl":"https://www.hindawi.com","currentPath":"/journals/bmri/2013/210604/","host":"www.hindawi.com"},"page":"/journal_article","query":{},"buildId":"cpr9K8AjZYaP4CWVbtn5c","dynamicBuildId":false,"assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c"}</script><script async="" id="__NEXT_PAGE__/journal_article" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js"></script><script async="" id="__NEXT_PAGE__/_app" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js"></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" async=""></script><script src="https://www.hindawi.com/static/themes/hindawi/base.js"></script></body></html>